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1. Respiratory muscle weakness and critical illness
Mechanical ventilation in a patient with acute respiratory failure is a life saving 
intervention. In most of these patients mechanical ventilation can be discontinued 
as soon as the underlying reasons for acute respiratory failure have been 
resolved. However, in 20 – 30 % of ventilated critical ill patients, weaning from 
mechanical ventilation is difficult [1, 2]. In a substantial proportion of patients on 
the ventilator respiratory muscle weakness develops, which is associated with 
difficult weaning [3]. It should be noted that prolonged weaning is associated 
with adverse clinical outcome, including mortality [3-8]. In addition to prolonged 
weaning, respiratory muscle weakness is associated with increased hospital length 
of stay [8]. Respiratory muscle weakness develops rapidly in patients on controlled 
mechanical ventilation. For instance, Jaber and colleagues demonstrated that 
pressure generation of the diaphragm is decreased by ±25% after 3-4 days of 
controlled mechanical ventilation [9]. More recently it was demonstrated that 
high level of ventilator assist is associated with the development of diaphragm 
muscle atrophy and dysfunction [10]. 
Since respiratory weakness is associated with prolonged mechanical ventilation, 
it has a tremendous financial impact on societies [3, 8, 11, 12]. Off all patients 
receiving mechanical ventilation, 6% of those patients receive prolonged 
mechanical ventilation (>7 days), but consume about a third of intensive care unit 
resources [3, 13]. In the United States in 2008, approximately 377.000 critically 
ill patients required ventilator support for more then 4 days and this is expected 
to increase up to 625.000 in 2020 [14]. This indicates that society resources for 
treatment of these critically ill patients are about to double in a time frame of 12 
years in Western society.  Since respiratory muscle weakness plays a key role in 
difficult weaning, it is of vital importance towards patients, health care providers 
and societies to further unravel pathophysiology of respiratory muscle weakness 
in critical illness and explore potential therapies. 
2. Origin of respiratory muscle weakness in critical illness
The pathophysiology of respiratory muscle weakness in the critically ill is 
incompletely understood, but proposed to be multifactorial [2, 15, 16]. 
Theoretically, it may result from modifications at any point between the respiratory 
centres in the brainstem and muscle contractile proteins. At the muscle level, 
weakness may result from loss of tissue (atrophy) or dysfunction of the remaining 
muscle fibers. Indeed, in critically ill patients both atrophy and muscle fiber 
dysfunction have been reported as summarized in figure 1 and further discussed 
below.
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Figure 1 Proposed mechanisms of respiratory muscle weakness (as published in chapter 7).
2.1 Respiratory muscle atrophy 
To maintain muscle mass, proteolysis and protein synthesis should be balanced 
[15]. Either an increase in proteolysis or decrease in protein synthesis will result 
in atrophy. It has been demonstrated that in patients on controlled mechanical 
ventilation respiratory muscle atrophy develops rapidly [17]. Today, there are 
data, which demonstrate that indeed both proteolysis is increased and protein 
synthesis is decreased in the diaphragm of ventilated ICU patients. A central 
pathway in the development of this respiratory muscle atrophy is the ubiquitin-
proteasome pathway (figure 2) [17, 18].
This pathway can be triggered by oxidative stress [19, 20], calpains and caspases [9, 
19, 21], decrease in p-AKT [22, 23] and cytokines [24]. The ubiquitin-proteasome 
is the main system of proteolysis for non-lysosomal break down of cell proteins 
in eukaryotic cells [25]. In this pathway, released myofibril proteins are labelled 
by adding ubiquitin chains by E3-ligases MuRF-1 and MAFbx. With these labels 
proteins are recognized for further degradation by the proteasome complex [25, 
26]. Large skeletal muscle proteins like actomyosin have to be cleaved from the 
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sarcomere before further breakdown is possible in the ubiquitin-proteasome 
pathway [27]. Caspase-3 [21, 27, 28] and calpains [9, 29] have been suggested to 
play a prominent role in cleaving muscle proteins from the sarcomere. 
Another important regulating pathway in skeletal muscle is the autophagy-
lysosome pathway [24]. This autophagy-lysosome pathway is continuously active 
in cells and can be up regulated under certain conditions, such as oxidative stress 
or mechanical ventilation [30, 31]. 
Despite the clues that the autophagy-lysosome pathway and the ubiquitin-
pathway are activated in skeletal muscles during critical illness, it is unknown to 
what extent proteolysis contributes to a reduced force-generating capacity of the 
diaphragm muscle. 
As mentioned earlier, decreased protein synthesis may contribute to the 
development of atrophy. In ventilated animals, after only six hours of controlled 
mechanical ventilation contractile protein synthesis is reduced [32]. In healthy 
volunteers, LPS infusion markedly decreased skeletal muscle protein synthesis 
[33]. Moreover, in skeletal muscle of critical ill patients contractile protein 
synthesis was found to be reduced [34, 35], suggesting a role for reduced protein 
synthesis in the development of respiratory muscle weakness in the critically ill.
Figure 2  Schematic view of ubiquitin-proteasome pathway.
Adapted from Jackman, American Journal of Physiology, Cell Physiology 2004.
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2.2 Oxidative and nitrosative stress
Oxidative stress has been shown to modify and damage respiratory muscle 
proteins [36]. These modifications may result in contractile protein dysfunction 
[37]. Also, damaged contractile proteins are prone for degradation [26]. Thereby 
oxidative stress can cause respiratory muscle atrophy during mechanical 
ventilation [19, 20] and endotoxemia [36]. One of the proteolytic pathways that 
is activated by oxidative stress, is the ubiquitin-proteasome pathway [26, 38]. In 
addition, enhanced production of the reactive nitrogen species nitric oxide (NO) 
and peroxynitrite may result in nitrosative stress [39, 40]. During nitrosative 
stress, contractile proteins may be nitrosylated, which could affect contractile 
function [41]. 
2.3 Inflammatory pathways
Evidence has accumulated that inflammatory pathways are involved in the 
development of respiratory muscle atrophy in critically ill patients [15]. Pro-
inflammatory cytokines, such as IL-6 induce muscle atrophy [42, 43].  The ubiquitous 
transcription factor Nuclear Factor KappaB (NFκB) plays a key role in activation of 
the inflammatory response and activation of proteolytic pathways [44, 45]. For 
example NFκB enhances the expression of pro-inflammatory cytokines such as 
interleukin (IL)-1β, IL-6 and tumor necrosis-α [46, 47]. Moreover, NFκB activates 
the E3 ligase MuRF-1, which is involved in the proteolytic ubiquitin proteasome 
pathway [48].  NFκB can be activated by a variety of upstream signals including 
bacterial products like lipopolysacharide (LPS), pro-inflammatory cytokines and 
oxidative stress [49]. Exposing respiratory muscles to LPS increases expression of 
several pro-inflammatory cytokines via NFκB [50]. LPS-induced activation of NFκB 
is known to be mediated through Toll Like Receptor(TLR)4 [47, 51]. However, it 
is unknown if inhibiting TLR4 prevents the development of ventilator-induced 
diaphragm atrophy. 
2.4 Contractile protein dysfunction
Besides a reduction in contractile protein content, respiratory muscle 
weakness can develop as consequence of contractile protein dysfunction. 
Posttranslational modifications of contractile proteins may occur as a result of 
oxidation, nitrosylation or phosphorylation [16, 20, 37, 52-54]. Due to these 
posttranslational modifications, contractile proteins may become less sensitive to 
changes in intracellular calcium concentration (reduced calcium sensitivity) [16, 
54]. However, the effect of mechanical ventilation on contractile protein function 
has not been evaluated. 
12
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3. Aims and outline of the thesis 
The overall aims of this thesis are 1. to improve the understanding of ventilator 
induced respiratory muscle dysfunction and 2. to evaluate possible strategies that 
may improve respiratory muscle function during mechanical ventilation. 
Studies in humans and animal models have demonstrated that diaphragm weakness 
develops during mechanical ventilation, but the underlying pathophysiology is 
incompletely understood. It is known however, that respiratory muscle weakness 
induced by mechanical ventilation results from modifications at the muscle fiber 
level. For example, decreased cross sectional area was reported after mechanical 
ventilation in both rodents and ICU patients [17, 32]. Furthermore, in muscle 
bundles obtained from the diaphragm of ventilated animals decrease in force 
generation exceeds the loss of cross sectional area (reduced specific force) [55, 
56]. However, it is unknown if reduced specific force (force corrected for cross 
sectional area) following mechanical ventilation can be explained by loss of 
diaphragm contractile proteins. Notably, next to atrophy, myofibrillar damage has 
been reported in the ventilated diaphragm [9, 55]. The underlying mechanisms 
for the development of muscle injury are obscure, but it is known that passive 
elastic properties are important determinants for sarcomere stability during force 
generation [57]. The giant muscle protein titin is the major factor for optimal 
passive elastic properties of skeletal muscles [58]. Titin contains a spring-like 
molecular structure, the PEVK segment that largely determines its mechanical 
properties. Posttranslational modifications of this PEVK segment, for instance by 
phosphorylation, may affect passive mechanical characteristics of the muscle fiber. 
Today, the effects of mechanical ventilation on passive elastic force generation 
and titin structure are unknown. In chapter 2 we therefore investigated the 
consequences of mechanical ventilation on diaphragm structure and function. 
To this end, diaphragm was analysed for contractile protein content and titin 
content. Diaphragm function was studied for active force and passive force upon 
stretch. The effect of titin phosphorylation status on passive force generation was 
evaluated. 
Sepsis is an important risk factor for the development of ICU-acquired weakness 
[59]. Previous studies in septic rodents have shown that skeletal muscle protein 
breakdown is increased due to activation of the ubiquitin-proteasome pathway 
[60]. Circulating ligands may induce skeletal muscle protein breakdown during 
sepsis [61, 62]. However, it is unknown if ligands in plasma of septic patients can 
activate the ubiquitin-proteasome pathway and so induce loss of skeletal muscle 
protein. In chapter 3 the effects of plasma derived from patients with septic shock 
13
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was studied on cultured skeletal myotubes. To determine if plasma from septic 
patients induces loss of muscle protein we examined contractile protein content 
in these cultured skeletal muscle cells. With that, inflammatory pathways and 
components of the ubiquitin-proteasome pathway were studied. 
Mechanical ventilation can induce a pulmonary inflammatory response, which 
after decompartmentalization may result in a systemic inflammatory response 
[63]. TLR receptors, present in the lung, are essential for initiation of an 
inflammatory response, for instance by recognizing specific ligands like microbial 
components, but also proteins from injured tissue [64, 65]. TLR4, a subtype of 
TLR receptors expressed on muscle, can upregulate inflammatory genes in the 
diaphragm of rodents after exposure to specific ligands [66]. However, it is 
unknown if mechanical ventilation induces diaphragm TLR4 activation and if so, 
induces an inflammatory response in the diaphragm. Therefore, we studied in 
chapter 4 the role of TLR4 signaling in ventilator-induced diaphragm atrophy. 
In this study wild-type and TLR4 deficient animals were subjected to controlled 
mechanical ventilation. Diaphragm was thereafter analysed for contractile protein 
content, pro-inflammatory cytokines and markers of autophagy.
In critically ill patients on the ventilator, hypercapnic acidosis is an accepted side 
effect of the so-called lung protective mechanical ventilation strategy (“permissive 
hypercapnia”). Recently it was proposed that hypercapnic acidosis itself has 
beneficial effects (“therapeutic hypercapnic acidosis”), such as dampening of 
the inflammatory response and limiting ventilator-induced lung injury [67-69]. 
However, it is unknown whether hypercapnic acidosis protects the diaphragm 
from the deleterious effects of controlled mechanical ventilation. In chapter 5 the 
effects of acute hypercapnic acidosis on the respiratory muscles was evaluated in 
mechanically ventilated animals. Diaphragm muscle was analysed for contractility 
and several biochemical markers for inflammation, proteolysis and oxidation.
Mechanical ventilation and experimental sepsis have been shown to enhance 
nitrosative and oxidative alterations in diaphragm muscle and are associated 
with dysfunction [20, 70]. Accordingly, strategies that aim to reduce nitrosative, 
oxidative and inflammatory stress may protect the diaphragm during critical 
illness. Levosimendan is a relatively new cardiac inotrope that enhances 
calcium sensitivity of cardiac muscle. Interestingly, preliminary data suggest that 
levosimendan exhibits anti-inflammatory and anti-oxidative properties as well [71-
74]. For example, levosimendan decreases IL-1b levels during experimental sepsis 
in rodents [73]. In-vitro, levosimendan reduces LPS-induced upregulation of IL-6, 
nitrite production and inducible nitric oxide synthase expression [71]. Although 
14
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levosimendan has been shown to improve respiratory muscle function [75], the 
effects of levosimendan on inflammatory and nitrosative markers have not been 
studied in the diaphragm. Therefore, in chapter 6 the effects of levosimendan 
on the diaphragm in a model of systemic inflammation (endotoxemia) under 
mechanical ventilation was studied.
Finally, chapter 7 reviews the current knowledge regarding potential strategies to 
optimize respiratory muscle function in the critically ill patient. 
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ABSTRACT
Purpose Diaphragm weakness induced by mechanical ventilation may contribute 
to difficult weaning from the ventilator. For optimal force generation the muscle 
proteins myosin and titin are indispensible. The present study investigated if 
myosin and titin loss or dysfunction are involved in mechanical ventilation induced 
diaphragm weakness. 
Methods Male Wistar rats were either assigned to a control group (n=10) 
or submitted to 18 hours of mechanical ventilation (MV, n=10). At the end of 
the experiment, diaphragm and soleus muscle were excised for functional and 
biochemical analysis. 
Results Maximal specific active force generation of muscle fibers isolated from 
the diaphragm of MV rats was lower than controls (128±9 versus 165±13 mN/
mm2, p=0.02) and was accompanied by a proportional reduction of myosin 
heavy chain concentration in these fibers. Passive force generation upon stretch 
was significantly reduced in diaphragm fibers from MV rats by ~35%. Yet, titin 
content was not significantly different between control and MV diaphragm. In 
vitro pre-incubation with phosphatase-1 decreased passive force generation 
upon stretch in diaphragm fibers from control, but not from MV rats. Mechanical 
ventilation did not affect active or passive force generation in the soleus muscle. 
Conclusions Mechanical ventilation leads to impaired diaphragm fiber active force 
generating capacity and passive force generation upon stretch. Loss of myosin 
contributes to reduced active force generation, while reduced passive force 
generation is likely to result from a decreased phosphorylation status of titin. In 
the soleus muscle of 18 hours mechanically ventilated rats these impairments 
were not discernable. 
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INTRODUCTION
Mechanical ventilation is a life-saving intervention in critically ill patients, but 
comes with several adverse events including weakness of the diaphragm muscle 
[1, 2]. This is clinically important as weakness of the inspiratory muscles plays 
an important role in difficult weaning from mechanical ventilation [3-5]. Several 
studies have indicated that respiratory muscle weakness induced by mechanical 
ventilation primarily results from changes within the diaphragm muscle 
fibers. For example, diaphragm fibers isolated from patients and rodents that 
underwent controlled mechanical ventilation show decreased cross-sectional 
areas, i.e. atrophy [6-8], which most likely affects force generating capacity of the 
diaphragm. Moreover, studies on isolated diaphragm bundles from mechanically 
ventilated animals demonstrate reduced generation of specific force, i.e. force 
per cross-sectional area [9-12]. This either suggests that contractile protein 
concentration is reduced or that remaining contractile proteins have reduced 
functionality. Measuring contractile function of permeabilized muscle single 
fibers is the most appropriate technique to study the involvement of contractile 
protein dysfunction [13]. Force generating capacity of permeabilized muscle 
fibers strongly depends on the content of the contractile protein myosin [14]. 
Accordingly, the first aim of the present study was to investigate whether reduced 
force generating capacity of diaphragm muscle fibers from mechanically ventilated 
rats is associated with decreased myosin concentration. 
In addition to atrophy, signs of muscle fiber injury like myofibrillar disarray 
and Z-band streaming have been observed in the diaphragm of mechanically 
ventilated humans and animals [8, 9, 15, 16]. The mechanisms leading to muscle 
fiber injury are largely unknown. For structural stability and optimal active force 
generation, passive elastic structures are indispensible [17]. Titin is the major 
determinant of passive-elastic properties of striated muscle [18]. In an animal 
model of peripheral muscle disuse a preferential loss of titin explained abnormal 
sarcomeric organization [19]. Passive elastic properties of skeletal muscle fibers 
can also be modulated by posttranslational modifications or alternative splicing of 
titin [20], as occurs in diaphragm fibers from patients with COPD [21]. The effect 
of mechanical ventilation on titin function in respiratory muscles is unknown. 
Accordingly, the second aim of the present study was to investigate the passive 
elastic properties of permeabilized diaphragm fibers from mechanically ventilated 
rats. 
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Previous studies indicated that the diaphragm is more susceptible to the 
deleterious effects of mechanical ventilation than peripheral skeletal muscles [6, 
7, 10]. Whether the effects of mechanical ventilation on muscle protein function 
are different between respiratory and peripheral muscle is currently unknown. 
Therefore, we additionally determined active and passive force generation of 
soleus muscle fibers from the same animals. We hypothesized that mechanical 
ventilation induces loss of myosin and titin, resulting in reduced active and passive 
force generation of diaphragm muscle fibers. We expected the impairments to be 
less prominent in soleus muscle fibers.
MATERIALS & METHODS
Experimental design
Two groups of male Wistar rats (body weight ~300 g) were studied, controls 
(n=10) and after 18 hours of mechanical ventilation (MV, n=10). Five to six 
isolated skinned single muscle fibers from the diaphragm and the soleus of each 
animal were investigated on cross-sectional area, myosin heavy chain isoform and 
concentration, calcium-induced maximal active force generation and passive force 
generation upon stretch (total number of approximately 60 fibers per group). Titin 
content was studied in diaphragm homogenates and in diaphragm cryosections. 
Since impaired passive force generation upon stretch in diaphragm fibers of MV 
rats was not accompanied by reduced titin content, we subsequently examined 
the effect of post-translational dephosphorylation on passive force generation of 
the rat diaphragm. All experiments were approved by the Regional Animal Ethics 
Committee (Nijmegen, The Netherlands) and performed under the guidelines of 
the Dutch Council for Animal Care.
Animal model
Our animal model of mechanical ventilation was based on previously described 
methods [11], with minor modifications.
 Skinned fiber contractile measurements 
Maximal active force generation and passive force generation upon stretch of 
skinned single fibers isolated from the diaphragm muscle were determined as 
described previously [22].
Effect of post-translational dephosphorylation 
The effects of post-translational dephosphorylation on passive force generation 
were investigated according to previous described methods [23]. Skinned 
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diaphragm bundle preparations were incubated with phosphatase-1 (PP-1; 1.5U/
µl) in relax solution for two hours at room temperature. Subsequently single fibers 
were isolated and passive tension upon stretch was measured.
Myosin heavy chain isoform and concentration
Determination of myosin heavy chain isoform composition and content by SDS-
PAGE was described previously [24] and adapted from Geiger et al. [14]. Since 
only 5 diaphragm fibers from each group expressed the slow isoform of myosin 
heavy chain, these were excluded from further analysis. Accordingly all fibers 
were classified as type II. 
Titin content
Content of the major sarcomeric protein titin was determined by SDS-agarose gel 
electrophoresis and by immunohistochemistry as described previously [21]. 
Statistical methods
Sample size of approximately 50 fibers per group, calculated a priori, was based 
upon the assumption to detect a reduction of passive force of at least 25%, with 
a standard deviation of 50% [21], 80% probability and an alpha level of 0.05. 
Differences between MV and control rats regarding maximal force generation, 
myosin heavy chain concentration and titin content were analyzed with Student 
t-tests. Repeated-measures analysis was performed with post hoc Student 
t-testing at each fiber length to evaluate the statistical significance of differences 
in single fiber passive-tension data between groups. A probability level of p<0.05 
was considered significant. Mean ± SE values are presented in text, tables and 
figures.
RESULTS
Animal characteristics 
MV rats exhibited stable hemodynamics during 18 hours mechanical ventilation 
(mean arterial pressure; 99±1 mmHg) and pH, PaO2, and PaCO2 were normal at the 
end of the experiment (7.48 ± 0.02, 13.4 ± 0.8kPa and 5.5 ± 0.2 kPa respectively). 
Active force generation 
The cross-sectional area of skinned diaphragm fibers from MV animals was ~25% 
lower than in control animals (2.0±0.1 versus 2.6±0.2 x10-3 mm2, p=0.002), which 
is consistent with the development of muscle fiber atrophy. Moreover, mechanical 
ventilation significantly reduced diaphragm fiber force generating capacity, even 
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when corrected for loss of cross-sectional area (p=0.02, Figure 1). 
In soleus muscle fibers mechanical ventilation did neither affect cross-sectional 
area (2.4±0.1 versus 2.6±0.2 x10-3 mm2, for MV and control rats) nor specific force 
generating capacity (136±6 versus 127±12 mN/mm2 for control and MV rats). 
Figure 1 Maximal active specific force generation of diaphragm fibers from control and 
mechanically ventilated rats (MV). * p<0.05.
Myosin heavy chain concentration and active force
Myosin heavy chain concentration was ~25% lower in diaphragm fibers from MV 
animals than in diaphragm fibers from control animals (p=0.03, Figure 2). Maximal 
force generation per myosin molecule, i.e. maximal force divided by myosin heavy 
chain content, was not significantly different between MV diaphragm fibers and 
control (2.31±0.26 and 2.97±0.55 N/mg respectively, p=0.3)
Myosin heavy chain concentration in soleus muscle fibers was not significantly 
affected by mechanical ventilation (80±12 versus 79±10 µg/µl for control and MV 
animals respectively).
Figure 2 Myosin heavy chain concentration in diaphragm fibers from control and 
mechanically ventilated rats (MV). * p<0.05.
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Passive force generation
Passive force generation upon stretch was impaired in diaphragm fibers from MV 
animals (Figure 3). At fiber lengths longer than 120% of optimal length, diaphragm 
fibers from MV animals displayed significantly lower passive forces compared to 
fibers from control rats. 
In soleus muscle fibers passive force generation was not affected by mechanical 
ventilation. For example, at 140% of optimal fiber length soleus fibers generated 
passive forces of 47±3 versus 51±4 mN/mm2 for control and MV animals 
respectively.
Figure 3 Passive force generation at different muscle fiber lengths of diaphragm fibers from 
control and mechanically ventilated rats (MV). Lines represent fourthorder polynomial 
fits. *p<0.05.
Titin content
Reduced passive tension of skeletal muscle fibers can result from loss of titin, 
increased expression of longer titin molecules or posttranslational modifications 
of titin [20]. 
Titin content analyzed by SDS-agarose gel electrophoresis was not significantly 
different in diaphragm samples from MV animals compared to control (Figure 4). 
Furthermore, the content of titin’s degradation product T2 in the diaphragm was 
not significantly different between MV and control rats (2.7±0.5 versus 4.0±0.9 
AU/µg muscle weight, p=0.23), which excludes titin breakdown as a reason for 
lower passive force in MV fibers. To gain insight into the size of titin in diaphragm 
muscle of MV rats, we studied the mobility of titin on gel. A representative gel 
shows that the mobility of titin from rat diaphragm samples is distinctly faster 
than the mobility of titin from human soleus muscle, which is explained by a 
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smaller molecule size. The mobility of titin was not different between diaphragm 
samples from MV rats and controls, indicating the absence of detectable size 
differences in titin.
Immunohistochemical analysis confirmed the absence of titin loss in the 
diaphragm of MV rats. Staining intensities of antibodies directed against the titin 
epitopes T12 (Z-line) and T51 (M-line) were comparable between MV and control 
diaphragm (Figure 5). 
Figure 4 Titin content in diaphragm samples from control and mechanically ventilated rats 
(MV).
Figure 5 Representative photographs of cryosections of the diaphragm from control and 
mechanically ventilated rats stained with antibodies against two specific titin epitopes T12 
(Z-line) and T51 (M-line). Bar = 100 μm.
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Passive force and dephosphorylation
As titin content and size were not affected by mechanical ventilation, we 
investigated if posttranslational modification of titin could explain increased 
compliance of diaphragm fibers in MV animals. Recent studies have shown that 
titin’s compliance can be increased by lowering the phosphorylation state of titin 
[23]. Accordingly, we examined the effect of dephosphorylation on passive force 
generation of diaphragm fibers from control and MV rats. Figure 6 shows that pre-
incubation with PP-1, a dephosphorylating enzyme, significantly reduced passive 
force generation upon stretch in diaphragm fibers from control animals. However, 
PP-1 did not affect passive force generation in diaphragm fibers of MV rats. 
Figure 6 Effect of dephosphorylation on passive force generation at different muscle 
fiber lengths of diaphragm fibers from control and mechanically ventilated rats (n=5 
fibers per group). Lines represent fourth-order polynomial fits. Dotted lines: fibers were 
pre-incubated with phosphatase-1 (PP1, 1.5U/μl, for two hours). * p<0.05 vs control + 
PP1.
DISCUSSION 
Previous studies have reported that controlled mechanical ventilation has 
profound effects on structure and force generating capacity of the inspiratory 
muscle in humans and animal models [1, 6-8, 10, 12]. The data of the present 
study provide the following new and important insights in the effects of 18 hours 
controlled mechanical ventilation on diaphragm muscle function; (1) in addition 
to atrophy, decreased myosin concentration contributes to reduced active force 
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generation, (2) mechanical ventilation significantly reduces passive force of 
diaphragm muscle fibers, (3) the effects of mechanical ventilation on passive 
force can be mimicked by dephosphorylating the elastic protein titin and (4) the 
effects of mechanical ventilation on active and passive force do not occur in the 
soleus muscle within this time frame.
Reduced force generation and loss of myosin 
Several studies, both in humans and in animal models, showed that mechanical 
ventilation rapidly induces atrophy of diaphragm muscle fibers [1, 6-8]. Our results 
are in line with those studies as we found that 18 hours mechanical ventilation 
provoked a 20% reduction of diaphragm fiber cross-sectional area. The capacity 
of a muscle to generate force strongly depends on the number of cross-bridges 
that can be formed in parallel [14]. As such, reduction of diaphragm muscle 
fiber cross-sectional area may explain reduced diaphragm force output when 
cross-sectional area and contractile protein content decrease proportionally. 
Yet, reduction of cross-sectional area only partially explains mechanical 
ventilation-induced diaphragm weakness, since several studies have shown 
that prolonged mechanical ventilation reduces diaphragm bundle or single fiber 
specific force generating capacity, i.e. absolute force divided by cross-sectional 
area [9-12, 25]. Our data are in line with these studies and show that fiber 
specific force generating capacity is already reduced after 18 hours of mechanical 
ventilation (figure 1). Moreover, we found that myosin concentration is reduced 
in diaphragm fibers from mechanically ventilated animals (figure 2), indicating 
that the severity of myosin loss exceeds the degree of fiber atrophy. This can 
explain the large decrease in contractile protein content recently observed in 
the diaphragm of mechanically ventilated humans [26]. Notably, after correction 
of force for myosin concentration, no differences exist in force between control 
and ventilated diaphragm. This implies that contractile protein loss is a strong 
determinant of diaphragm weakness upon mechanical ventilation. In addition, this 
finding indicates that the remaining contractile proteins display normal maximal 
force generating capacity. This is in contrast to the diaphragm in patients with 
COPD, where loss of force results from reduction in protein content and impaired 
function of the remaining contractile protein [27, 28]. Contractile protein loss 
can result from both increased proteolysis as well as reduced synthesis. Indeed, 
previous studies have demonstrated that synthesis of contractile proteins is 
reduced [29], and proteolytic systems like the ubiquitin-proteasome pathway, 
caspase-3, calpains and lysosomes are activated in the diaphragm of mechanically 
ventilated rodents and humans [6, 7, 12, 26, 30, 31]. 
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Titin function modulation due to mechanical ventilation: causes and consequences 
Passive elastic structures within muscle are indispensible for structural stability 
and optimal active force generation [17]. Titin is the most important determinant 
of passive-elastic properties of striated muscle fibers [18]. The current study 
demonstrates that mechanical ventilation reduces stiffness of diaphragm 
muscle fibers. As disuse may enhance titin degradation [19], we anticipated 
that reduced stiffness of diaphragm fibers from mechanically ventilated animals 
resulted from the loss of titin. Surprisingly, both agarose gel electrophoresis and 
histochemical analysis demonstrated that titin content in diaphragm fibers is not 
affected by mechanical ventilation. Alternatively, reduced elasticity of muscle 
fibers can result from post-translational modifications of titin [32]. The part of 
titin that largely determines its elastic properties is the PEVK (Pro-Glu-Val-Lys) 
segment, which encodes a coil-like structure that acts as a molecular spring [33]. 
Accordingly, post-translational modifications of aminoacids within the PEVK 
segment may modulate stiffness of the titin molecule. The present findings 
indicate that titin’s stiffness depends on its phosphorylation state, because 
incubation with the dephosphorylating enzyme phosphatase-1 (PP-1) reduces 
the stiffness of diaphragm fibers from control animals. This is in line with 
previous findings in cardiac muscle, which showed that phosphorylation of two 
constitutively expressed sites within the PEVK segment increased stiffness of 
isolated cardiomyoctyes [23]. In contrast to control diaphragm fibers, PP-1 did 
not affect elastic properties of diaphragm fibers from mechanically ventilated 
rats. These data suggests that the phosphorylation state of titin’s PEVK domain in 
diaphragm fibers from mechanically ventilated animals is already low. Therefore, 
we conclude that mechanical ventilation decreases the phosphorylation status of 
titin in diaphragm fibers, resulting in reduced stiffness. Phosphorylation of specific 
sites in the PEVK domain is controlled by protein kinase C (PKC) [23]. Interestingly, 
a recent study showed that 3 days of disuse leads to a rapid reduction of PKC 
activity in peripheral skeletal muscles [34]. Since the diaphragm is contractile 
inactive during mechanical ventilation, it may be hypothesized that mechanical 
ventilation reduces PKC activity in the diaphragm.
Alterations in diaphragm muscle stiffness as reported in our study may be linked 
to muscle protein degradation and synthesis. Proteolytic systems can be activated 
by the abundance of damaged proteins and indeed, evaluation by electron 
microscopy revealed sarcomeric injuries in diaphragm fibers of mechanically 
ventilated humans and animals [8, 9, 15, 16]. Elastic structures inside and outside 
striated muscle fibers provide sarcomeric stability and minimize the occurrence 
of sarcomeric injuries. As titin is the main elastic protein within the sarcomere, 
deletion of titin is known to result in a loss of muscle fiber elasticity and sarcomeric 
injuries [17]. The loss of stiffness in the diaphragm fibers of ventilated rats may 
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contribute to the occurrence of saromeric injuries and promote the degradation 
of contractile proteins, such as myosin. A second consequence of reduced titin 
stiffness is that it may affect muscle protein synthesis. Evidence exists that 
titin can act as a mechanosensor regulating protein expression in a sarcomere 
strain-dependent fashion. Two studies have demonstrate that reduced strain 
on a kinase domain of titin results in downstream inhibition of muscle protein 
synthesis [35, 36]. It has therefore been hypothesized that reduced stiffness of 
titin in the diaphragm fibers from mechanically ventilated animals leads to a lower 
strain on titin kinase and in this way impedes muscle protein synthesis [37]. This 
would make sense as reduced strain may occur when the load on the diaphragm 
is reduced and less muscle mass is required.
Respiratory versus peripheral muscle
Although the respiratory muscles as well as the peripheral muscles are inactive 
during controlled mechanical ventilation, several studies have demonstrated 
that the diaphragm is more sensitive to the detrimental effects of mechanical 
ventilation than peripheral muscles. Diaphragm atrophy in rodents occurs as 
early as 12 hours of mechanical ventilation [31], while it takes much longer 
periods of mechanical ventilation to induce significant reductions of peripheral 
muscle mass [7, 10]. In humans that underwent mechanical ventilation of 18-69 
hours, diaphragm fiber cross-sectional area reduced by more than 50%, while 
pectoralis major fibers did not show any signs of atrophy [6]. Our data is in 
line with those findings as we did not observe a significant reduction of soleus 
fiber cross-sectional area in mechanically ventilated animals. More important, 
our data show that active force and passive force generating capacity of soleus 
muscle fibers were not affected by mechanical ventilation. So, in contrast to the 
diaphragm, muscle protein function in the soleus is preserved at least up to 18 
hours of mechanical ventilation. We recognize that the comparison of fast-typed 
diaphragm fibers to slow-typed soleus fibers may be confound by fiber-type 
specific effects of mechanical ventilation. However, this seems unlikely, because a 
previous study showed that all diaphragm fiber types developed atrophy upon 18 
hours of mechanical ventilation [7]. 
Clinical relevance
Mechanical ventilation-induced diaphragm dysfunction complicates weaning 
from the ventilator [3, 4]. Weaning failure is a major clinical problem, as it occurs 
in a large group of patients undergoing mechanical ventilation. It increases the 
risk of secondary complications, it prolongs rehabilitation and it puts a huge 
financial burden on the healthcare system [38]. Although supported modes of 
ventilation may reduce the development of respiratory muscle atrophy [39], 
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controlled mechanical ventilation is inevitable in certain patients. In fact, a recent 
study advocated the use of controlled mechanical ventilation in early ARDS 
[40]. Unfortunately, no adequate therapies are currently available that improve 
diaphragm function in these patients. The current findings indicate that loss of 
myosin and titin dephosphorylation contribute to mechanical ventilation-induced 
diaphragm dysfunction. The development of treatment strategies aimed at 
preventing or reversing myosin loss and titin dephosphorylation might therefore 
be an interesting focus of future studies on mechanical ventilation-induced 
diaphragm weakness. 
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ABSTRACT
Introduction ICU-acquired muscle weakness commonly occurs in patients with 
septic shock and is associated with poor outcome. Although atrophy is known 
to be involved, it is unclear whether ligands in plasma from these patients are 
responsible for initiating degradation of muscle proteins. The aim of the present 
study was to investigate if plasma from septic shock patients induces skeletal 
muscle atrophy and to examine the time course of plasma-induced muscle 
atrophy during ICU stay.
Methods Plasma was derived from septic shock patients within 24h after hospital 
admission (n=21) and healthy controls (n=12). From 9 patients with septic 
shock plasma was additionally derived at 2, 5 and 7 days after ICU admission. 
These plasma samples were added to skeletal myotubes, cultured from murine 
myoblasts. After incubation for 24h, myotubes were harvested and analyzed on 
myosin content, mRNA expression of E3-ligase and NFkappaB activity. Plasma 
samples were analyzed on cytokine concentrations. 
Results Myosin content was ~25% lower in myotubes exposed to plasma from 
septic shock patients than in myotubes exposed to plasma from controls (p<0.01). 
Furthermore, patient plasma increased expression of E3-ligases MuRF-1 and 
MAFbx (p<0.01), enhanced Nuclear Factor kappaB activity (p<0.05) and elevated 
levels of ubiquitinated myosin in myotubes. Myosin loss was significantly 
associated with elevated plasma levels of IL-6 in septic shock patients (p<0.001). 
Addition of anti-IL-6 to septic shock plasma diminished the loss of myosin in 
exposed myotubes by ~25% (p<0.05). Patient plasma obtained later during ICU 
stay did not significantly reduce myosin content compared to controls. 
Conclusion Plasma from patients with septic shock induces loss of myosin and 
activates key regulators of proteolysis in skeletal myotubes. IL-6 is an important 
player in sepsis-induced muscle atrophy in this model. The potential to induce 
atrophy is strongest in plasma obtained during the early phase of human sepsis. 
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INTRODUCTION
Skeletal muscle weakness frequently develops in patients admitted to the 
intensive care unit (ICU), with a reported incidence between 25% and 60% after 
more than 1 week of mechanical ventilation [1]. ICU-acquired weakness of the 
respiratory muscles is associated with prolonged weaning. Weakness of peripheral 
muscles is associated with prolonged rehabilitation [2]. Mortality in patients with 
ICU-acquired weakness is higher than in ICU patients without weakness [3]. In 
addition, in survivors the consequences of ICU-acquired muscle weakness may 
persist for more than one year after ICU discharge [2]. Besides the devastating 
physical and psychological effects to patients and their family, ICU-acquired 
weakness has a major economical impact. 
Among other factors, sepsis is known to be an important predictor for the 
development of ICU-acquired muscle weakness [4]. In septic patients, weakness 
may originate from any point between the central nervous system and the 
contractile proteins (for review [5]). The effect of sepsis on contractile proteins 
has received much attention [6,7]. For instance, Tiao et al [6] found that in septic 
rats, skeletal muscle protein breakdown was increased due to enhanced activity of 
the proteolytic ubiquitin-proteasome pathway. However, it is unknown whether 
ligands in human septic plasma can activate the ubiquitin-proteasome pathway 
and induce loss of myosin. This is of relevance, as it will help to understand the 
importance of systemic components compared to intrinsic muscle factors, such as 
disuse, in sepsis-induced muscle atrophy. Previous studies indeed have indicated 
that cytokines and bacterial cell wall components induce muscle proteolysis 
in sepsis [8,9], but specific pathways have not been evaluated. Therefore, 
the objective of the current study was to investigate whether plasma from 
patients with septic shock induces loss of myosin associated with activation of 
the ubiquitin-proteasome pathway. We exposed non-diseased cultured skeletal 
muscle to plasma from patients with septic shock. It was hypothesized that 
septic plasma induces loss of muscle proteins in highly differentiated skeletal 
muscle cells. In a follow-up study we investigated the time course of the atrophic 
response induced by plasma obtained from patients admitted with septic shock. 
In addition, we explored the relation between myosin loss and plasma levels of 
inflammatory cytokines. 
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MATERIALS & METHODS
Experimental design
Two separate sets of experiments were performed. The first set of experiments 
was conducted to establish whether plasma in the early phase of septic shock 
induces muscle proteolysis and atrophy. To this end, cultured skeletal muscle 
myotubes were incubated with either plasma from patients with septic shock 
obtained within 24 hours of ICU admission or plasma from healthy subjects 
(controls). After 24 hours of exposure to plasma, skeletal myotubes were harvested 
for biochemical analysis, including myosin heavy chain content and expression of 
E3-ligases. The activity of Nuclear Factor kappaB (NFkB) was measured after 1 
hour of exposure to plasma. 
The second set of experiments was conducted to investigate if the ability of plasma 
from septic shock patients to induce muscle atrophy changes during the course 
of ICU admission and if a correlation exists between inflammatory cytokines and 
loss of myosin. Hence, plasma was derived at different time points during ICU stay 
of patients with a septic shock and the ability of each plasma sample to induce 
proteolysis and atrophy in differentiated muscle cells was examined. In addition, 
plasma levels of cytokines were determined at each time point. 
Study population
Twenty-one patients with established septic shock, according to the 2001 
International Sepsis Definitions Conference [10], were included in the first set of 
experiments. Blood was withdrawn from the indwelling arterial catheter within 
24 hours of ICU admission. In twelve control subjects blood was obtained through 
venapuncture. 
For the second set of experiments, additional blood samples were obtained from 
9 of the 21 septic shock patients at day 2, 5 and 7 of ICU stay. The institutional 
review board, the medical ethical committee, approved the current study and 
waived the need for informed consent.  
 
Muscle culture
Muscle cells, C2C12 myoblasts, were cultured into myotubes according to 
previously described methods [11]. Pilot studies showed stable myosin content 
in myotubes that differentiated for 7 days and that plasma from healthy subjects 
does not affect myosin content in these myotubes. 
Analysis of myosin content
Myosin content in myotubes was determined by Western blotting according to 
previous described methods [16]. 
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Analysis of NFkB activity
NFkB is a ubiquitous transcription factor for a variety of cytokines. The DNA 
binding activity of NFkB has been shown to be highest within several hours after 
exposure to different stimuli [12,13], which was confirmed by pilot-experiments 
in our lab. Therefore, in the current study NFkB activity was measured 1 hour 
after incubation of the myotubes with plasma.
NFkB DNA binding activity was determined by electrophoretic mobility shift assay 
(EMSA) conform previously described methods [14]. 
Analysis of E3-ligase mRNA and ubiquitinated myosin levels 
Expression of muscle specific E3-ligases, MuRF1 and MAFbx and ubiquitination of 
myosin was analyzed, conform previously described methods [15].
Cytokines
Plasma levels of IL-6, IFN-γ, TNF-α and IL-1β were measured by enzyme-linked 
immunosorbent assay (ELISA) (for IL-6, IFN-γ and TNF-α  ELISA kits from Sanquin 
Reagents, Amsterdam, the Netherlands, for  IL-1β Quantikinekit from R&D 
systems, Minneapolis, USA). To further examine the role of IL-6, we first studied 
myosin content in myotubes that were exposed to septic shock plasma containing 
an antibody directed against human IL-6 (R&D systems, Minneapolis, USA). In 
addition, we studied myosin content in myotubes exposed to control plasma 
containing different concentrations of recombinant human IL-6 (Invitrogen, 
Carlsbad, California, USA). 
Data analysis
Data are presented as means ± standard deviation. The statistical significances of 
differences regarding myosin content, MuRF-1 and MAFbx expression between 
myotubes exposed to plasma from controls and patient plasma were analyzed 
by performing Student t-tests. Differences regarding NFkB activity and cytokine 
concentrations were statistically tested by performing Mann Whitney U test. 
Sample size calculations for the follow-up study showed that 9 patients should be 
sufficient to detect a 25% reduction of myosin content with a standard deviation 
of 20%, 80% probability and an alpha level of 0.05. One-way ANOVA with post-hoc 
Bonferroni’s multiple comparison testing was used to evaluate whether myosin 
content, MuRF-1 and MAFbx expression and cytokine levels at each day were 
statistically different from control. Repeated measures one-way ANOVA with 
post-hoc Bonferroni’s multiple comparison testing was performed to analyze 
differences between day 0 and subsequent days. The relation between myosin 
and IL-6 levels was explored using a linear model estimated by Generalized 
Least Squares to allow for correlations between the measurements caused by 
repeatedly measuring the same subjects; an unstructured correlation matrix was 
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used to model this dependence. Since IL-6 levels were not normally distributed, 
log transformation on these values was applied. P values below 0.05 were 
considered significant.
RESULTS
Patient characteristics
Patient characteristics are shown in table 1. All patients met septic shock criteria. 
Thirteen of the 21 patients received 1 bolus of 100 mg hydrocortisone before 
blood withdrawal. Additional characteristics of patients included in the second 
set of experiments. None of the control subjects reported any significant past 
medical history or current use of prescribed medication.
Table 1 Subject characteristics
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Effects of early septic shock  
Myosin content
Myosin content in skeletal myotubes that were exposed to plasma from septic 
shock patients was ~25% lower than in myotubes that were exposed to plasma 
from controls (p < 0.01, Figure 1). In addition, the representative Western blot 
shows that tubulin content was not affected by septic plasma, excluding the 
involvement of a general protein loss. Furthermore, myosin could not be detected 
in cell medium (experimental plasma), also excluding cell lysis. Discrimination 
between patients that did and did not receive steroids prior to blood withdrawal 
shows that plasma samples from both groups induce a significant and similar 
myosin loss in myotubes compared to controls.
Figure 1 Myosin content in myotubes that were either exposed to plasma from controls 
(n=12) or plasma from patients with a septic shock (n=21). *p < 0.01 vs. controls.
NFkB activity and activation of the ubiquitin-proteasome pathway
We measured NFkB activity as it is a key regulator of the inflammatory 
response and increased NFkB activity has been associated with activating the 
ubiquitin-proteasome pathway and inducing muscle atrophy [16]. Figure 2A 
shows that NFkB activity is significantly increased upon exposure to septic plasma 
(p<0.05).
The E3 ligases, MuRF-1 and MAFBx are key regulating enzymes of the proteolytic 
ubiquitin-proteasome pathway [17]. The mRNA levels of MAFbx and MuRF-1 were 
significantly higher in myotubes exposed to septic plasma (Figure 2B). 
Finally, exposure to septic shock plasma increased ubiquitination of myosin 
(p<0.05, Figure 2A).
44
Plasma from septic shock patients induces loss of muscle proteinChapter 3
Figure 2 A) NFkB activity in myotubes that were exposed for 1 hour to either plasma 
from controls (n=6) or to plasma from patients with septic shock (n=6) and ubiquitinated 
myosin per total myosin levels in myotubes after incubation for 24 hours with either 
plasma from controls (n=12) or plasma from patients with septic shock (n=12). *p < 0.05 
vs. controls. B) MAFbx and MuRF-1 expression in myotubes after incubation for 24 hours 
with either plasma from controls (n=5) or plasma from patients with septic shock (n=14). 
*p < 0.05 vs. controls.
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Effects of prolonged septic shock
Because the current data demonstrate that plasma from patients with septic 
shock induces atrophy at ICU admission, we performed additional experiments to 
follow this atrophic response in the course of ICU stay.
Myosin content
Figure 3 shows that plasma of patients with septic shock induced the strongest 
atrophic response at the first day of ICU admission. Exposure of myotubes to plasma 
obtained at day 2 and 5 after ICU admission also resulted in lower reduced myosin 
content compared to control, but these differences were borderline statistically 
significant (p=0.08 and p =0.05 respectively). Myosin content in myotubes that 
were exposed to plasma obtained after 7 days of ICU care was not significantly 
different from control (p=0.28). Myosin content at day 7 was significantly higher 
than at day 0 (p<0.01).
Figure 3 Myosin content in myotubes that were exposed for 24 hours to plasma from 
healthy controls (n=12) and plasma derived from patients with septic shock (n=9) at 
subsequent time points during their stay on ICU. *p < 0.05 vs. controls. #p < 0.05 vs. day 0.
E3-ligase expression
MAFbx expression was highest in myotubes that were exposed to plasma taken 
at the first day of ICU admission (Figure 4). Plasma taken beyond that day did not 
significantly enhance MAFbx expression. MAFbx expression at day 5 and 7 were 
significantly lower than at day 0. In contrast, MuRF-1 expression was enhanced in 
myotubes by plasma obtained up to day 7 after ICU admission (Figure 4). 
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Figure 4 MAFbx and MuRF-1 expression in myotubes that were exposed for 24 hours to 
plasma from healthy controls (n=5) and plasma derived from patients with septic shock 
(n=9) at subsequent time points during their stay on ICU. *p < 0.01 vs. controls. #p < 0.05 
vs. day 0.
Cytokines
Since cytokines are known to induce proteolysis in muscle cells, we measured 
IL-1β, IL-6, IFN-γ and TNF-α levels in the plasma samples that were used in the 
experiments described above. Upon admission to the ICU, IL-6 levels were ~50-fold 
higher in plasma from patients with septic shock compared to controls (p<0.001, 
Figure 5). Although IL-6 levels decreased rapidly during hospitalization, levels at 
day 2, 5 and 7 were still ~10-fold higher than in controls (p=0.05, p=0.09 and 
p=0.10 respectively), but significantly lower than at day 0 (p<0.01). Correlation 
statistics showed a significant negative association between myosin content and 
plasma IL-6 levels (p=0.001, Figure 6). 
IFN-γ, TNF-α and IL-1β levels were below the detection limit (resp. 8, 3 and 8 pg/
ml) for all controls and for 7 of 9 patients with septic shock.
As these data suggest a causative role of plasma IL-6 in inducing muscle atrophy 
during septic shock, we performed two additional experiments. First we examined 
the effect of blocking IL-6 in septic shock plasma on the atrophic response of 
skeletal myotubes. Figure 7A demonstrates that addition of anti-IL-6 (100ng/ml) to 
plasma from septic shock patients results in ~25% higher myosin content in skeletal 
myotubes. In addition, we examined the effect of elevated IL-6 concentration in 
plasma from controls on the atrophic response of skeletal myotubes. Figure 7B 
shows that addition of physiological IL-6 concentrations (i.e. 200 and 600 pg/ml, 
the mean IL-6 plasma levels in septic patients at respectively day 2 and day 0) and 
supra-physiological (50 ng/ml) concentrations of IL-6 to plasma from controls did 
not induce an atrophic response in skeletal myotubes.  
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Figure 5 IL-6 levels in plasma from controls (n=9) and from patients with septic shock 
(n=9) taken within 24 hours of ICU admission and two, five and seven days later. *p < 0.01 
vs. controls. #p < 0.05 vs. day 0.
Figure 6 Correlation between plasma IL-6 levels and myosin content in myotubes exposed 
to plasma from septic shock patients.
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Figure 7 A) Myosin content in myotubes that were exposed to plasma from septic shock 
patients (n=10), with and without addition of anti-IL6 ( 100 ng/ml). * p<0.05. B) Myosin 
content in myotubes that were exposed to plasma from controls (n=10) with addition of 
IL-6 in different concentrations.
DISCUSSION 
The present study is the first to demonstrate that (1) plasma from patients with 
septic shock induces loss of myosin and activation of the ubiquitin-proteasome 
pathway and (2) that the atrophic response initiated by plasma from septic shock 
patients is most severe immediately upon arrival at the ICU and decreases during 
subsequent days and (3) IL-6 plays a prominent role in inducing the atrophic 
response. 
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Study limitations
The use of cultured C2C12 skeletal myotubes in the current study is highly 
appropriate to specifically study the contribution of plasma ligands in muscle 
wasting, since the use of non-diseased muscle tissue virtually excludes any 
contribution of intrinsic muscle abnormalities. Other in vitro models have 
been used previously by others, including dissected muscle bundles [8,18]. A 
disadvantage of this latter model is the absence of muscular microcirculation. 
This induces oxidative stress and limits the supply of ligands to the muscle bundle 
[19,20]. This may explain why incubation with non-septic human plasma also 
increased protein degradation in these models [8]. Therefore, we considered that 
model not suitable for the current research questions. 
C2C12 skeletal myotubes reach a considerable degree of differentiation, as 
indicated by expression of fast twitch skeletal muscle troponin T, alpha-actin and 
tropomyosin [21]. Permeabilized myotubes generate force when perfused with 
calcium solutions, with a similar calcium sensitivity of force generation compared 
to mature skeletal muscle fibers [21]. Nevertheless, data from our own lab [11] 
and others [22,23] demonstrated differences in some physiological processes 
compared to mature skeletal muscle, such as intracellular calcium handling. 
Accordingly, C2C12 cultured myotubes are suitable for addressing specific 
research questions, but limitations should be recognized.
Induction of muscle atrophy in septic shock
Sepsis affects skeletal muscle physiology at different stages of excitation-
contraction coupling, including contractile protein function, muscle protein 
content (atrophy), membrane excitability and mitochondrial function [24]. 
We found that myosin content is reduced by ~25% after exposure of muscle to 
plasma from patients with septic shock. These data are in line with previous 
studies on rodents, showing a rapid loss of muscle mass upon induction of sepsis 
[6,25,26]. The triggers that activate muscle proteolysis in early septic shock 
are largely unknown. Observational studies have proposed several risk factors, 
including cytokines, corticosteroids, hyperglycemia and immobilization [1]. Yet, 
as their effects intermingle in vivo, it is very difficult to establish which of these 
risk factors do play a role in skeletal muscle wasting in critically ill patients. By 
specifically studying the potency of plasma to induce muscle wasting, the current 
study demonstrates that plasma ligands play a prominent role in inducing muscle 
proteolysis in patients with septic shock. A previous study found that serum of 
critically ill patients affect membrane excitability and the excitation-contraction 
coupling process of isolated muscle fibers [27]. Altogether these findings indicate 
that circulating factors contribute to the development of muscle weakness in 
critically ill patients. 
50
Plasma from septic shock patients induces loss of muscle proteinChapter 3
We demonstrated that the atrophic response to plasma obtained beyond 
the day of ICU admission was less prominent, but still present. These findings 
underscore the necessity of early interventions in the prevention of muscle 
atrophy in septic shock patients. Since the set-up in the current study specifically 
addresses the effect of plasma ligands, we do not exclude that other factors, such 
as immobilization [28] and production of inflammatory mediators by the muscle 
itself [29,30] also contribute to muscle wasting in septic patients, in particular 
during prolonged ICU stay.
Circulating ligands
An important question is which plasma factors in septic shock patients initiate 
muscle atrophy. First, inflammatory cytokines such as IL-6, TNF-α, IL-1-β and IFN-γ 
are often implicated in muscle wasting diseases. In our study, the latter three 
cytokines were below the detection limit in all healthy subjects and majority 
of the septic shock patients, suggesting that these were not a major factor in 
the development of atrophy in our model. Plasma IL-6 levels were elevated in 
patients with septic shock and plasma levels significantly correlated with the 
severity of myosin loss. Moreover, blocking IL-6 in plasma from septic shock 
patients diminished the atrophic response in skeletal myotubes. These data 
indicate a prominent role of IL-6 in inducing muscle atrophy during septic shock. 
Noteworthy, addition of IL-6 to plasma from controls did not induce atrophy of 
skeletal myotubes, even when a supra-physiological IL-6 concentration of 50 ng/
ml was applied.  Thus, while IL-6 in plasma from septic shock patients is important 
to induce severe muscle atrophy, other plasma factors seem to be needed as well. 
Secondly, hyperglycemia has been associated with muscle wasting in critically ill 
patients [31] and hyperglycemia induces protein degradation in cultured muscle 
[32]. Yet, patients in the current study were normoglycemic (average glucose 
level 6.8 ± 0.9 mM), as strict glucose control is part of our routine clinical care. 
Accordingly, it is unlikely that hyperglycemia did directly contribute to muscle 
wasting in our model. Thirdly, neuromuscular blocking agents have been 
associated with the development of muscle atrophy [33], although this has 
been challenged in recent clinical studies [34]. Nevertheless, the last bolus of 
rocuronium was administered more than 4 hours before blood withdrawal, ruling 
out an effect of rocuronium in muscle wasting in our study. Fourthly, high dose 
of corticosteroids have been associated with skeletal muscle wasting [35]. In the 
current study, 13 out of 21 patients received low dose (maximal one bolus of 
100 mg i.v.) hydrocortisone prior to blood withdrawal. No significant difference 
in atrophy response at day 1 was observed between patients that had received 
hydrocortisone and steroid naive patients (Figure 3C).  Moreover, at the time 
more patients had received hydrocortisone (day 2 to 7) the atrophic response 
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was lower than on day 1. Plasma cortisol concentrations in five of the studied 
septic shock patients were above normal levels (150-700nM). Yet, these plasma 
samples provoked similar reductions of myosin in myotubes as plasma samples 
with normal cortisol levels (data not shown). Finally, metabolic acidosis is known 
to induce muscle proteolysis by a glucocorticoid-dependent mechanism [36]. 
Although plasma pH in most patients was acidic, there was no significant relation 
between plasma pH and myosin concentration (data not shown). 
Intracellular mechanisms
The main focus of this study was to investigate whether myosin loss is triggered 
by plasma from patients with septic shock, but we also studied activation of 
proteolysis in these skeletal myotubes. The ubiquitin-proteasome pathway is 
the main proteolytic system in eukaryotic cells and controls both protein quality 
and quantity [37]. During the course of this pathway proteins are linked to a 
chain of ubiquitin molecules under regulation of E3-ligases such as MuRF-1 and 
MAFBx and subsequently recognized and degraded by the proteasome. Recent 
evidence from our lab indicates that myosin degradation follows this pathway, 
as proteasome inhibition restores myosin content and muscle function in animal 
models for respiratory muscle weakness [15]. Moreover, components of the 
ubiquitin-proteasome pathway are up-regulated in skeletal muscle of septic shock 
patients [38,39]. The current study adds to these earlier observations as we show 
that plasma from septic shock patients increases ubiquitinated myosin levels and 
activates MuRF-1 and MAFBx in skeletal myotubes. MuRF-1 has been shown to 
specifically ubiquitinate myosin, thereby promoting myosin degradation [40,41]. 
MuRF-1 expression is under control of the transcription factor NFkB [42]. Indeed, 
exposure to patient plasma increases the activity of NFkB in myotubes within 
1 hour. MAFbx expression occurs independent from NFkB activity, but is also 
associated with loss of muscle proteins [43]. Noticeably, in mice overexpression 
of circulating IL-6 enhances MAFbx mRNA and induces loss of muscle mass [44]. 
In line with that study, we found that MAFbx expression diminished after day 2 
on the ICU and followed a similar trend as IL-6, which in turn is inversely related 
to myosin content. Therefore, these data further support the notion that IL-6 is 
involved in the initiation of skeletal muscle atrophy in septic shock patients.
CONCLUSION
The present study demonstrates that plasma from patients with septic shock 
induces loss of the contractile protein myosin in skeletal myotubes. This atrophic 
response is most severe to plasma from the early phase of sepsis and is associated 
with activation of key regulators of proteolysis. IL-6 may play a role in the early 
development of muscle atrophy in septic shock patients.
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ABSTRACT
Background Mechanical ventilation induces diaphragm muscle atrophy, which 
plays a key role in difficult weaning from mechanical ventilation. The signaling 
pathways involved in ventilator-induced diaphragm atrophy are poorly understood. 
The current study investigated the role of toll-like receptor 4 signaling in the 
development of ventilator-induced diaphragm atrophy. 
Methods Unventilated animals were selected for control: wild-type (n=6) 
and toll-like receptor 4 deficient mice (n=6). Mechanical ventilation (8 hours): 
wild-type (n=8) and toll-like receptor 4 deficient (n=7) mice.
Myosin heavy chain content, pro-inflammatory cytokines, proteolytic activity 
of the ubiquitin-proteasome pathway, caspase-3 activity and autophagy were 
measured in the diaphragm. 
Results Mechanical ventilation reduced myosin content by ~50% in diaphragm of 
wild-type mice (p < 0.05). In contrast, ventilation of toll-like receptor 4 deficient 
mice did not significantly affect diaphragm myosin content. Likewise, mechanical 
ventilation significantly increased interleukin-6 and keratinocyte-derived 
chemokine in the diaphragm of wild-type mice, but not in ventilated toll-like 
receptor 4 deficient mice. Mechanical ventilation increased diaphragmatic 
Muscle Atrophy Factor box transcription in both wild-type and toll-like receptor 
4 deficient mice. Other components of the ubiquitin-proteasome pathway and 
caspase-3 activity were not affected by ventilation of either wild-type mice or 
toll-like receptor 4 deficient mice. Mechanical ventilation induced autophagy in 
diaphragm of ventilated wild-type mice, but not toll-like receptor 4 deficient mice.
Conclusion Toll-like receptor 4 signaling plays an important role in the development 
of ventilator-induced diaphragm atrophy, most likely through increased expression 
of cytokines and activation of lysosomal autophagy. 
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INTRODUCTION
Invasive mechanical ventilation is a life saving intervention in patients with 
acute respiratory failure. However, it is well known that mechanical ventilation 
comes with important adverse events. For instance, studies in both rodents and 
humans have shown that controlled mechanical ventilation results in atrophy and 
weakness of the respiratory muscles [1,2]. This is an important clinical problem, 
as inspiratory muscle weakness plays a prominent role in patients difficult to 
wean from mechanical ventilation [3].
The molecular pathways involved in the development of respiratory muscle 
atrophy during mechanical ventilation are incompletely understood. Increased 
muscle protein breakdown as well as reduced muscle protein synthesis have 
been associated with diaphragm atrophy induced by mechanical ventilation [1-5]. 
The upstream pathways that induce this imbalance in muscle protein turnover 
are currently unclear. Cytokines are well-known modulators of muscle protein 
turnover [6] and are involved in the development of respiratory muscle atrophy 
under inflammatory conditions [7]. In the last decade it has been established that 
mechanical ventilation itself is able to provoke a local and systemic inflammatory 
response [8,9]. Yet, whether mechanical ventilation induces an inflammatory 
response in the diaphragm has never been investigated. Toll-like Receptors (TLR) 
are crucial receptors in the initiation of an inflammatory response. Different types 
of TLRs recognize specific ligands, which include microbial components, but also 
proteins released from damaged tissue (‘alarmins’) (For review [10]). Recent 
research demonstrated that the pulmonary inflammatory response to mechanical 
ventilation partly depends on TLR4 signaling [11,12]. TLR4 is also expressed on 
muscle tissue, including the diaphragm [13]. Accordingly, administration of the 
TLR4 specific ligand lipopolysaccharide to rodents elicits an up regulation of 
pro-inflammatory genes in the diaphragm [14] and reduces diaphragm strength 
[15]. Whether TLR4 plays a role in ventilator-induced diaphragm atrophy is 
unknown, but of potential interest as TLR4 antagonists are available for use in 
humans.
Therefore, the first aim of the present study was to investigate whether 
mechanical ventilation-induced diaphragm atrophy is associated with an 
inflammatory response in the diaphragm. The second aim was to establish 
whether ventilator-induced diaphragm atrophy and inflammation depend on 
TLR4 signaling. 
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MATERIALS & METHODS
Animals
Experiments were carried out in male C57BL/6 mice (n=14) aged 21 ± 0.7 weeks, 
bodyweight 27 ± 0.5 gram (Charles River, Sulzfeld, Germany) and male TLR4 
knockout mice (n=13) aged 20 ± 0.6 weeks, weighing 31 ± 0.7 gram (C57BL/6 
background). All TLR4 knockout mice were extensively backcrossed (at least 10 
times) and were a gift from Professor Shizuo Akira, M.D., Ph.D. (Osaka University, 
Osaka, Japan). Animals were fed ad libitum. 
To determine the role of TLR4 in ventilator-induced diaphragm atrophy, four 
groups of mice were studied: control wild-type (cWT; n=6), mechanically ventilated 
wild-type (mvWT; n=8), control TLR4 knockout (cTLR4 KO; n=6) and mechanically 
ventilated TLR4 knockout (mvTLR KO; n=7). 
All experiments were approved by the Regional Animal Ethics Committee 
(Nijmegen, The Netherlands) and performed under the guidelines of the Dutch 
Council for Animal Care.
Controlled mechanical ventilation
Mice selected for ventilation were anesthetized and mechanically ventilated as 
described previously with minor modifications [11]. Briefly, mice were ventilated 
with a tidal volume of 8 ml/kg bodyweight, respiratory rate of 170/min, positive 
end-expiratory pressure of 1.5 cm H2O and inspired oxygen fraction of 0.45.
A sterile catheter was inserted in the carotid artery for continuous blood pressure 
monitoring. The cWT and cTLR4 KO mice were anesthetized and sacrificed 
without being mechanically ventilated as described previously [9]. Previous 
investigations from our lab have established that this experimental setting is free 
from contamination with lipopolysaccharide [11].
Tissue collection
After 8 hours of mechanical ventilation (mechanical ventilation groups) or 
immediately after anesthesia  (controls), mice were exsanguinated and a combined 
thoracotomy and laparotomy was performed. Left and right hemidiaphragm 
tissue was rinsed with the left part quickly frozen in liquid nitrogen and stored at 
−80 °C for later biochemical analysis and the right hemidiaphragm submersed in 
cooled Krebs solution at pH 7.4 for single fiber isolation.
Cytokines in diaphragm and plasma
Levels of tumor necrosis factor α, interleukin (IL)-1α, IL-1β, IL-6 and keratinocyte-
derived chemokine (KC) in the diaphragm and IL-1β, IL-6 and KC in plasma were 
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analyzed by enzyme-linked-immunosorbent assay as published previously [11]. 
To determine cytokine levels in the diaphragm, the muscle was homogenized in 
100 volumes of ice-cold buffer, pH 7.2 (10 mM Tris/Maleate, 3 mM EGTA, 275 
mM sucrose, 0,1 mM dithiothreitol, 2 mg/ml Leupeptine, 2 mg/ml Aprotinine, 
10 mg/L Pepstatine A, 0,57 mM phenylmethylsulphonylfluoride) three cycles of 
freezing and thawing and centrifuged at 17.000 G at 4°C for 30 minutes. Lower 
detection limits were 40 pg/ml for IL-1α and IL-1β; 32 pg/ml for tumor necrosis 
factor α; 160 pg/ml for IL-6 and for KC.
Single fiber myosin heavy chain content 
As described previously, content of myosin heavy chain was determined in isolated 
single fibers [16] with minor modifications. In short, after isolation, the length of a 
single fiber was measured by making a microscopic image on top of a metal raster. 
The single fiber length was analyzed using an image analysis system (ImageJ 
version 1.42, U.S. National Institutes of Health, Bethesda, MD). Subsequently, 
fibers were analyzed for myosin heavy-chain content by SDS–polyacrylamide gel 
electrophoresis. 
Ubiquitinated myosin heavy chain content
Ubiquitinated myosin and total myosin were determined as described before 
[17]. Diaphragm samples were homogenized in 100 volumes of ice-cold buffer 
containing 20mM Tris-HCl (pH 7.4), 20 mM EGTA, 1mM dithiothreitol, 0,5% SDS 
and protease inhibitor cocktail (Sigma, Saint Louis, MO), boiled and centrifuged. 
Soluble proteins were subjected to routine Western blotting. Anti-ubiquitin 
antibodies (PW8805, Biomol, Plymouth Meeting, PA) and anti-myosine (my-
32, Sigma) were used to stain ubiquitinated myosin and total myosin, i.e. 
both ubiquitinated and not ubiquitinated myosin. Secondary goat antimouse-
polyvalent immunoglobulins peroxidase conjugate (A0412, Sigma) and ECL kit 
(GE healthcare, Buckinghamshire, United Kingdom) were applied for detection 
and analysis of ubiquitinated protein bands (optical densitometry software from 
Syngene, Cambridge, United Kingdom). Goat antimouse IRDye 800CW (LI-COR, 
Lincoln, NE) and subsequent Odyssey scan and Odyssey application software 
version 2.1 (LI-COR) were used for analysis of the myosin signal. For each lane the 
ratio of optical densities of ubiquitinated myosin per total myosin was calculated.
Ubiquitin-proteasome pathway and caspase-3 activity
To assess involvement of proteolysis we measured 20S proteasome proteolytic 
activity and caspase-3 activity as described previously [17]. The proteolytic 
activity of isolated 20S proteasomes was determined by measuring the 
generation of the fluorogenic cleavage product methylcoumarylamide from the 
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fluorogenic substrate succinyl-Leu-Leu-Val-Tyr-7-amido-4-methylcoumarin (LLVY) 
by spectrophotometry. 
The caspase-3 activity was determined by measuring the generation of the 
fluorogenic cleavage product methylcoumarylamide from the fluorogenic 
substrate N-acetyl-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin (Ac-DEVD-AMC) 
by spectrophotometry. In addition, we measured the presence of 14kD actin, a 
specific breakdown product of caspase-3 [18] by Western blotting and anti-actin 
antibody (A2066, Sigma). 
To establish whether regulation of the ubiquitin-proteasome pathway was 
modulated, Muscle RING-finger protein-1 (MuRF-1) protein content was assessed 
by Western blotting using anti-MuRF-1 antibodies (Ab77577, Abcam, Cambridge, 
United Kingdom) and messenger ribonucleic acid levels of MuRF-1 and Muscle 
Atrophy Factor box (MAFbx) were determined by quantitative polymerase chain 
reaction [17]. Levels of MAFbx and MuRF-1 messenger ribonucleic acid were 
normalized to glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic 
acid. Forward and reverse oligonucleotides used were as following: 
MAFbx, 5’-GACTGGACTTCTCGACTGCC-3’ and 5’-TCAGCCTCTGCATGATGTTC-3’, 
MuRF-1, 5’-CAACCTGTGCCGCAAGTG-3’ and 5’-CAACCTCGTGCCTACAAGA
TG-3’; Glyceraldehyde-3-phosphate dehydrogenase, 5’-TGATGGGTGTGA
ACCACGAG-3’ and 5’-GGGCCATCCACAGTCTTCTG -3’.
Induction of autophagy
To study the role of lysosomal autophagy, the content of autophagy marker 
Light Chain 3B-II [19] (LC3B-II) was measured using standard Western blotting 
as described previously [20] using a specific antibody against LC3B 2775 (Cell 
signaling Technology, Danvers, MA). Optical density of LC3B-II bands on blot were 
quantified using Odyssey scan and Odyssey application software version 2.1 (LI-
COR). 
Statistical Analysis
A two-sided unpaired Student t-test was performed to evaluate the statistical 
significance of differences for myosin heavy chain and LC3B-II between cWT and 
mvWT animals, between cTLR4 KO and mvTLR4 KO animals.
Differences between the groups regarding cytokines, MAFbx, MuRF-1 messenger 
ribonucleic acid, MuRF-1 and actin protein, caspase-3 activity were analyzed with 
one-way ANOVA. Student-Newman-Keuls post hoc testing was used to test the 
probability level of differences between cWT and mvWT animals, between cTLR4 
KO and mvTLR4 KO animals, between cTLR4 KO and cWT and between mvWT and 
mvTLR4 KO animals. For statistical analysis of cytokine measurements the value 
of the detection limit was used for samples that did not reach the detection limit. 
63
Toll-like Receptor 4 signaling in Ventilator-Induced Diaphragm Atrophy Chapter 4
4
Graphpad prism was used to conduct statistical analysis (Graphpad Software Inc., 
San Diego, CA). A probability level of p<0.05 was considered significant. All data, 
except plasma cytokines, are presented as mean ± SE. Plasma cytokines were 
presented as median (interquartile range, IQR) and mean.
RESULTS
Although initially mean arterial blood pressure decreased in both groups, most 
likely resulting from anesthesia  (Figure 1), hemodynamics stabilized thereafter. 
Bloodgas analysis after 8 hours of mechanical ventilation showed that PaO2, 
PaCO2, bicarbonate and A-a gradient were not significantly different between 
both ventilated groups (Table 1). mvWT mice were mildly acidotic after 8 hours of 
mechanical ventilation.
Figure 1 Mean Arterial Pressure during mechanical ventilation.
Table 1 Arterial bloodgas and alveolar-arterial gradient after 8 hours of mechanical 
ventilation * p < 0.05 vs. ventilated TLR4 KO; Values are mean ± SEM. BE = base excess; 
PaCO2 = arterial carbon dioxide tension; PaO2 = arterial oxygen tension; A-a gradient = 
Alveolar arterial gradient.
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Cytokines in diaphragm
Mechanical ventilation significantly increased levels of IL-6 (cWT 230 ± 26 pg/
mg vs. mvWT 356 ± 37 pg/mg) by ~55% (Figure 2A, p < 0.02) and KC (cWT 87 
± 28 pg/mg vs. mvWT 183 ± 22 pg/mg) by ~110% (Figure 2B, p < 0.002) in the 
diaphragm of WT mice. Although levels of IL-1β (cWT 49 ± 11 pg/mg vs. mvWT 67 
± 10 pg/mg) were ~37% higher in the diaphragm of mechanically ventilated WT 
mice compared to unventilated WT mice this difference did not reach statistical 
significance  (Figure 2C). A similar trend regarding elevation of cytokine levels 
was observed in the diaphragm of mvTLR4 KO mice. Yet, knock out of TLR4 
clearly dampened the inflammatory response in the diaphragm upon mechanical 
ventilation, since none of the cytokine protein levels in the diaphragm were 
significantly different between ventilated and unventilated TLR4 KO mice. KC and 
IL-6 levels in the diaphragm were significantly lower in ventilated TLR4 KO than in 
ventilated WT mice (p < 0.05). Diaphragmatic levels of IL-1α and tumor necrosis 
factor α were not affected after 8 hours of mechanical ventilation in either WT or 
TLR4 KO mice. Deficiency of TLR4 did not affect diaphragm muscle cytokine levels 
in unventilated animals. 
Cytokines in plasma
In ventilated WT mice, plasma levels of KC were significantly increased compared 
to unventilated mice (below detection limit for control WT and median 5060 
[1440, 10910] pg/ml, mean 5952 pg/ml for ventilated WT; p < 0.02). Although 
plasma levels of IL-1β (below detection limit for control WT and median 40 
[40, 252] pg/ml, mean 125 pg/ml for ventilated WT) and IL-6 (below detection 
limit for control WT and median 4130 [1295, 15575] pg/ml, mean 7574 pg/ml 
for ventilated WT) were higher in ventilated mice than in control mice, these 
differences did not reach statistical significance. Similarly, but also statistically 
not significant, mechanical ventilation of TLR4 KO mice led to elevated plasma 
levels of KC (below detection limit for control TLR4 KO and median 2020 [1090, 
2685] pg/ml, mean 1914 pg/ml for ventilated TLR4 KO) and IL-6 (below detection 
limit for control TLR4 KO and median 2810 [985, 3505] pg/ml, mean 2358 pg/
ml for ventilated TLR4 KO). Plasma IL-1β was not different between control and 
ventilated TLR4 KO (both TLR4 KO groups were below detection limit). Plasma 
KC levels, but not IL-6 and IL-1β, were significantly higher in mvWT compared to 
mvTLR4 KO mice (p < 0.05).
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 A
 B
 C
Figure 2 A) IL-6 cytokine level in diaphragm homogenates. * p < 0.02 vs. control WT; # p 
< 0.05 vs. ventilated WT. B) KC cytokine level in diaphragm homogenates. * p < 0.002 vs. 
control WT; # p < 0.05 vs. ventilated WT. C) IL-1β cytokine level in diaphragm homogenates.
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Myosin heavy chain content 
In 8 hours ventilated WT mice myosin heavy chain content in diaphragm muscle 
single fibers was significantly reduced by ~50 % (Figure 3; p < 0.05). In contrast, 
myosin heavy chain content in diaphragm fibers from TLR4 KO mice was not 
significantly reduced by mechanical ventilation. Myosin heavy chain content 
was not different between unventilated WT and TLR4 KO mice, neither between 
ventilated WT and ventilated TLR4 KO mice.
Figure 3 Myosin heavy chain content in diaphragm single fibers from control WT and TLR4 
KO, and ventilated WT and TLR4 KO mice. * p < 0.05 vs. control WT. Data are represented 
as % from cWT for mvWT and as % from cTLR4 KO for mvTLR4 KO.
Ubiquitin-proteasome pathway
Mechanical ventilation significantly enhanced transcription of MAFbx in both 
wild-type and TLR4 KO diaphragm (p < 0.001; Figure 4A). MuRF-1 transcription 
levels and protein content in the diaphragm were not different after 8 hours of 
mechanical ventilation of either wild-type or knock-out mice (Figure 4B, 4C and 
4D). TLR4-deficiency did not affect MAFbx, nor MuRF-1 expression in unventilated 
animals (Figure 4 A/B/C).
The ratio of ubiquitinated myosin heavy chain over total myosin heavy chain was 
not significantly affected by mechanical ventilation nor by TLR4 knockout, and 
levels between cWT and cTLR4 KO were not different (Figure 5). Proteasome 
activity in the diaphragm was not affected by mechanical ventilation nor by TLR4 
deficiency (Figure 6).
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Figure 4 E3-ligase expression levels in the diaphragm of control WT and TLR4 KO and 
ventilated WT and TLR4 KO mice (ratio of mRNA transcripts relative to GAPDH). 
A) MAFbx mRNA levels. * p < 0.001 vs. control WT; # p < 0.001 vs. control TLR4 KO.
B) MURF-1 mRNA. C) MuRF-1 protein levels. Data are represented as % from cWT for 
mvWT and as % from cTLR4 KO for mvTLR4 KO. D): representative Western blot stained 
against MuRF-1.
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Figure 5 Ubiquitinated myosin levels in diaphragm from control WT and TLR4 KO and 
ventilated WT and TLR4 KO mice. Data are represented as % from cWT for mvWT and as 
% from cTLR4 KO for mvTLR4 KO.
Figure 6 Proteasome activity in the diaphragm of control WT and TLR4 KO, and ventilated 
WT and TLR4 KO mice. Data are represented as % from cWT for mvWT and as % from 
cTLR4 KO for mvTLR4 KO.
Caspase-3 activity
No differences in diaphragm caspase-3 activity were observed between groups 
(Figure 7A). To support this observation we determined levels of 14 kD actin 
fragments, a product of caspase-3 activation. Indeed, no 14 kD fragment was 
found in diaphragm homogenates of any group, supporting the absence of 
caspase-3 activation (Figure 7B).
Autophagy
Content of the autophagy marker LC3B-II was significantly increased by ~31% in 
diaphragm muscle of 8 hours mechanical ventilated WT mice compared to control 
WT mice (Figure 8). In contrast, diaphragmatic LC3B-II content in ventilated TLR4 
KO mice, was not different from unventilated TLR4 KO. LC3B-II was not different 
between unventilated WT and TLR4 KO mice, neither between ventilated WT and 
TLR4 KO mice.
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Figure 7 A) Caspase-3 activity in the diaphragm of control WT and TLR4 KO, and ventilated 
WT and TLR4 KO mice. B) Representative Western blot stained against actin.
Figure 8 LC3B-II concentration in the diaphragm of control WT and TLR4 KO, and ventilated 
WT and TLR4 KO mice, data are presented as arbitrary units (a.u.) from Western blot. 
Mechanical ventilation increases levels of LC3-II in diaphragm of WT mice (* vs. control 
WT; p = 0.05) and not in TLR4 KO mice.
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DISCUSSION
The present study investigated the signaling pathways of ventilator-induced 
diaphragm muscle atrophy in particular related to TLR4. The main new findings are 
that: (1) mechanical ventilation-induced diaphragm muscle atrophy is associated 
with increased expression of cytokines in the diaphragm and (2) TLR4 signaling 
is involved in myosin loss, the inflammatory response and lysosomal autophagy 
in the diaphragm during controlled mechanical ventilation. These findings are of 
potential clinical interest, as diaphragm atrophy plays a prominent role in weaning 
from mechanical ventilation.  
Inflammatory response in diaphragm upon mechanical ventilation
This is the first study to examine the effects of mechanical ventilation on 
inflammatory responses in the diaphragm. We found that mechanical ventilation 
increases diaphragm levels of IL-6, KC and to a lesser extend IL-1β. It has previously 
been proposed that increased expression of cytokines induce skeletal muscle 
atrophy. For example, overexpression of IL-6 in transgenic mice engenders profound 
skeletal muscle atrophy, which can be completely blocked by administration of an 
IL-6 antagonist [21]. Subcutaneous administration of IL-6 also results in skeletal 
muscle atrophy in rats [22]. Noticeably, dose-response experiments showed 
diaphragm weight loss at concentrations where no peripheral muscle weight loss 
was detected, suggesting that the diaphragm is more sensitive to the atrophic 
effects of IL-6 than peripheral muscles. Furthermore, local infusion of IL-6 into 
the tibialis anterior in rats causes a preferential loss of myofibrillar proteins, such 
as myosin [23]. A recent study from our lab showed that IL-6 in plasma of septic 
patients plays a prominent role in inducing muscle atrophy [24]. Besides IL-6, we 
found increased levels of KC and IL-1β in the diaphragm of mechanically ventilated 
mice. As far as we know, no previous studies have investigated the role of KC and 
IL-1β on muscle atrophy in vivo. Nevertheless high circulating levels of IL-1β have 
been associated with skeletal muscle wasting [25]. Some evidence for a causative 
role for IL-1β in skeletal muscle wasting comes from in vitro studies. For example, 
exposure of skeletal myotubes to IL-1β during 48 hours results in muscle atrophy 
[26]. In line with these studies, results from the current study show a relation 
between increased expression of cytokines and myosin loss in the diaphragm, 
i.e. in contrast to wild-type mice, mechanical ventilation of TLR4 deficient mice 
did not result in enhanced cytokine expression nor in reduced myosin content. 
Although the current data support the concept that the increased levels of 
cytokines elicited by mechanical ventilation are associated with myosin loss in 
the diaphragm, we did not investigate a causal relationship. To that end, future 
studies should examine whether administration of IL-6 antagonists can prevent 
the induction of diaphragm atrophy during mechanical ventilation.
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Role for TLR4 in ventilator induced diaphragm atrophy
The present study shows that knocking out the TLR4 gene prevented increased 
expression of cytokines and loss of myosin in the diaphragm upon mechanical 
ventilation. This implicates a role for TLR4 signaling in ventilator-induced 
diaphragm dysfunction. TLR’s are well-known for their role in innate immunity. 
Each TLR homologue senses a specific set of conserved microbial molecules. 
The post-receptor signaling of TLR’s is very complex (for a detailed review see 
[27]), but noteworthy is that activation of TLR’s eventually results in the release 
of inflammatory cytokines, necessary to combat infection. Recent discoveries 
show that TLRs, in particular TLR4, are expressed in skeletal muscle [13,28,29]. 
Moreover, several studies have demonstrated that stimulation of TLR4 by 
lipopolysaccharide increases the expression of cytokines, like IL-6, KC, IL-1β and 
tumor necrosis factor α, in skeletal muscles [13,28,30]. The inflammatory response 
to lipopolysaccharide administration also occurs in the diaphragm, where it is 
even more vigorous than in limb muscle [14]. In line with these data, the current 
study shows that TLR4-deficiency attenuated the upregulation of cytokines in the 
diaphragm upon mechanical ventilation. Moreover, we found that knocking out 
the TLR4 gene partially prevented myosin loss in the diaphragm of mechanically 
ventilated mice. Since myosin plays a central role in muscle contraction, these 
data indicate that TLR4 signaling is involved in mechanical ventilation-induced 
diaphragm dysfunction. 
Although it was not a main objective of this study, our data provide some 
additional insight into the down-stream mechanisms by which TLR4 signaling 
induces loss of myosin. For instance, considering the well established effect of 
increased expression of cytokines on myosin content as described above, it seems 
likely that myosin loss in the diaphragm upon mechanically ventilation is caused 
by TLR4-mediated upregulation of inflammatory cytokines.
A recent publication by Doyle et al. suggested that TLR4 activation might also 
directly induce myosin loss by the p38 mitogen-activated protein kinase pathway, 
i.e. independent from actions of cytokines [20]. Myosin loss in that study was 
provoked by coordinate downstream activation of the ubiquitin-proteasome and 
autophagy-lysosome pathways. Interestingly, our data indicate that mechanical 
ventilation activates autophagy in the diaphragm already after 8 hours. This is in 
line with a recent study in humans, which showed activation of autophagy after 
prolonged mechanically ventilation [31]. More importantly, our data show that 
TLR4 plays a prominent role in inducing autophagy during mechanical ventilation, 
because TLR4 knockout mice did not show upregulation of LC3B-II after 8 hours 
of mechanical ventilation. Remarkably, our data do not support an important role 
for the ubiquitin-proteasome pathway in ventilator-induced diaphragm atrophy. 
First of all, 8 hours of mechanical ventilation did not enhance proteasome activity. 
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Secondly, reduced total myosin content was not accompanied by increased 
ubiquitination of myosin. In accordance, expression of the E3-ligase MuRF-1, that 
is known to ubiquitinate myosin [32], was unaffected by mechanical ventilation. 
Finally, although mechanical ventilation increased MAFbx expression, the 
protective effects of TLR4 deficiency on myosin content were independent from 
MAFbx activation. In contrast, some previous studies showed that diaphragm 
atrophy was associated with activation of the ubiquitin-proteasome pathway in 
the diaphragm of mechanical ventilated rats [5,33,34] and brain-dead humans 
[35]. Yet, those studies do not provide unambiguous evidence that this pathway is 
responsible for the loss of myosin. In contrast to the current study, ubiquitination 
of myosin was not specifically studied. Our data indicate that 8 hours of mechanical 
ventilation does not increase ubiquitination of myosin. Furthermore, attenuation 
of mechanical ventilation-induced diaphragm atrophy by anti-oxidants occurs 
independent from elevated MuRF-1 and MAFbx expression [36]. Caspase-3 
is known to cleave the contractile protein actin, which may induce release of 
myosin from the sarcomere [18]. However, data from the present study do not 
support a role for caspase-3, as its cleaving activity in the diaphragm was not 
affected by mechanical ventilation and actin fragments could not be detected. In 
apparent contrast with our study, previous studies have shown enhanced content 
of activated caspase-3 in the diaphragm of mechanical ventilated animals [37,38] 
and humans [1]. However, in those studies cleavage activity of caspase-3 itself 
was not measured nor were concentrations of contractile proteins determined. 
With respect to those studies, we do therefore not exclude that the ubiquitin-
proteasome pathway and caspase-3 may be activated, in particular after long 
periods of mechanical ventilation, but to our opinion there is currently no solid 
evidence that activation of this pathway is responsible for loss of myosin. Our 
data rather suggest that increased proteolysis through lysosomal autophagy is 
involved after 8 hours of mechanical ventilation. More importantly, our results 
show that activation of lysosomal autophagy depends on TLR4 signaling. This 
is in line with previous data of Doyle et. al. who showed that the TLR4 agonist 
lipopolysaccharide induces lysosomal autophagy in cultured muscle cells [20]. 
Of note, after 8 hours of mechanical ventilation, wild-type mice exhibited 
mild metabolic acidosis, despite insignificant difference in PaCO2 and HCO3-. 
Unfortunately, this could not be prevented as sequential blood gas analysis is not 
feasible in mice due to low circulating volume. However, it is unlikely that this mild 
acidosis explains the differences in myosin and cytokine analysis between groups. 
Previous studies have demonstrated myosin loss after mechanical ventilation in 
nonacidotic animals [37,39]. 
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Endogenous ligands for TLR4 during mechanical ventilation
Two other questions that remain to be solved are the nature and origin of the 
ligands that activate TLR4 during mechanical ventilation. Evidence is accumulating 
that TLR4 can be activated by non-microbial molecules such as endogenous 
ligands [40] including hyaluronan and heat shock protein 70 [41,42]. Interestingly, 
these ligands are released from the lung upon mechanical ventilation with high 
tidal volumes [43,44]. In the current study we choose to ventilate with relatively 
low tidal volumes, as we wanted to resemble the clinical setting. Nevertheless, 
a recent study from our lab showed that even low-tidal volume mechanical 
ventilation results in the appearance of TLR4 ligands in the bronchoalveolar 
lavage fluid [11]. An attractive hypothesis is therefore that TLR4’s in diaphragm 
are activated by ligands released from the mechanically ventilated lung.
Clinical implications
Respiratory muscle weakness plays an important role in difficult weaning from 
mechanical ventilation. Recently, the development of respiratory muscle atrophy 
in mechanically ventilated humans has been demonstrated [1]. Today, no proven 
strategies are available to prevent or reverse ventilator-induced respiratory 
muscle atrophy. The current study provides a rationale to test the effects of 
TLR4 antagonists on ventilator-induced muscle atrophy. Interestingly, a phase 2 
trial with the TLR4 antagonist eritoran tetrasodium (Eisai Research Institute of 
Boston, Andover, MA), showed a trend towards lower mortality rate in severe 
septic patients [45]. However, this paper did not study the effects of eritoran on 
duration of mechanical ventilation or respiratory muscle function. Ideally, TLR4 
should be selectively blocked in the diaphragm muscle without compromising the 
innate immune system.
CONCLUSION
In conclusion, controlled mechanical ventilation induces loss of myosin, autophagy 
and an increased expression of cytokines in the diaphragm muscle. The present 
study demonstrates that TLR4 signaling is involved in eliciting this response. 
These findings may prove helpful in the development of strategies to attenuate 
ventilator-induced diaphragm dysfunction. 
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ABSTRACT
Introduction Diaphragm weakness induced by prolonged mechanical ventilation 
may contribute to difficult weaning from the ventilator. Hypercapnia is an 
accepted side effect of low tidal volume mechanical ventilation, but the effects 
of hypercapnia on respiratory muscle function are largely unknown. The present 
study investigated the effect of hypercapnia on ventilator-induced diaphragm 
inflammation, atrophy and function.
Methods Male Wistar rats (n=10 per group) were unventilated (CON), mechanically 
ventilated for 18 hours without (MV) or with hypercapnia (MV+H, Fico2 = 0.05). 
Diaphragm muscle was excised for structural, biochemical and functional analyses.
 
Results Myosin concentration in the diaphragm was decreased in MV versus CON, 
but not in MV+H versus CON. MV reduced diaphragm force by ~22% compared 
with CON. The force generating capacity of diaphragm fibers from MV+H rats 
was ~14% lower compared with CON. Inflammatory cytokines were elevated in 
diaphragm of MV rats, but not in MV+H group. Diaphragm proteasome activity 
did not significantly differ between MV and CON. However, proteasome activity 
in the diaphragm of MV+H was significantly lower compared with CON. LC3B-II a 
marker of lysosomal autophagy was increased in both MV and MV+H. Incubation 
of MV+H diaphragm muscle fibers with the antioxidant dithiothreitol restored 
force generation of diaphragm fibers. 
Conclusions Hypercapnia partly protects the diaphragm against adverse effects of 
mechanical ventilation.
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INTRODUCTION
It is well-known that controlled mechanical ventilation adversely affects the 
respiratory muscles [1, 2]. For instance, Levine and colleagues demonstrated 
that, in brain dead patients, 18 – 69 hours mechanical ventilation is associated 
with profound atrophy of the diaphragm [1]. Enhanced proteolysis [3] and 
pro-inflammatory cytokines [4] have been implicated in the development of 
ventilator-induced diaphragm dysfunction. 
Hypercapnia is a well-tolerated side effect of low tidal volume ventilation in 
patients with acute respiratory distress syndrome. Moreover, experimental 
studies indicate that hypercapnic acidosis may exert beneficial effects by reducing 
inflammation and lung injury during mechanical ventilation [5-8]. For instance, in 
rats with ventilator-induced lung injury, hypercapnic acidosis reduced interleukin 
(IL)-6 and tumor necrosis factor-alpha in bronchoalveolar lavage fluid compared 
with normocapnia [6]. Recently, Jung and colleagues demonstrated that in pigs 
hypercapnic acidosis prevents the loss of diaphragm force induced by controlled 
mechanical ventilation [9]. The latter study was largely descriptive and the effects 
of hypercapnic acidosis on downstream mechanisms of ventilator-induced 
diaphragm dysfunction remain largely unknown [10]. Inflammatory and oxidative 
pathways have been implicated in the development of skeletal muscle atrophy 
and dysfunction [4, 9-12]. For instance, we have reported that IL-6 may be an 
important mediator in sepsis-induced skeletal muscle atrophy [11]. 
Accordingly, the following hypotheses were tested in the present study. First, 
hypercapnic acidosis attenuates ventilator-induced diaphragm atrophy and 
dysfunction. Second, hypercapnic acidosis inhibits upregulation of inflammatory 
cytokines and proteolysis in the diaphragm of mechanically ventilated rats. 
To test these hypotheses healthy rats were randomized to an unventilated group, 
controlled mechanical ventilation during normocapnia or mechanical ventilation 
under hypercapnic conditions. Diaphragm atrophy, function, inflammation and 
proteolysis were assessed. Based on these results, additional experiments were 
performed to assess the role of oxidative protein modification on contractile 
function of the diaphragm. 
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MATERIALS & METHODS
Design 
Animal experiments were approved by the Regional Animal Ethics Committee 
(Nijmegen, The Netherlands) and performed under the guidelines of the Dutch 
Council for Animal Care. 
Experiments were performed in male Wistar rats (Harlan, Horst, The Netherlands) 
randomly divided in three groups (N = 10 per group): control group (CON, 
bodyweight 313 ± 20 gram), mechanical ventilation group (MV, bodyweight 294 ± 
15 gram) and mechanical ventilation with hypercapnia group (MV+H, bodyweight 
313 ± 12 gram). The CON group was anesthetized with pentobarbital (50 mg/kg) 
and sacrificed without being mechanically ventilated. 
Rats allocated to mechanical ventilation were anesthetized with an intra-peritoneal 
injection of pentobarbital (induction 50 mg/kg), orally intubated and ventilated 
(ventilator UB 7025 from Hugo Sachs, March-Hugstetten, Germany) as described 
previously [13]. Briefly, in all mechanically ventilated animals a catheter was 
inserted under sterile conditions in the carotid artery for continuous measurement 
of blood pressure and periodic blood sampling (at ½, 2, 4, 8, 12, 16 and 18 hours; 
i-STAT, Blood Gas Analyzer, Abbott, Hoofddorp, The Netherlands). Tidal volume was 
set at 6 ml/kg bodyweight, respiratory rate of 110/min, positive end-expiratory 
pressure of 1.5 cm H2O and inspired oxygen fraction of 0.45. Hypercapnic acidosis 
was induced by adding Fico2 0.05 in the MV+H group. Ventilated rats were 
fed iso-caloric AIN-76 rodent diet (SSNIFF, Soest, The Netherlands) through an 
oro-gastric tube and received a continuous intra-venous doses pentobarbital (10 
mg/kg/hour) via a tail vein catheter as previously described [14]. To compensate 
for loss of circulating volume, Ringer’s solution at 2 ml/hour was administered 
intravenously. Body temperature was kept between 36.0°C and 37.0°C using a 
heating pad [13]. All animals survived the 18 hours of mechanical ventilation 
without complications.
Tissue collection 
Immediately after anesthesia (CON) or after 18 hours of mechanical ventilation 
(MV and MV+H groups), rats were exsanguinated and a combined thoracotomy 
and laparotomy was performed, as described previously [13]. Left and right 
hemidiaphragm tissue was rinsed with the left part quickly frozen in liquid nitrogen 
and stored at −80 °C for later biochemical analysis and the right hemidiaphragm 
submersed in cooled Krebs solution at pH 7.4 for single fiber isolation, as described 
previously [15].
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Myosin heavy chain isoform and concentration
Content of myosin heavy chain was analysed in diaphragm muscle homogenates 
using standard Western blotting as described previously [4, 19]. Myosin heavy 
chain content on blot was corrected for loaded amount of muscle weight. For 
a more accurate determination of myosin heavy chain content in diaphragm, 
myosin heavy chain concentration (i.e. amount of myosin per muscle volume) 
was measured in diaphragm single fibers. Determination of myosin heavy chain 
isoform composition and concentration in same diaphragm fibers as used for 
contractile measurements by means of SDS-PAGE, was described previously [16] 
and adapted from Geiger et al. [17]. Briefly, single fibers were placed in a sample 
buffer, thereafter run on gel and afterwards silver stained and quantified. Since 
only 5 diaphragm fibers in each group expressed the slow isoform of myosin 
heavy chain, these were excluded from further analysis. Accordingly, all fibers 
were classified as fast  (2x and 2b) typed fibers. 
Skinned fiber: cross sectional area, contractile measurements 
Cross sectional area (CSA) and maximal active force generation of skinned single 
fibers isolated from the diaphragm muscle were determined (5 - 6 fibers per rat) 
as described previously [16].
To obtain single fibers, a rectangular bundle from the central costal region of 
the right hemidiaphragm was dissected, parallel to the long axis of the muscle 
fibers. The muscle bundle was chemically skinned, i.e. permeabilization of lipid 
membranes. Subsequently, single fibers were isolated from the muscle bundle, 
attached to aluminium foil clips, and mounted in a flow-through acrylic chamber 
on two hooks connected to a force transducer (model AE-801; SensoNor, Horten, 
Norway) and a servomotor (model 308B, Aurora Scientific, Aurora, ON, Canada). 
Sarcomere length was set at 2.4 μm as the optimal length for force generation. 
Muscle fiber CSA area was deduced from fiber width and depth measurements 
using a reticule in the microscope eyepiece. Maximum isometric force was 
determined by measuring force after perfusing the experimental chamber with, 
successively, pCa 9.0 and pCa 4.5 solutions. Maximum specific force was derived 
from dividing maximum isometric force by fiber CSA [18].
Cytokines 
Concentrations of IL-1beta, IL-6, keratinocyte-derived chemokine, IL-10 and 
tumor necrosis factor-alpha in diaphragm homogenates were analysed with ELISA 
as described previously (R&D Systems, Minneapolis, Minnesota) [4].
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E3-ligases, Ubiquitin-proteasome pathway, Autophagy and Transcription 
To assess involvement of proteolysis we measured 20S proteasome proteolytic 
activity as described previously [19]. Levels of muscle specific E3-ligases, markers 
for muscle atrophy, MAFbx and MuRF-1 mRNA were determined using qPCR as 
previously described [19]. Concentration of ubiquitinated myosin and total myosin 
were determined as described before in whole diaphragm muscle homogenates, 
using standard Western blotting [4, 19]. To study the role of lysosomal autophagy, 
the content of autophagy markers Light Chain 3B-II (LC3B-II) and beclin-1 were 
measured by standard Western blotting as described previously [4], using specific 
antibodies against LC3B (anti-LC3B-II 2775, Cell signaling Technology, Danvers, 
MA) and beclin-1 (anti-beclin-1, PRS3613, Sigma-Aldrich, Saint Louis, MO). Gels 
were equally loaded with 40 μg protein per sample. Optical density of LC3B-II and 
beclin-1 bands on blot were quantified using Odyssey scan and Odyssey application 
software version 2.1 (LI-COR, Lincoln, NE). In addition, myosin heavy chain (MyHC) 
expression of isoforms I, IIa, IIb and IIx was analysed according to methods 
described for MAFbx and MuRF-1 mRNA. Forward and reverse oligonucleotides 
used were as follows: MyHC I: 5’–GCCAAGAGCCGTGACATTGGC–3’ and 5’–
CTGCCTGAAGGTGCTGTTTCA–3’, MyHC IIa 5’–TATCCTCAGGCTTCAAGATTTG–3’ 
and 5’–TAAATAGAATCACATGGGGACA–3’, MyHC IIB 5’CACACCAAAGTCATAAG
CGAA–3’ and 5’–CCTTGATATACAGGACAGTGA–3’, MyHC IIX 5’–
TGATCGATCCAAAGCAGG–3’ and 5’–CTCCCAAAGTCGTAAGTA–3’.
Effect of oxidation/reduction state on force generation and the presence of 
oxidative stress
To investigate involvement of reversible protein modifications by oxidative agents, 
additional experiments were performed using reducing agent Dithiothreitol (DTT) 
(Sigma, Zwijndrecht, the Netherlands). Maximal active force generation of skinned 
diaphragm fibers (n=16) was determined before and after 20 min incubation with 
DTT (10mM in relax solution) [20].
To investigate the presence of oxidative stress, HNE (4-Hydroxy-2-nonenal) was 
measured using a specific antibody against HNE (anti-HNE 393206, Calbiochem, 
Darmstadt, Germany). Diaphragm muscle homogenates were prepared as 
described previously [4]. Optical density of HNE bands on blot were quantified 
using Odyssey scan and Odyssey application software version 2.1 (LI-COR, Lincoln, 
NE).
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Data treatment and statistical methods
Differences among groups were analysed with one-way ANOVA and 
Student-Newman-Keuls post hoc testing if appropriate. A two-sided paired 
Student t-test was performed to evaluate the statistical difference between 
maximal forces before and after DTT incubation. Difference among groups 
regarding time courses of pH, Paco2, Pao2 and mean arterial pressure (MAP) 
were performed with a two-way ANOVA. GraphPad Prism was used to conduct 
statistical analysis (GraphPad Software Inc., San Diego, CA). A probability level of 
p < 0.05 was considered statistically significant. All data are presented as mean ± 
SE, except bodyweight that is presented as mean ± SD.
RESULTS
Animal characteristics
Animals allocated to ventilated groups were hemodynamically stable during the 
18 hours of ventilation. No respiratory efforts were observed clinically or from the 
pressure tracing of the ventilator. Figure 1A-B-C-D shows the course of pH, Paco2, 
Pao2 and MAP during mechanical ventilation. As expected MV+H rats developed 
respiratory acidosis that was partly metabolically compensated. Plasma HCO3- 
after 18 hours of mechanical ventilation was 33.6 ± 0.7 mmol/L in MV and 43.7 ± 
3.1 mmol/L in MV+H. 
Hypercapnia and diaphragm structure and function
Hypercapnia prevented the loss of myosin in ventilated rats (Figure 2A). 
Subsequently, for a more precise measurement of muscle atrophy, myosin heavy 
chain concentration was measured in diaphragm single fibers. Accordingly, 
mechanical ventilation significantly decreased myosin concentration in diaphragm 
muscle fibers (Figure 2B). Hypercapnia prevented the loss of myosin induced 
by mechanical ventilation, in fact, mean myosin concentration was higher in 
diaphragm fibers from MV+H group compared with CON (Figure 2B). 
Besides myosin concentration, muscle fiber CSA was measured as an additional 
marker for atrophy. Diaphragm fiber CSA was reduced by ~25% in MV animals 
(Figure 2C, P < 0.05 versus CON). The reduction of CSA was less pronounced, i.e. 
~15%, in diaphragm fibers from MV+H rats (P = 0.06, versus CON). 
Mechanical ventilation reduced specific force generation of diaphragm muscle 
fibers by ~22% compared with CON (Figure 2D, P < 0.05). The force generating 
capacity of diaphragm fibers from MV+H group was ~14% lower compared with 
CON, but this difference did not reach statistical significance (P = 0.16). 
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Figure 1 A) Course of blood pH 
during 18 hours of mechanical 
ventilation. As expected 
increasing Fico2 reduces blood 
pH. * Two-way repeated measure 
analysis showed that pH values 
over time were significantly 
different between groups. 
B) Course of blood CO2 during 18 
hours of mechanical ventilation. 
CO2 was significantly increased 
at the end of experiment in 
hypercapnic rats.* Two-way 
repeated measure analysis showed 
that CO2 values over time
were significantly different 
between groups. 
C) Course of blood O2 during 18 
hours of mechanical ventilation. 
O2 was not significantly different 
between mechanically ventilated 
groups. 
D) Course of blood MAP during 18 
hours of mechanical ventilation. 
MAP was significantly lower at 4 
hours and at the end of experiment 
in hypercapnic rats. * Two-way 
repeated measure analysis showed 
that MAP was significantly 
different between groups at 4, 12, 
16 and 18 hours of mechanical 
ventilation.
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Figure 2 A) Myosin heavy chain content per muscle weight in diaphragm of MV showed 
a decreased trend compared with CON and MV+H, but was not significantly different 
between groups. B) Myosin heavy chain concentration in diaphragm single fibers. Control 
diaphragm fibers (n = 51) showed a higher concentration of myosin heavy chain compared 
with fibers from ventilated rats (n = 57) (* vs. control; P < 0.05). Fibers from hypercapnic 
rats (n = 53) showed higher concentration of myosin heavy chain versus fibers from 
normocapnic ventilated animals (# vs. MV and vs. control; P < 0.05). C) Diaphragm fast 
typed fibers cross sectional area. Cross sectional area was reduced in MV animals versus 
CON (* P < 0.05). The reduction of cross sectional area was less pronounced in diaphragm 
fibers from MV+H rats. D) Maximal force corrected for cross sectional area. Force of fibers 
from 18 hours mechanical ventilated rats were significantly lower compared with control 
(* P < 0.05).
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Inflammation
Mechanical ventilation resulted in increased levels of inflammatory cytokines 
in the diaphragm. For instance, IL-1beta, IL-6 and tumor necrosis factor-alpha 
increased by 37%, 109%, and 35%, respectively compared with CON. This 
inflammatory response was largely abolished in MV+H animals (Figure 3). 
Figure 3 Cytokine levels in diaphragm homogenates. Mechanical ventilation significantly 
increased levels of IL-1beta, KC, IL-10 and tumor necrosis factor-alpha (* vs. control; P < 
0.05). Hypercapnia largely abolished ventilator-induced inflammation in the diaphragm 
after 18 hours of MV (# vs. MV P < 0.05 for IL-1beta, KC and TNF-alpha). MV+H versus CON 
was not significantly different for all cytokines
E3-ligases, Ubiquitin-proteasome pathway, Autophagy and Transcription
To test whether the protective effects of hypercapnia on diaphragm myosin 
concentration in the ventilation group were mediated by inhibition of 
proteolytic pathways, we subsequently analysed essential segments of the 
ubiquitin-proteasome pathway and a key lysosomal autophagy marker. 
Mechanical ventilation significantly enhanced mRNA expression of the E3-ligases 
MuRF-1 (11,4 fold expression in MV versus CON, P < 0.05) and MAFbx (11.9 fold 
expression in MV versus CON, P < 0.05) in the diaphragm. Hypercapnia did not 
affect ventilator-induced activation of these E3-ligases in the diaphragm (13.1 
fold increase in MuRF-1 and 9.1 fold increase in MAFbx versus CON, both P < 
0.05). A trend for an increased amount of ubiquitinated myosin molecules was 
found in MV (Figure 4A/B, 128% in MV versus CON) and MV+H group (138% in 
MV+H versus CON) compared with control, but these differences did not reach 
statistical significance. Diaphragm proteasome activity was not significantly 
different between MV and CON (Figure 4C). However, proteasome activity in the 
diaphragm of the hypercapnic ventilated group was 24% lower compared with 
CON p < 0.05 (Figure 4C). Light Chain 3B-II, a marker for autophagy, was increased 
in both ventilated groups compared with CON (Figure 4D/E). Another marker for 
autophagy, beclin-1, was not different between groups. Myosin expression in 
relation to the expression of tubulin was not different between groups for myosin 
heavy chain isoforms I, IIa, IIb and IIx (Figure 5). 
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Figure 4 A) Concentration of 
ubiquitinated myosin per total 
myosin in diaphragm of MV and 
MV+H showed an increased trend 
compared with control, but was 
not significantly different between 
groups. 
B) Representative Western blot of 
ubiquitinated myosin. 
C) 20S Proteasome activity in 
diaphragm. Hypercapnic ventilated 
animals demonstrate decreased 
activity versus control animals (* P 
< 0.05). 
D) LC3B-II content. Both ventilated 
and hypercapnic ventilated 
animals were significantly different 
compared with control (* P < 0.05). 
E) Representative Western blot 
against LC3B-II.
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Figure 5 Expression of mRNA Myosin Heavy Chain isoforms I, IIa, IIb and IIx per tubulin in 
rat diaphragm. Transcription was not different between groups.
A
B
Figure 6 A) Delta force, corrected for cross sectional area, in single fibers before and after 
incubation with DTT. Delta force in MV+H (both n = 16) versus CON and MV was significant 
increased (* P < 0.05). B) 4-Hydroxy-2- nonenal (HNE) optical density (OD) in diaphragm 
was not significantly different between groups.
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Effect of oxidation/reduction state on force generation
An unexpected finding was that the protective effect of hypercapnia on contractile 
protein concentration was only partly accompanied by a protective effect on force 
generation (see Figure 2B and 2D respectively). 
Reduced force generation without the loss of contractile protein in hypercapnic 
rats suggests posttranslational modifications of the contractile proteins. Oxidative 
modifications are known to affect respiratory muscle force and indeed mechanical 
ventilation has been associated with oxidative stress [12, 21]. Accordingly, 
we investigated if reversible protein oxidation is involved in the reduced force 
generating capacity of diaphragm fibers in the MV+H group. Incubation of 
diaphragm muscle fibers from hypercapnic ventilated rats with the antioxidant 
DTT increased force generation by 27% (P < 0.05 versus CON, Figure 6A). In 
contrast, DTT did not affect force generation of diaphragm fibers from MV group 
(Figure 6A). Concentration of HNE, a marker for reversible oxidative stress, in 
diaphragm was not different between groups (Figure 6B).
DISCUSSION
Previous studies have shown that controlled mechanical ventilation has 
detrimental effects on diaphragm structure and function. In the present study 
we report beneficial effects of hypercapnic acidosis on the diaphragm during 
controlled mechanical ventilation. The most important new findings are that 1) 
Mechanical ventilation under hypercapnic conditions prevents loss of myosin 
in the diaphragm. 2) Hypercapnic acidosis largely abolishes ventilator-induced 
inflammation in the diaphragm.  3) Hypercapnic acidosis does not attenuate the 
immediate effects of mechanical ventilation on diaphragm single fiber function. 
4) The antioxidant DTT restores diaphragm muscle function in the hypercapnic 
ventilated group.  
Effects of hypercapnia on ventilator-induced diaphragm dysfunction
In line with previous studies in animals and humans the present findings confirm 
that diaphragm weakness upon prolonged mechanical ventilation is accompanied 
by increased levels of inflammatory mediators in the diaphragm, activation of 
proteolytic pathways and loss of contractile proteins [1, 3, 4, 22-26].
Hypercapnic acidosis has been shown to impair diaphragm function [27-30]. Very 
recently however, Jung et al. showed that hypercapnic acidosis protects against 
diaphragm dysfunction in piglets after 72 hours of mechanical ventilation [9]. In 
apparent contrast, we observed a decreased force in single fibers after 18 hours of 
hypercapnic mechanical ventilation. Of note, Jung et al. used an in vivo model of 
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diaphragm function, by stimulating phrenic nerves while the present study looked 
specifically at contractile proteins and their function. A plausible explanation 
for this discrepancy is that recovery of diaphragm function upon hypercapnia 
becomes significant after 18 hours of mechanical ventilation. Interestingly, in 
the study by Jung et al. diaphragm function was also decreased after 12 hours in 
both normal and hypercapnic ventilated groups [9]. Although that study clearly 
showed a potential beneficial effect of hypercapnia after 72 hours of mechanical 
ventilation, the mechanisms by which hypercapnia exerts these effects were 
not studied [10]. An important finding of the present study is that hypercapnia 
completely prevented mechanical ventilation induced loss of myosin (Figure 
2B). Preservation of myosin most likely resulted from reduced degradation, 
as mechanical ventilation under hypercapnic conditions was associated with 
reduced 20S proteasomal activity and a trend of increased ratio of ubiquitinated 
myosin over total myosin (Figure 4A/B). Of note, the correction for total myosin 
presumably underestimates the actual amount of ubiquitinated myosin in MV+H, 
since the concentration of myosin is increased in this group. We observed a 
trend of decreased myosin content per muscle weight in ventilated rats, but 
not in hypercapnic ventilated rats. Since myosin is one of the major proteins in 
skeletal muscle, correcting myosin content for total muscle weight is expected 
to underestimate the loss of myosin. Therefore we chose to analyse myosin loss 
more precisely by measuring myosin concentration (i.e. the amount of myosin 
per muscle volume) in single fibers. Remarkably, concentration of myosin in 
diaphragm single fibers of hypercapnic ventilated animals was even higher than in 
controls. This can be explained by the fact that the CSA was slightly decreased in 
the hypercapnic ventilated group compared with control (Figure 2C). Accordingly, 
myosin concentration increases when myosin content remains stable, but the 
volume of the muscle fiber, reflected by CSA, decreases. These data suggest that 
loss of myosin and loss of muscle fiber circumference are likely not tightly linked 
[31]. Preservation of myosin in the hypercapnic ventilated group however did 
not protect the diaphragm muscle from reduced force generation, implicating 
more dysfunctional myosin in hypercapnic ventilated rats. This discrepancy is 
most likely the result of posttranslational modifications of contractile proteins. 
Indeed, the antioxidant DTT increases force-generating capacity of diaphragm 
fibers from the MV+H group, indicating that oxidative protein modifications 
play a role in loss of force induced by controlled mechanical ventilation under 
hypercapnic conditions. Notably, DTT did not improve force generation in muscle 
fibers in the group ventilated under normocapnic conditions (Figure 6A). There 
are two reasonable explanations for the different effect of DTT on normocapnic 
and hypercapnic fibers. First, as hypercapnia reduced proteasomal activity, 
degradation of post-translationally modificated (i.e. oxidated) myosin in the 
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diaphragm is attenuated. In line with that, hypercapnic ventilation tended to 
increase levels of ubiquitinated myosin. In both ventilated groups, an increase 
of LC3B-II protein suggests activation of autophagy. However the autophagy 
marker beclin-1 was not increased. Such a discrepancy has also been observed 
recently in the diaphragm in septic mice [32], suggesting that autophagy can 
occur independent of beclin-1. 
Secondly, hypercapnia may be associated with oxidative stress. Indeed, Arbogast 
et al. demonstrated that elevated CO2 promotes oxidant activity in diaphragm 
muscle bundles [33]. We attempted to detect oxidative modifications of muscle 
proteins by measuring level of HNE. However, we did not see any difference 
between groups in HNE levels, which does not exclude that other oxidative 
modifications, e.g. formation of disulfide bonds, have occurred.
In the present study, hypercapnic ventilated animals showed an acidemia 
during most time of mechanical ventilation period (Figure 1A). The question 
that remains is if the effects on the diaphragm observed in the present study 
are the result of hypercapnia or the combination of hypercapnia and acidemia. 
We have recently concluded that most beneficial effects appear to be pH 
mediated in both in vivo and in vitro experiments, although synergistic effects 
of acidemia and hypercapnia have also been observed [8]. Besides its direct 
effects on muscle function, hypercapnia has systemic effects. For example, by a 
rightward shift of the oxyhemoglobin dissociation curve, oxygen release to the 
tissues is facilitated [8] and by sympathetic stimulation increasing cardiac output 
and MAP [8, 9]. Unexpectedly, we observed a significantly decreased MAP in 
hypercapnic ventilated animals. Whether systemic effects of hypercapnia could 
affect diaphragm function during controlled mechanical ventilation is however 
uncertain.
Effect of cytokines in muscle and hypercapnia
Recent work from our lab showed that 8 hours of mechanical ventilation induced 
an inflammatory response in the mouse diaphragm [4]. The current study confirms 
this observation in the mechanically ventilated group. Hypercapnia largely 
abolished the increases levels of inflammatory cytokines in the diaphragm of 
ventilated rats (Figure 3). Attenuating the inflammatory response by hypercapnia 
might protect the diaphragm from atrophy during mechanical ventilation. Previous 
studies have shown that hypercapnia dampens the inflammatory response, 
probably through inhibition of NF-κB, in acute lung injury [6, 8, 34]. The remaining 
question is whether myosin preservation and depression of proteasome activity 
in the diaphragm of the hypercapnic ventilated group is mediated by attenuation 
of the inflammatory response or by a direct effect of hypercapnia on NF-κB 
inhibition. Both tumor necrosis factor-alpha and IL-1beta have been associated 
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with skeletal muscle atrophy [35-37]. Tumor necrosis factor-alpha induces protein 
loss in cultured C2C12 skeletal muscle cells [36] and exposure of skeletal muscle 
cells to IL-1beta for 48 hours induces muscle atrophy [35]. Of note, although IL-10 
is an anti-inflammatory cytokine, its production is induced by pro-inflammatory 
mediators and therefore changes in IL-10 levels, as observed in the current 
study, can also be considered as a surrogate marker of the magnitude of the 
pro-inflammatory response [38, 39].
Clinical relevance
Hypercapnic acidosis has been shown to attenuate ventilator-induced lung injury 
and inflammation [8]. The present study shows that therapeutic hypercapnia 
may also protect the diaphragm from adverse events associated with controlled 
mechanical ventilation. This is of potential clinical importance, since respiratory 
muscle dysfunction frequently occurs in mechanically ventilated patients and is 
associated with prolonged weaning, increased morbidity and mortality in ICU 
patients [40-42]. Besides training, no specific treatment is currently available 
for muscle weakness in the critically ill. Therefore, therapeutic hypercapnia 
during mechanical ventilation in order to prevent ventilator-induced diaphragm 
weakness deserves further study. 
Our study also generates new hypotheses on the role of antioxidants in the 
prevention of ventilator-induced respiratory muscle dysfunction. Betters et al. 
have shown that administration of antioxidants at time of initiation of mechanical 
ventilation is effective in the prevention of diaphragm dysfunction [12]. Our 
data indicate that once ventilator-induced diaphragm dysfunction has occurred 
antioxidants might not be effective (Figure 6A), unless mechanical ventilation is 
performed under hypercapnic conditions. This study indicates that the timing of 
antioxidant administration may be of critical importance as well as the associated 
conditions (i.e. the presence of hypercapnia). 
CONCLUSION
The present study shows that mechanical ventilation under hypercapnic 
conditions protects the diaphragm from ventilator-induced diaphragm-atrophy 
and enables antioxidants to restore diaphragm muscle force after 18 hours of 
mechanical ventilation.
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ABSTRACT
Introduction Controlled mechanical ventilation and endotoxemia are associated 
with diaphragm muscle atrophy and dysfunction. Oxidative stress and activation 
of inflammatory pathways are involved in the pathogenesis of diaphragm 
dysfunction. Levosimendan, a cardiac inotrope, has been reported to possess 
anti-oxidative and anti-inflammatory properties. The current study aimed to 
investigate the effects of levosimendan on markers for diaphragm nitrosative and 
oxidative stress, inflammation and proteolysis in a mouse model of endotoxemia 
and mechanical ventilation.
Methods Three groups were studied: 1. unventilated mice (CON, n=8), 2. 
mechanically ventilated endotoxemic mice (MV LPS, n=17) and 3. mechanically 
ventilated endotoxemic mice treated with levosimendan (MV LPS+L, n=17). 
Immediately after anesthesia (CON) or after 8 hours of mechanical ventilation, 
blood and diaphragm muscle were harvested for biochemical analysis. 
Main results Mechanical ventilation and endotoxemia increased expression of 
inducible nitric oxide synthase (iNOS) mRNA and cytokine levels of interleukin 
(IL)-1beta, IL-6 and keratinocyte-derived chemokine (KC), and decreased IL-10 in 
the diaphragm, but had no effect on protein nitrosylation and 4-hydroxy-2-non-
enal-protein concentrations. Levosimendan decreased nitrosylated proteins by 
10% (p < 0.05) and 4-hydroxy-2-nonenal-protein concentrations by 13%  (p < 
0.05), but augmented the rise of iNOS mRNA by 47% (p < 0.05). Levosimendan did 
not affect the inflammatory response in the diaphragm induced by mechanical 
ventilation and endotoxemia.
Conclusions Mechanical ventilation in combination with endotoxemia results 
in systemic and diaphragmatic inflammation. Levosimendan partly decreased 
markers of nitrosative and oxidative stress, but did not affect the inflammatory 
response. 
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INTRODUCTION
Respiratory muscle dysfunction frequently develops in critically ill patients [1-4]. 
Clinical entities associated with respiratory muscle dysfunction in these patients 
include systemic inflammation [3, 5] and controlled mechanical ventilation 
[6]. Recent data obtained from both animal and human studies have provided 
insight in the biochemical pathways underlying muscle atrophy and dysfunction 
in these patients [1, 7-9]. Nitrosative and oxidative protein modifications are 
increased in the diaphragm during both mechanical ventilation and experimental 
sepsis [10, 11]. Moreover, protein degradation is increased in the diaphragm of 
mechanically ventilated animals and patients [2, 12, 13]. Inflammatory cytokines 
are well-known modulators of muscle protein turnover during endotoxemia [14, 
15] and are increased in diaphragm after mechanical ventilation [16, 17]. For 
example, tumor necrosis factor (TNF)-alpha activates the proteolytic enzymes 
caspase 8 and 3 in diaphragm of mice exposed to lipopolysaccharide (LPS) [5]. 
Accordingly, strategies that reduce oxidative stress or inflammation may limit 
respiratory muscle dysfunction due to endotoxemia and mechanical ventilation 
[11, 17]. 
Levosimendan is a cardiac inotrope approved for the treatment of heart failure 
in many countries world-wide. We have recently shown that levosimendan also 
improves respiratory muscle function in healthy subjects and patients with chronic 
obstructive pulmonary disease [18, 19]. The mechanisms of levosimendan include 
calcium sensitization of the contractile proteins and vasodilation through activation 
of ATP sensitive K-channels [20]. Interestingly, previous studies have shown that 
levosimendan reduces inflammation and also oxidative- and nitrosative stress 
[21-23]. For instance, in experimental septic rodents, levosimendan decreases 
IL-1beta [24]. In addition, levosimendan decreases LPS-induced upregulation 
of IL-6, nitrite production and iNOS protein expression in macrophages and 
fibroblasts [21]. However, the effects of levosimendan on inflammation and 
oxidative / nitrosative stress in muscle have not been investigated, despite the 
importance of these pathways in ICU acquired muscle weakness. 
Accordingly, the hypothesis of the current study is that levosimendan dampens 
both oxidative and nitrosative stress and the inflammatory response in the 
diaphragm induced by endotoxemia.
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MATERIALS & METHODS
Animals
Experiments were performed using male C57BL/6 mice aged 19 ± 0.5 weeks, 
bodyweight 24 ± 0.3 gram (Charles River, Sulzfeld, Germany). 
To test the hypothesis that levosimendan dampens both oxidative and nitrosative 
stress and the inflammatory response in the diaphragm induced by mechanical 
ventilation and experimental sepsis, forty-two mice were divided into three groups: 
1. Unventilated controls (CON, n=8), 2. mechanical ventilation and LPS (MV LPS, 
n=17) and 3.) Mechanical ventilation and LPS + levosimendan (MV LPS+L, n=17). 
The effects of mechanical ventilation on inflammatory markers in mice have been 
investigated before in our lab [16]. Because patients admitted to the intensive 
care with endotoxemia often require mechanical ventilation, we used an animal 
model in which endotoxemia was administered prior to mechanical ventilation. In 
both groups, LPS (10 microgram) was administered by intra-peritoneal injection 
directly before initiation of mechanical ventilation.
The final choice for the dose of LPS was based on pilot experiments. In a pilot 
study we found that administration of 100 ug of LPS resulted in high mortality. 
Nevertheless, immediately after intraperitoneal injection of LPS bolus, one mouse 
in MV LPS+L died and was excluded from the study. At the start of mechanical 
ventilation, mice in the levosimendan group received a dose of levosimendan 
(Orion Pharma, Espoo, Finland) (24 µg/kg bodyweight in 5% glucose solution) via 
the tail vein. Subsequently, levosimendan (0,2 µg/kg/min i.v.) was administered 
during mechanical ventilation [20]. Experiments were approved by the Regional 
Animal Ethics Committee (Nijmegen, The Netherlands) and performed under the 
guidelines of the Dutch Council for Animal Care. 
Controlled mechanical ventilation
Mice selected for mechanical ventilation were anesthetized and mechanically 
ventilated as described previously [16]. Briefly, mice were anesthetized with 
an intraperitoneal injection of a combination of ketamine, medetomidine, and 
atropine (KMA): 7.5 ml per gram of body weight of induction KMA mix (consisting 
of 1.26 ml ketamine, 100 mg/ml; 0.2 ml medetomidine, 1 mg/ml; 1 ml atropine, 0.5 
mg/ml; and 5 ml NaCl, 0.9%). Tidal volume was 8 ml/kg bodyweight, respiratory 
rate of 170/min, positive end-expiratory pressure of 1.5 cmH2O and inspired 
oxygen fraction of 0.45. A sterile catheter was inserted in the carotid artery for 
continuous blood pressure measurement and blood sampling at the end of the 
experiment (Blood Gas Analyzer i-STAT, Abbott, Hoofddorp, The Netherlands). To 
maintain anesthesia, 5.0μl/gram bodyweight of bolus of KMA mix (consisting of 
0.72 ml ketamine, 100 mg/ml; 0.08 ml medetomidine, 1 mg/ml; 0.3 ml atropine, 
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0.5 mg/ml; and 18.9 ml NaCl, 0.9%) was administered through an intraperitoneal 
catheter, every 30 min. The CON mice were anesthetized and sacrificed without 
being mechanically ventilated as described previously [16]. 
Tissue collection
Immediately after anesthesia  (CON) or after 8 hours of mechanical ventilation 
(MV LPS and MV LPS+L), mice were exsanguinated and a combined thoracotomy 
and laparotomy was performed. Left and right hemidiaphragm tissue were rinsed, 
quickly frozen in liquid nitrogen and stored at −80 °C for later biochemical analysis 
[16].
Nitrotyrosine 
Protein nitrosylation was evaluated by detection of nitrotyrosine residues by 
performing SDS–polyacrylamide gel electrophoresis, as described previously 
[25]. In short, diaphragm muscle was homogenized in ice-cold buffer, (pH 7.2 10 
mM Tris/Maleate, 3 mM EGTA, 275 mM sucrose, 0,1 mM dithiothreitol, 2 mg/ml 
Leupeptine, 2 mg/ml Aprotinine, 10 mg/L Pepstatine A, 0,57 mM phenylmethyl-
sulphonylfluoride) using a polytron, followed by 3 cycles of freeze/thawing and 
30 minutes centrifugation at 17.000g at 4˚C. Supernatant protein content was 
measured by Bradford analysis and 20 microgram of proteins in Laemmli buffer 
were analysed by standard Western blotting protocols. Blots were stained using 
an anti-nitrotyrosine antibody (clone 1A6; Upstate Biotechnology, Lake Placid, NY) 
and goat anti-mouse IRDye 800CW (LI-COR, Lincoln, NE). Analysis was done using 
ODYSSEY scanner and ODYSSEY 2.1 software (LI-COR).
iNOS expression
Messenger ribonucleic acid levels of iNOS mouse: Mm01309902 m1, Applied 
Biosystems, Carlsbad, CA, USA) were determined by quantitative polymerase 
chain reaction as described previously [26]. 
HNE-protein
4-hydroxy-2-nonenal-protein (HNE)-protein was analysed as follows, sample was 
homogenized in 100 volumes buffer (20 mM Tris pH 7,4, 20 mM EGTA, 1 mM 
DTT, 0,5 % SDS, 1ul/20 mg Protease inhibitor cocktail (P8340, Sigma, Zwijndrecht, 
The Netherlands)), by polytron tissue homogenization. Samples were diluted 
in standard Laemmli sample buffer and 2 minutes boiled. 10 microliter of each 
sample was analysed by standard Western Blotting protocols. Used antibodies 
were: anti-HNE (Fluorophore Rabbit pAb, Cat. No. 393206, Calbiochem, Darmstadt, 
Germany); anti-Actin (A2066, Sigma-Aldrich, St. Louis, MO, USA); second antibody 
IRDye®800CW Goat anti-Rabbit IgG (926-32211, LI-COR Biosciences, Lincoln, 
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Nebraska, USA). Odyssey scan and Odyssey application software version 2.1 
(LI-COR, Lincoln, NE) were used for analysis of HNE-protein signal.
Cytokines in diaphragm and plasma
Levels of IL-1beta, IL-10, TNF-alpha, IL-6 and KC in the diaphragm and IL-1beta, 
IL-10, TNF-alpha, IL-6 and KC in plasma were analysed by enzyme-linked-immu-
nosorbent assay as published previously [27]. To determine cytokine levels in the 
diaphragm, the muscle was homogenized in 100 volumes of ice-cold buffer, pH 
7.2 (10 mM Tris/Maleate, 3 mM EGTA, 275 mM sucrose, 0,1 mM dithiothreitol, 2 
mg/ml Leupeptine, 2 mg/ml Aprotinine, 10 mg/L Pepstatine A, 0,57 mM phenyl-
methylsulphonylfluoride) three cycles of freezing and thawing and centrifuged at 
17.000 G at 4°C for 30 minutes [16]. Lower detection limits were IL-10, 40 pg/ml 
for IL-1beta; 32 pg/ml for TNF-alpha; 160 pg/ml for IL-6 and for KC.
Caspase-3 activity
To assess involvement of proteolysis we measured caspase-3 activity as 
described previously [26]. The caspase-3 activity was determined by measuring 
the generation of the fluorogenic cleavage product methylcoumarylamide from 
the fluorogenic substrate N-acetyl-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin 
(Ac-DEVD-AMC) by spectrophotometry. 
MuRF-1 and MAFbx expression
Messenger ribonucleic acid levels of muscle RING-finger (MuRF-1) and Muscle 
Atrophy Factor box (MAFbx) were determined by quantitative polymerase chain 
reaction [26]. Levels of MuRF-1 and MAFbx messenger ribonucleic acid were 
normalized to glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic 
acid. Forward and reverse oligonucleotides were used as following: MuRF-1, 
5’-CAACCTGTGCCGCAAGTG-3’ and 5’-CAACCTCGTGCCTACAAGATG-3’, MAFbx, 
5’-GACTGGACTTCTCGACTGCC-3’ and 5’-TCAGCCTCTGCATGATGTTC-3’; Glycer-
aldehyde-3-phosphate dehydrogenase, 5’-TGATGGGTGTGAACCACGAG-3’ and 
5’-GGGCCATCCACAGTCTTCTG -3’. 
Statistical Analysis
A logrank test was performed to test difference in survival between MV LPS and 
MV LPS+L. Difference among groups regarding time courses of mean arterial 
pressure (MAP) was performed with a two-way ANOVA. D’Agostino-Pearson 
test was used to test verify normal distribution of all parameters studied. A 
unpaired Student t-test was performed to evaluate the statistical significance 
of differences of the following normally distributed parameters (nitrosylated 
proteins and HNE-protein between MV-LPS and MV LPS+L animals). Differences 
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between normally distributed parameters of diaphragm KC, plasma IL-10, 
IL-6, KC and caspase-3 activity regarding were analyzed with one-way ANOVA. 
Student-Newman-Keuls post hoc testing was used to test the probability level 
of differences between nominal divided groups. Differences between parameters 
not normally distributed (iNOS mRNA, diaphragm IL-1beta, IL-10, TNF-alpha, IL-6, 
plasma IL-1beta and TNF-alpha, MuRF-1 and MAFbx mRNA) were analyzed with 
one-way ANOVA Kruskal-Wallis and Dunn’s post hoc testing. For statistical analysis 
of cytokine measurements the value of the detection limit was used for samples 
that did not reach the detection limit. Graphpad prism was used to conduct 
statistical analysis (Graphpad Software Inc., San Diego, CA). A probability level of 
p < 0.05 was considered significant. All data are presented as mean ± SD. 
RESULTS
Animal characteristics
Blood pressure decreased progressively in both groups during 8 hours of 
mechanical ventilation (Figure 1, p = 0.09), despite volume therapy (0,3 ml/h). 
Bloodgas analysis at the end of the experiment is shown in table 1. Alveolar-arterial 
(A-a) oxygen gradient was high after 8 hours of mechanical ventilation in both 
groups (Table 1). Within the 8 hours of mechanical ventilation 30% (n=5) of the 
animals in the MV LPS group died (respectively 4 hours, 5 hours, 5½ hours and 2 
mice after 6 hours after initiation of mechanical ventilation). In the levosimendan 
treated group, 12% (n=2) of the mice died before the end of planned duration of 
mechanical ventilation (after 5 and 7 ½ hours of ventilation respectively; p = 0.2 
between groups). Animals that did not survive until the end of the study were 
excluded from further biochemical analysis. Accordingly, for biochemical analysis 
8 CON mice, 12 MV LPS mice and 14 MV LPS+L mice were included.
Nitrosative- and oxidative stress 
To investigate the effects of levosimendan on nitrosative- and oxidative stress 
in endotoxemic mechanically ventilated mice, diaphragm was analyzed on iNOS 
expression, protein nitrosylation and HNE-protein. Diaphragm iNOS expression 
was significantly increased by 274% in LPS exposed ventilated mice (p < 0.05 vs 
CON, Figure 2A). Unexpectedly, levosimendan enhanced the expression of iNOS 
by 47% (Figure 2A; p < 0.05 MV LPS vs MV LPS+L), but decreased diaphragm 
protein nitrosylation by 10% (Figure 2B/C; MV LPS vs MV LPS+L; p < 0.05). 
Diaphragm HNE-protein concentration was not significantly different between 
MV LPS animals versus CON animals. Levosimendan decreased the amount of 
HNE proteins in the diaphragm compared to MV LPS by 13% (Figure 2D/E; MV LPS 
vs MV LPS+L; p < 0.05).
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Figure 1 Course of blood MAP during 8 hours of mechanical ventilation.
Table 1 Arterial bloodgas and alveolar-arterial gradient after 8 hours of mechanical 
ventilation and endotoxemia exposure. Values are mean ± SEM. BE = base excess; PaCO2 
= arterial carbon dioxide tension; PaO2 = arterial oxygen tension; A-a gradient = Alveolar 
arterial gradient .
Inflammation
In MV LPS mice, proinflammatory cytokines were significantly upregulated in 
diaphragm muscle and plasma (Figure 3 and Figure 4). Levosimendan did not 
affect this inflammatory response.
Caspase-3 and E3-ligases 
Caspase-3 and E3-ligases, MuRF-1 and MAFbx, were analyzed as measures for 
muscle proteolysis. No differences in caspase-3 activity and MuRF-1 mRNA 
were observed between different groups. MAFbx expression was significantly 
increased in MV LPS and MV LPS+L animals compared to control (CON 27±12; 
MV LPS 102±35; MV LPS+L 114±47, ratio to GAPDH). Levosimendan did not affect 
expression of MAFbx in ventilated endotoxemic mice. 
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                                                                               A
                                                                               B
                                                                               C
                                                                               D
                                                                               E
Figure 2 A) Expression of iNOS in 
diaphragm. iNOS expression was 
increased in MV LPS versus CON 
(* p < 0.05). iNOS expression was 
increased in MV LPS+L versus CON 
and MV LPS (# p < 0.05). 
B) Nitrotyrosine concentration 
in diaphragm. Nitrotyrosine 
concentration was higher in MV LPS 
from MV LPS+L (* p < 0.05). 
C) Representative Nitrotyrosine blot. 
D) HNE-protein concentration relative 
to actin concentration in diaphragm. 
HNE-protein concentration was 
higher in MV LPS from MV LPS+L (* 
p < 0.05). 
E) Representative HNE-protein blot.
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Figure 3 Cytokine levels in diaphragm homogenates. MV LPS and MV LPS+L increased 
levels of IL-1beta, IL-6, KC and IL-10 (* p < 0.05 versus CON).
Figure 4 Plasma cytokines. Levels of IL-10 and TNF-alpha, IL-6 and KC were increased in 
MV LPS and MV LPS+L (* p < 0.05 versus CON).
Figure 5 Chemical reactions involved in the formation of nitrotyrosine.
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DISCUSSION
The main findings of the current study are that (1) levosimendan decreased 
protein nitrosylation and markers of oxidative stress in the diaphragm of 
endotoxemic mechanically ventilated mice. However, (2) levosimendan did not 
attenuate diaphragmatic and systemic inflammatory response, diaphragm iNOS 
and E3-ligase expression nor caspase-3 activity.
Effects of endotoxemia and mechanical ventilation on the diaphragm 
LPS in rodents is a widely used model to study the effects of endotoxemia on organ 
function, including respiratory muscles [28-31]. We found increased expression 
of inducible nitric oxide synthase (iNOS) in the diaphragm of these animals. 
This is in line with the only previous study that investigated a combination of 
endotoxemia and mechanical ventilation, reporting that diaphragm weakness 
was associated with elevated levels of iNOS protein [10]. In addition, in the 
current study pro-inflammatory cytokines were upregulated in the diaphragm of 
endotoxemic ventilated animals. This inflammatory response is consistent with 
earlier experimental models of either mechanical ventilation or endotoxemia [16, 
31, 32]. Mechanical ventilation as well as endotoxemia are known to increases 
proteolysis in the diaphragm, as supported for example by elevated caspase-3 
activity and expression of E3-ligases MuRF-1 and MAFbx [5, 33-35]. Expression 
of MAFbx was also enhanced in our endotoxemic ventilated mice. MuRF-1 
expression and caspase-3 activity were not elevated in endotoxemic ventilated 
mice. This suggests that the proteolytic response to a combination of mechanical 
ventilation and endotoxemia is weaker than to mechanical ventilation or 
endotoxemia separately. Reduced proteolysis could preserve diaphragm function. 
This is supported by findings from a previous study in rats [10], where mechanical 
ventilation was shown to partly prevent the development of diaphragm 
dysfunction during endotoxemia. However, it should be acknowledged that in 
the current study the effect of mechanical ventilation solely on the diaphragm 
was not evaluated, as this was not required to test the hypotheses of the current 
study.
It has been shown previously that endotoxemia is associated with pulmonary 
inflammation and elevated the alveolar-arterial oxygen gradient [36]. In line with 
those observations, we found in endotoxemic ventilated mice a high A-a gradient 
(Table 1). The A-a gradient was not assessed in control mice in the current study. 
We have previously shown that the alveolar-arterial oxygen gradient in healthy 
mice ventilated for 8 hours was higher than normal, (79 +/- 21 mmHg) [16], but 
significantly lower than reported in the current study for LPS exposed ventilated 
mice. This indicates that systemic effects of LPS further impaired oxygen uptake in 
the endotoxemic ventilated groups of the present study.
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Effects of levosimendan 
Among its inotropic effects through calcium sensitization, levosimendan has been 
shown to affect several intracellular pathways involved in oxidative stress and 
inflammation [21, 23]. In the present study, levosimendan infusion decreased 
nitrosylated protein levels in ventilated endotoxemic mice (Figure 2B). Peroxynitrite 
formation is one of the chemical reactions involved in the nitrosylation of tyrosine 
residues in proteins (Figure 5), [37, 38]. Peroxynitrite is an extremely reactive free 
radical generated from the reaction between nitric oxide and superoxide [39]. NO 
is synthesized from l-arginine under influence of the three NOS enzymes, iNOS, 
eNOS and nNOS [40]. 
In the current study, levosimendan did not reduce iNOS expression (Figure 2A) 
in diaphragm of mechanically ventilated endotoxemic animals. This may suggest 
that levosimendan reduced peroxynitrite formation by lowering superoxide levels. 
Decreased superoxide levels are expected to be accompanied by a reduction of 
markers for oxidative stress. In line with that assumption, HNE protein levels (a 
marker for oxidative stress) were decreased in the diaphragm of levosimendan 
treated mice (Figure 2D). In accordance with the possible ability of levosimendan 
to reduce oxidative stress, a recent investigation showed that levosimendan 
treatment increased protective antioxidant enzyme levels in renal tissues of rats 
[41]. Independent from the peroxynitrite formation, myeloperoxidases can induce 
tyrosine nitrosylation (Figure 5) [42]. Interestingly, previous experimental studies 
have shown that levosimendan reduces myeloperoxidase activity in the heart 
and spinal cord [43, 44], but this has not been investigated in the diaphragm. 
Although we did not specifically investigate this pathway, we cannot exclude 
that levosimendan decreased protein nitrosylation by reducing myeloperoxidase 
activity. 
In the current study, levosimendan did not attenuate the pro-inflammatory 
response to endotoxemia and mechanical ventilation neither in plasma nor 
in the diaphragm (Figure 3 & 4). The lack of effect of levosimendan on plasma 
inflammation after levosimendan exposure is in line with previous studies [45, 
46]. In apparent contrast, in experimental sepsis induced by cecal ligation and 
incision, levosimendan did reduce high plasma levels of IL-1beta [24]. However, in 
our animal model plasma levels of IL1-beta were not elevated after LPS exposure. 
Furthermore, levosimendan did not dampen MAFbx expression in endotoxemic 
ventilated mice. Interestingly, IL-6 is a well-known regulator of MAFbx gene 
expression [47]. The absence of an effect of levosimendan on plasma and diaphragm 
IL-6 could be an explanation for the absence of a dampened effect of levosimendan 
on MAFbx expression. The activation of caspase-3, another essential player in 
muscle protein degradation, was reduced in the spleen of septic animals treated 
with levosimendan [24]. Also, in cardiac muscle cells levosimendan could protect 
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against hydrogen peroxide induced caspase-3 activation [23]. In the present study 
caspase-3 activity in the diaphragm was unchanged by levosimendan, but also 
not enhanced by endotoxemia and mechanical ventilation. 
Study limitations 
The present study has limitations that should be acknowledged. First, the 
duration of mechanical ventilation and endotoxemia in the present study is 
relatively short when compared to critically ill patients. It should be noted that 
mechanical ventilation in mice is challenging, due to limited possibilities of vital 
function monitoring and the fact that due to very small intravascular volume (~2 
ml), no repetitive samples can be withdrawn for blood gas analysis. Nevertheless, 
in the current study 8 hours mechanical ventilation resulted in modulation of 
important biochemical pathways in the diaphragm, in line with our previous 
study shown previously [16]. Therefore, this time period is appropriate to study 
the effects of levosimendan on activation of inflammatory and proteolytic 
pathways. A second limitation of our study is that we did not assess the effects 
of levosimendan on diaphragm muscle function. Previously, we have shown that 
levosimendan improves diaphragm muscle function, both in vitro and in vivo in 
healthy subjects, in patients with COPD and animal models for congestive heart 
failure [18, 19, 48]. We can only speculate that it also will improve diaphragm 
function in the current model, but this should be confirmed in future studies. 
Thirdly, as mechanical ventilation of endotoxemic mice is technically challenging, 
we were reluctant to invasively monitor cardiac output or tissue perfusion, which 
is of potential interest as levosimendan has both been shown to improve cardiac 
output and induce vasodilation [20]. Finally, in the present study LPS was used to 
induce an inflammatory response, LPS administration to animals has been proven 
to be a predictable model of systemic inflammation [49]. However it should be 
acknowledged that this is a model for systemic inflammation, and not necessarily 
reflect the physiological processes observed in human septic shock. 
CONCLUSION
In an animal model of endotoxemia and mechanical ventilation, levosimendan 
decreases markers of oxidative and nitrosative stress. Therefore our data may 
suggest, that the beneficial effects of levosimendan in clinical trials [20, 50] 
may partly result from effects beyond calcium sensitization. The current study 
provides a rationale to investigate such a mechanism in a clinical study. We are 
currently investigating levosimendan in a randomized clinical trial (NCT01721434) 
in patients difficult to wean from the ventilator.
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treatment with levosimendan on oxidative stress in renal tissues of rats. Toxicol Ind Health 2014, 
30(1):47-51.
42. Van der Vliet A, Eiserich JP, Halliwell B, Cross CE: Formation of reactive nitrogen species during 
peroxidase-catalyzed oxidation of nitrite: a potential additional mechanism of nitric oxide-dependent 
toxicity. J Biol Chem, 1997, 272(12):7617-7625.
43. Yapici D, Altunkan Z, Ozeren M, Bilgin E, Balli E, Tamer L, Doruk N, Birbicer H, Apa D, Oral U: Effects of 
levosimendan on myocardial ischaemia-reperfusion injury. Eur J Anaesthesiol, 2008; 25(1):8-14.
44.  Katircioglu SF, Seren M, Parlar AI, Turan NN, Manavbasi Y, Aydog G, Cicekcioglu F, Tutun U, Ulus AT: 
Levosimendan Effect on Spinal Cord Ischemia-Reperfusion Injury Following Aortic Clamping. J Card 
Surg, 2008, 23(1):44-48.
45. Chew MS, Hawthorne WJ, Bendall J, Whereat S, Huang S, Ting I, Simond D, Mclean A: No beneficial 
effects of levosimendan in acute porcine endotoxaemia. Acta Anaesthesiol Scand 2011, 55(7):851-861.
46. Zager RA, Johnson AC, Lund S, Hanson SY, Abrass CK: Levosimendan protects against experimental 
endotoxemic acute renal failure. Am J Physiol Renal Physiol 2006, 290(6):F1453-1462.
47. Baltgalvis KA, Berger FG, Peña MMO, Davis JM, White JP, Carson JA: Muscle wasting and 
interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse. Pflugers Arch 2009, 
457(5):989-1001.
48.  Van Hees HWH, Andrade Acuña Gl, Linkels M, Dekhuijzen PNR, Heunks LMA. Levosimendan improves 
calcium sensitivity of diaphragm muscle fibres from a rat model of heart failure. Br J Pharmacol. 2011; 
162:566–573.
49.  Remick DG, Ward PA: Evaluation of endotoxin models for the study of sepsis. Shock 2005, 24, Suppl. 1: 
7–11.
50. Fuhrmann JT, Schmeisser A, Schulze MR, Wunderlich C, Schoen SP, Rauwolf T, Weinbrenner C, Strasser 
RH: Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute 
myocardial infarction. Crit Care Med 2008, 36(8):2257-2266.
115
Levosimendan affects oxidative and inflammatory pathways in the diaphragm of ventilated endotoxemic mice Chapter 6
6
116
Chapter 7
Strategies to optimize respiratory muscle 
function in weak ICU patients
W.J.M. Schellekens
H.W.H. van Hees
J. Doorduin
L.H. Roesthuis
G.J. Scheffer
J.G. van der Hoeven
L.M.A. Heunks
Accepted for publication in Critical Care
118
Strategies to optimize respiratory muscle function in weak ICU patientsChapter 7 
ABSTRACT 
Respiratory muscle dysfunction may develop rapidly in critically ill ventilated 
patients and is associated with increased morbidity, length of ICU stay, costs and 
mortality. This review briefly discusses the pathophysiology of respiratory muscle 
dysfunction in ICU patients and will then focus on strategies that prevent the 
development of muscle weakness, or if weakness has developed how respiratory 
muscle function may be improved. The authors propose a simple strategy how 
these strategies can be implemented in clinical care.
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INTRODUCTION
Ventilatory failure develops in case of an imbalance in loading and capacity of 
the respiratory muscle pump. Reduced force output of the respiratory muscles is 
frequently seen in ventilated critically ill patients [1-4]. In fact, only a brief period 
of controlled mechanical ventilation (±1-3 days) is associated with development 
of diaphragm muscle atrophy [5]. Subsequently, Jaber and colleagues [1] 
demonstrated that after 5-6 days of controlled mechanical ventilation 
force-generating capacity of the diaphragm was reduced by ±32%. In ICU patients, 
impaired capacity of the respiratory muscles is accompanied by an increased 
load due to elevated elastic and resistive forces of the respiratory system. This 
imbalance in load and capacity of the inspiratory muscles plays an important 
role in the development of ventilatory failure, for instance during a weaning 
trial. Respiratory muscle weakness is associated with adverse clinical outcomes, 
including difficult weaning from mechanical ventilation, increased aspiration risk, 
increased mortality [6-9], increased risk of ICU / hospital readmission [10] and 
increased costs [11]. Proposed risk factors for the development of ICU acquired 
respiratory muscle weakness include disuse due to excessive ventilator support, 
systemic inflammation (infection, sepsis), neuromuscular blockers and steroids 
[12-15].
It is reasonable to propose that strategies that aim to improve respiratory muscle 
function in these patients improve outcome. Indeed, inspiratory muscle training 
enhances weaning from the ventilator in weak ICU patients [16]. However, today 
no drugs are approved to enhance respiratory muscle function. This is surprising, 
as several drugs are available to improve cardiac muscle contractility. However, 
physiological studies have provided evidence that pharmacological modulation of 
respiratory muscle contractility is indeed feasible [17, 18]. The aim of the present 
paper is to discuss (future) strategies that prevent the development of respiratory 
muscle weakness or restore respiratory muscle function in weak ICU patients. We 
will focus on interventions that are most likely to be of clinical importance in the 
near future. First, we will briefly summarize the pathophysiology of ICU acquired 
respiratory muscle weakness. 
Pathophysiology of respiratory muscle weakness in the critically ill
Reduced force output of the respiratory muscles in the critically ill may result from 
injury at any point between the central respiratory centres and the contractile 
proteins of diaphragm muscle fibers [12, 14]. In the absence of sedatives, 
reduced central respiratory drive is unlikely to explain reduced force output of the 
respiratory muscles in ICU patients [19]. Phrenic nerve neuropathy, as assessed 
by prolonged phrenic nerve conduction time, has been demonstrated in ICU 
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patients, indicating that injury of the peripheral nerve may play a role in reduced 
force output [20].
Contractile dysfunction of the respiratory muscles in ICU patients may result 
from the loss of muscle mass (atrophy) and / or dysfunction of the remaining 
contractile proteins. In a landmark paper, Levine and colleagues demonstrated 
the rapid development of diaphragm muscle atrophy in ventilated brain dead 
patients [5]. More recently, Hooijman and colleagues performed in depth 
functional and structural analysis of diaphragm biopsies in critically ill patients on 
the ventilator [21]. In that study, muscle fiber cross sectional area was reduced 
by ±25% after an average of 7 days of mechanical ventilation. Interestingly, the 
diaphragm appeared more susceptible to atrophy compared to other respiratory 
and non-respiratory muscles [5, 21, 22]. Muscle atrophy is the final result of an 
imbalance between protein synthesis and degradation. Upregulation of several 
proteolytic pathways has been demonstrated in the respiratory muscles of ICU 
patients [21, 23]. For instance, key regulators of the ubiquitin-proteasome pathway 
are upregulated in the diaphragm of these patients [5, 21]. Other pathways such 
as lysosomal protein degradation and autophagy may play a role as well (Figure 
1) [13, 24]. In addition to enhanced proteolysis, decreased protein synthesis has 
been reported in the diaphragm of rodents subjected to controlled mechanical 
ventilation [25, 26]. Also, decreased protein synthesis of non-respiratory skeletal 
muscles has been reported in critically ill patients [15, 27]. In addition to atrophy, 
diaphragm weakness may be the result of contractile protein dysfunction. Even 
when corrected for loss of protein, muscle fibers in ICU patients develop less 
force. In addition, the sensitivity for calcium of the contractile proteins is reduced 
[4]. The pathophysiology of contractile protein dysfunction in these patients is 
incompletely understood, but phosphorylation and oxidative modifications of the 
sarcomeric proteins appear to play a role [28, 29]. For extensive background on 
the pathophysiology of muscle dysfunction in the critically ill, we refer to a recent 
excellent review on this subject [30]. 
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Figure 1 Proposed scheme of pathofysiologic pathways in the development of respiratory 
muscle weakness during critical illness. Oxidative stress [31], inflammation [32, 33], increase 
in NF-κB activity [34] and mechanical unloading [5, 21] have been proposed to initiate 
respiratory muscle weakness. Due to these initiators, contractile protein can become 
dysfunctional [4], synthesis can be decreased [25, 26], or cause musculair autophagy [24]. 
Oxidative stress and inflammatory pathways can activate caspases and calpains [31, 35]. 
Thereby, these pathways can deliver substrate for the ubiquitin-proteasome [5, 21, 36] 
that further degradates contractile proteins.
In conclusion, the pathophysiology of ICU acquired respiratory muscle weakness 
involves the activation / inhibition of multiple molecular pathways associated 
with the protein balance and post-translational modifications of the contractile 
machinery. Understanding these pathways provides a rationale to evaluate 
specific interventions to improve respiratory muscle function in these patients. 
Evaluation of respiratory muscle function in ICU patients
Evaluation of respiratory muscle function is a challenge, in particular in ventilated 
ICU patients. However, both for diagnostic purposes and evaluation of the 
effect of interventions in depth analysis of respiratory muscle function may be 
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necessary. We will briefly discuss the readily available techniques that are relevant 
and feasible in clinical practice. For a detailed overview we refer to other review 
papers [37-39].
Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) are 
relatively simple tests to evaluate global respiratory muscle strength and can be 
applied to selected ICU patients. MIP and MEP are measured using a handheld 
pressure device connected to the endotracheal tube or tracheostomy while the 
patient performs specific manoeuvres. Alternatively, pressures can be assessed 
using the ventilator by performing an end-expiratory hold manoeuvre. It should 
be noted that high values exclude clinically significant weakness, but low values 
are common and may also reflect poor technique or effort [40]. A 20-second 
end-expiratory occlusion can be performed to obtain more reliable measurements 
in poorly cooperative patients [41]. 
Esophageal pressure (Pes) is an estimate of pleural pressure [42], and can be 
used to calculate the amount of work performed by the respiratory muscles. 
Simultaneous recording of Pes and gastric pressure (Pga) allows the calculation 
of transdiaphragmatic pressure (Pdi = Pga - Pes), a specific measure of diaphragm 
contractility. The latter is useful for close monitoring and evaluation of diaphragm 
function in difficult-to-wean patients [7], However, acquisition, calculation and 
interpretation of Pes, Pga and their derived measures are rather complex and 
therefore not widely accepted in clinical practice.
Ultrasonography is an increasingly popular tool for assessment of diaphragm 
function, as it is widely available, portable, non-invasive, rather easy to learn and 
has been validated in ICU patients [43-45]. Visualizing diaphragm excursion during 
unassisted respiration allows detection of reduced or paradoxal movement. 
Thickness of the diaphragm muscle at end-expiration is used to detect atrophy 
[46], and its thickening fraction during inspiration to asses contractile activity [44]. 
Future fields of application may be detection of patient-ventilator asynchrony 
[47], and assessment of respiratory workload [48, 49].
Diaphragm electromyography (EMG) reflects the electrical activity and is the gold 
standard to assess neural respiratory drive. Diaphragm EMG can be recorded best 
using an esophageal catheter with multiple electrodes. With the introduction of 
neurally adjusted ventilatory assist (NAVA) (Maquet, Solna, Sweden) [50], the 
(processed) EMG signal can be obtained continuously in clinical care of ventilated 
patients. In these patients, diaphragm EMG may be used to monitor respiratory 
muscle unloading [51] and patient-ventilator interaction [52]. 
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Modulation of contractile activity: Disuse and inspiratory muscle training
A. Prevention of disuse atrophy
Like any other striated muscle, respiratory muscle mass is affected by contractile 
activity. In fact, the respiratory muscles appear more sensitive to the effects of 
disuse compared to other striated muscles [5, 21, 22]. In humans, relatively brief 
periods of diaphragm disuse (< 3 days) due to controlled mechanical ventilation 
are associated with diaphragm muscle fiber atrophy [5]. 
Animal studies have demonstrated that mechanical ventilation-induced diaphragm 
atrophy and dysfunction is less severe in assisted modes of mechanical ventilation 
[53]. However, 48 hours of muscle relaxants in patients with early severe ARDS, in 
fact fastened liberation from mechanical ventilation and did not adversely affect 
peripheral muscle function, virtually excluding a clinically relevant adverse effect 
of short-term muscle relaxants on respiratory muscle function in the early phase 
of severe critical illness [54]. Therefore, it appears that under certain conditions 
(i.e. severe ARDS) controlled mechanical ventilation is preferred to facilitate 
lung-protective ventilation and this beneficial effect outweighs the possible 
adverse effects on the respiratory muscles. Nevertheless, it is reasonable to limit 
the duration of controlled mechanical ventilation and such diaphragm inactivity, 
to reduce the risk of disuse atrophy. Recently, we showed that assisted ventilation 
allows lung protective ventilation in selected patients with mild to moderate ARDS 
[55]. It is important to recognize that ventilator pressure and flow waveforms are 
unreliable to confirm the presence of respiratory muscle activity [37, 38, 56]. 
We recommend additional monitoring techniques such as continuous recording 
of esophageal pressure, diaphragm electrical activity or ultrasound [37, 38, 44, 
56]. Although the optimal level of activity for the respiratory muscles is unknown 
during mechanical ventilation, these monitoring techniques allow us to detect 
complete inactivity of the muscles. 
B. Inspiratory muscle training
In general, training can be instituted to enhance muscle endurance or strength. 
These types of training require different strategies and have distinct physiological 
responses. In healthy subjects, respiratory muscle activity is characterized 
by development of low pressure during the entire life span of a subject. The 
pressure generated by the inspiratory muscles is only ±5 cmH2O (5% of maximum 
inspiratory pressure) to generate a tidal volume of 500 ml, when respiratory 
compliance is 100 ml/cmH2O. At first sight, training of the respiratory muscle 
should therefore be designed to improve endurance. Indeed, in patients difficult 
to wean from the ventilator progressive weaning trials (T-tube or low pressure 
support) are frequently instituted as training stimulus. Although reasonable from 
a physiological perspective, it has never been proven that this strategy indeed 
improves respiratory muscle endurance. 
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There are very few circumstances where high inspiratory pressure is required for 
prolonged periods of time and therefore strength training of the diaphragm seems 
of limited relevance. However, it has been demonstrated that respiratory effort 
sensation depends on the maximal inspiratory pressure [57]. In healthy subjects, 
pharmacological induction of inspiratory muscle weakness increases respiratory 
effort sensation for the same workload [57] confirming the importance of 
adequate strength beyond the strength strictly required to generate tidal volume. 
It has been shown that inspiratory muscle strength training (IMST) improves 
whole body exercise performance, in particular in less fit subjects [58]. Also, 
in patients with COPD inspiratory muscle training improves inspiratory muscle 
strength, total body exercise and reduces dyspnea sensation [59]. Only three 
randomized studies have reported the effectiveness of IMST in ventilated ICU 
patients. In the trial by Cader [60], 41 ventilated ICU patients with respiratory 
muscle weakness were randomized between inspiratory threshold loading and no 
training intervention. Training consisted of an inspiratory load of 30% maximum 
inspiratory pressure for 5 minutes, twice a day, seven days a week throughout 
the weaning period. Maximum inspiratory pressure was significantly increased 
in the training group (15 ± 3 cmH2O to 25 ± 4 cmH2O), but not in the control 
group (15 ± 2 cmH2O to 18 ± 2 cmH2O). The study was underpowered for clinical 
relevant endpoints, although weaning time was reduced in the training group. 
In another study, Martin and colleagues [16] randomized 69 ventilator bound 
patients (mean duration of ventilation at inclusion ±44 days) to inspiratory muscle 
training or sham training added to endurance training. Strength training consisted 
of four sets of 6-10 breaths per day with 2 minutes rest between each set. Loading 
was individualized and set at a level that could just be tolerated by the patient. 
Inspiratory muscle strength training significantly improved maximum inspiratory 
pressure (end of training 54cmH2O in intervention group and 45cmH2O in sham 
group, P<0.05). Also, successful weaning at day 28 after inclusion was more 
likely in the intervention group compared to sham (71% versus 47%, P<0.05). No 
adverse events of IMST were reported in these two trails. Finally, Condessa [61] 
randomized ventilated patients to inspiratory strength training on top of usual 
care versus usual care only. Each training session consisted of 5 sets of loaded 
breaths (40% maximum inspiratory pressure), twice a day, seven days a week. 
In this study, inspiratory strength training significantly increased maximum 
inspiratory pressure, but did not affect weaning time.   
In conclusion, inspiratory muscle training is feasible and appears safe in patients 
with respiratory muscle weakness difficult to wean from the ventilator. Studies in 
other patient categories, including COPD, indicate that inspiratory muscle training 
improves outcome. In our opinion, it is reasonable to add inspiratory muscle 
strength training to endurance training in stable difficult to wean patients with 
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confirmed respiratory muscle weakness. Future studies are needed to determine 
the optimal training protocol and appropriate timing for initiation of inspiratory 
muscle training.
Antioxidants and nutrition
As outlined above oxidative stress may play a role in the pathophysiology of 
ICU acquired respiratory muscle weakness. Several studies have evaluated the 
effects of a variety of antioxidants on respiratory muscle function, including 
ICU patients. Numerous animal studies have demonstrated that antioxidants 
attenuate the detrimental effects of controlled mechanical ventilation and / or 
systemic inflammation on respiratory muscle structure and function [62-68]. 
In healthy subjects, high dose N-acetylcysteine (150 mg/kg i.v.), attenuated 
diaphragm fatigue induced by an inspiratory resistive load [69]. Today, no study 
has specifically evaluated the effect of antioxidants on respiratory muscle function 
in ICU patients. However, some indirect evidence is available. In an open trial, 595 
critically ill surgery or trauma patients were randomized between antioxidants 
suppletion (alpha-tocopherol and ascorbic acid) and standard care or standard 
care only [70]. Patients in the antioxidant group spent less time on the ventilator 
(3.7 versus 4.6 days; P<0.05). It should be noted that patients in this study were 
young (38±15 yrs) and total ventilation time was rather short. Therefore, it is 
questionable whether the beneficial effects of antioxidants were the result of 
improved respiratory muscle function. Heyland studied the effects of antioxidants 
and glutamine in a heterogeneous ICU population (N=1223) [71]. Patients were 
divided in 4 groups: placebo, glutamine (0,35 gram/kg/24hours of body weight 
intravenously), antioxidants (selenium, zinc, beta carotene, vitamin E and vitamin 
C), or antioxidants + glutamine. Again, respiratory muscle function was not 
specifically evaluated, but no difference in duration of mechanical ventilation was 
observed among the four groups.
Today, only one study has evaluated the effects of two nutritional strategies on 
skeletal muscle structure and function in critically ill patients [72]. This study was 
a planned subanalysis of the EPaNIC trial, that compared the effects of tolerating 
macronutrient deficiency versus early parenteral nutrition on skeletal muscle 
structure and function [73]. In that study, patients were randomized between 
early (within 2 days of ICU admission) versus late (<8 days after ICU admission) 
parenteral nutrition to prevent macronutrient deficiency.  Skeletal muscle strength 
was assessed in 600 ICU patients using the Medical Research Council sum score. 
Weakness occurred less often in late versus early parenteral nutrition group (34% 
vs 43% P=0.030). Compared to healthy subjects, muscle fibers exhibited atrophy, 
but not significantly different between the early and late parenteral nutrition 
group. However, markers for autophagosome formation were significantly 
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higher in the late parenteral nutrition group. This marks that autophagy plays an 
important role in protein turnover next to other effects to provide substrate for 
recycling. In conclusion, tolerating macronutrient deficit in the first week after 
ICU admission is not associated with the development of muscle fiber atrophy, 
but surprisingly appears to improve muscle contractility, together with activation 
of autophagy. 
Although the effect of high dose antioxidant administration on respiratory 
muscle structure and function is encouraging in animals models, no data support 
the routine administration of high dose antioxidants or other specific feeding 
strategies on respiratory muscle function in the critically ill ventilated patient. 
Therefore, we do not recommend routine suppletion of antioxidants to the weak 
ICU patients in order to improve respiratory muscle function. 
Improve respiratory muscle protein content: anabolics
Loss of muscle mass plays an important role in the development of ICU acquired 
respiratory muscle weakness [5, 21] and is the result of an imbalance between 
protein synthesis and degradation. Aiming to restore the protein imbalance is a 
reasonable approach in these patients. First, inhibitors of proteolysis have been 
used in animal models [74, 75], and indeed improve respiratory muscle mass. 
However, these agents are relatively toxic and not approved to enhance muscle 
mass in humans. 
Second, protein synthesis can be increased with anabolic hormones. Anabolic 
hormones and its analogues have been used to enhance skeletal muscle mass 
under a variety of conditions (for review: ref. [76]). We will focus on the effects 
of endogenous and exogenous anabolic hormones on the respiratory muscles. 
The most important endogenous anabolic hormones are growth hormone (GH), 
insulin-like growth factor-1 (IGF-1), insulin and the anabolic steroid testosterone 
and its analogues. 
The effects of GH on skeletal muscle have been reviewed recently [77]. GH 
enhances production of the powerful anabolic hormone IGF-1 in the liver, but 
GH has direct anabolic effects on skeletal muscle as well. The effect of GH / IGF-1 
or its exogenous analogues administration on respiratory muscle function in 
critically ill patients has not been studied. However, Takala reported the effects of 
recombinant-GH (Genotropin) administration in critically ill ICU patients relatively 
early during ICU stay (inclusion between day 5 and 7) in two placebo controlled 
trials [78]. Surprisingly, both trials demonstrated significantly increased mortality 
in rGH treated patients (47% vs. 25% in the finish study and 61% vs. 26% in the 
multinational study). The mechanisms for increased mortality are incompletely 
understood, but modulation of immune function may play a role. Although there 
is still a good rationale for GH / IGF-1 in stable ICU patients with respiratory 
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muscle weakness and difficulty to wean from mechanical ventilation, the safety 
and efficacy needs to be established. 
No data are available concerning the effects of anabolic steroids on respiratory 
muscle function in critically ill patients. However, Schols [79] and colleagues 
reported the effects of the exogenous anabolic steroid nadrolone in patients 
with COPD during an eight weeks pulmonary rehabilitation program. Patients 
(N=217) were randomized between placebo, placebo with high caloric feeding 
and nadrolone with high caloric feeding. They found that nandrolone together 
with high caloric feeding, significantly improved inspiratory muscle strength. 
These findings were more or less confirmed in a later trial by the same group 
[80]. Although case series report the use of anabolic steroids in difficult to wean 
patients [81], no randomized studies have evaluated the safety and efficacy of 
anabolic steroids in ICU patients with respiratory muscle weakness. 
Insulin has anabolic properties as well and interestingly intensive insulin therapy 
versus conventional insulin therapy in critically ill patients reduces the duration of 
mechanical ventilation, although it does not affect ICU length of stay [82-84]. The 
beneficial effect of intensive insulin therapy was probably the result from reduced 
incidence of critical illness polyneuropathie.
In conclusion, enhancing protein synthesis is a potentially effective strategy 
to improve respiratory muscle function in patients with ICU acquired muscle 
weakness. GH is unattractive as it has been associated with increased mortality 
in ICU patients [78]. Given the encouraging studies on respiratory muscles in 
COPD, nandrolone would be the most reasonable anabolic hormone to improve 
respiratory muscle function in selected stable difficult to wean patients.
Positive inotropes  
In addition to the loss of contractile protein (atrophy), dysfunction of the remaining 
muscle fibers has been demonstrated in critically ill patients [4]. Accordingly, 
optimizing contractility using positive inotropes seems a reasonable approach 
in these patients. ß-adrenoreceptor agonists indeed exhibit a direct positive 
inotropic effect on the diaphragm muscle in vitro by increasing intracellular 
calcium influx [85, 86]. The effects of β2 adrenoreceptor agonists on respiratory 
muscle function in vivo is controversial [87, 88]. Albuterol (p.o.) did not affect 
fatigability of the diaphragm in healthy subjects [88]. However, fenoterol (p.o.) 
delayed the development of diaphragm fatigue in healthy volunteers subjected to 
inspiratory loading [87]. In mechanically ventilated COPD patients with respiratory 
failure, respiratory muscle function significantly improved after dopamine infusion 
probably by augmentation of diaphragm blood flow and improved cardiac output 
[89]. 
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Muscle fibers isolated from the diaphragm of ICU patients display decreased 
maximal force generating capacity, indicating intrinsic muscle weakness [21]. 
In fast-twitch diaphragm fibers the reduction of sub-maximal force generation 
even exceeds the loss of maximal force generating capacity [4]. This implies 
that these fibers require more calcium to generate normal force levels, i.e. 
their sensitivity to calcium is reduced (“reduced calcium sensitivity”). Calcium 
sensitizers have been developed to treat similar pathology of cardiac muscle 
[90, 91]. Currently, levosimendan is the only calcium sensitizer approved for use 
in humans (>50 countries worldwide). Experimental studies have shown that 
levosimendan also improves calcium sensitivity of diaphragm muscle fibers [17, 
92]. Moreover, a recent double-blind, randomized, crossover study demonstrated 
that administration of levosimendan improved neuromechanical efficiency by 
>20% and prevented contractile fatigue during diaphragm loading task in healthy 
subjects [18]. Therefore, levosimendan is a promising drug to improve respiratory 
muscle function in ICU patients. A current randomized clinical trial (ClinicalTrials.
gov identifier NCT01721434) is investigating whether levosimendan indeed 
facilitates liberation from the ventilator. Levosimendan is generally well tolerated 
by patients, hypotension is the most observed side effect, but is not common 
when the treatment remains within the recommended dose, or can easily be 
counteracted by low dose norepinephrine [93]. In contrast to levosimendan, the 
effectiveness of other calcium sensitizers has so far only been studied in vitro. 
For example, exposure to EMD 57033 partially restored calcium sensitivity in 
diaphragm fibers isolated from piglets after 5 days of mechanical ventilation 
[94]. Furthermore, in diaphragm fibers from critically ill patients, CK-2066260 
completely restores calcium sensitivity [4]. These findings underscore the 
therapeutic potential of calcium sensitizers and the necessity to evaluate in vivo 
effects in clinical trials. 
Taken together the evidence for improvement of respiratory muscle function with 
β2 adrenoreceptor agonists is at least controversial. In addition, the inotropic 
effect of β adrenoreceptor agonists is mediated through enhanced intracellular 
calcium concentration, which increases muscular energy expenditure and as 
such CO2 production. Therefore, β receptor agonists are not very attractive in 
the critically ill patient. In contrast, calcium sensitizers might very well exert an 
energetically beneficial effect on diaphragm work [17]. When less calcium is 
needed to maintain force generation, muscle work becomes more efficient [18] 
and potentially improve respiratory muscle contractility in critically ill patients. 
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Future developments
I. Modulation of inflammation 
Activation of pro-inflammatory pathways is associated with respiratory muscle 
weakness [33, 95-97]. Therefore, modulation of the inflammatory response to 
combat respiratory muscle dysfunction has been scope of interest in recent 
experimental studies [32, 33, 98]. We demonstrated that interleukin (IL)-6 plays 
an important role in the loss of contractile proteins in muscle fibers exposed to 
plasma from septic shock patients [33]. However, diaphragm fiber atrophy due to 
disuse in brain death patients was not associated with upregulation of Il-6 [5]. IL-10 
exhibits anti-inflammatory properties [99]. In a murine model of Pseudomonas 
aeruginosa pneumonia, diaphragm dysfunction was attenuated after experimental 
IL-10 expression [99]. During critical illness with subsequent inflammatory status, 
NF-κB is the key factor for transcription of several cytokines [100]. Recently, 
evidence was found that inhibition of NF-κB in endotoxemic mice protects 
against diaphragm muscle weakness, probably due to decreased generation of 
pro-inflammatory cytokines [98]. Proteolytic pathways can be activated through 
Toll Like Receptor (TLR)-4, present in muscle plasma membrane [32]. TLR’s are 
essential receptors in recognizing microbes and initiate an inflammatory immune 
response [101]. In TLR-4 knockout mice, loss of diaphragm contractile protein 
associated with controlled mechanical ventilation was attenuated compared 
to wild type mice [32]. In a large clinical trial the TLR-4 antagonist eritoran did 
however not improve outcome in patients with severe sepsis or septic shock 
(±80% on mechanical ventilation) [102]. Nevertheless, neither skeletal muscle 
function, nor duration of mechanical ventilation was assessed in this trial. 
Recently, growth and differentiation factor-15 (GDF15) was recognised as a 
possible factor for inducing skeletal muscle atrophy during critical illness [103, 
104]. Bloch and colleagues reported increased plasma concentration of GDF 15 
and enhanced expression of GDF-15 in muscle biopsies of ICU patients compared 
to patients undergoing elective surgery. Furthermore, exposure of skeletal muscle 
cells to GDF-15 increased expression of muscle related atrophic genes [104]. 
However, today no clinical data are available to demonstrate if downregulating 
activity of GDF-15 protects against skeletal muscle for wasting in ICU patients. 
Traditionally, steroids are associated with myopathy, atrophy and dysfunction 
of the respiratory muscles [105-107]. However, the final effects appear to be 
dose and time dependent, at least in experimental studies. For instance, Maes 
demonstrated that “low dose” (5mg/kg) methylprednisolone exacerbated 
ventilator-induced diaphragm dysfunction, whereas high dose (30mg/kg) 
protected against the deleterious effects of controlled mechanical ventilation 
on diaphragm function [108]. In ICU patients the effect of steroids on muscle 
function are conflicting [109-111]. However, no study has prospectively evaluated 
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the effects of corticosteroids on respiratory muscle function in ventilated ICU 
patients. 
In conclusion, despite the encouraging data that modulation of inflammation 
improves respiratory muscle function in animals, data in human are scarce, and if 
present disappointing.
II. Modulation of proteolytic pathways
Since activation of proteolytic systems plays a key role in the development 
of respiratory muscle dysfunction during critical illness, several experimental 
studies have investigated the effect of specific inhibitors. In an animal model of 
endotoxemia, three different specific proteasome inhibitors (MG132, epoxomicin 
and bortezomib) reduced diaphragm proteolysis, but none of these could prevent 
the development of contractile dysfunction [36]. Similarly, in rats exposed to 12 
hours of mechanical ventilation epoxomicin inhibited proteasome activity, but 
did not affect diaphragm contractile function or protein content [112]. However, 
in rats exposed to 24hrs of mechanical ventilation, bortezomib treatment 
partially prevented the reduction of diaphragm force and atrophy [113]. These 
small positive effects were probably mediated by the ability of bortezomib to 
indirectly reduce caspase-3 activity [74]. Proteasomes are only able to process 
myofilaments that have been cleaved from the sarcomere by enzymes like 
caspases and calpains [114]. Accordingly, inhibition of the proteasome alone is 
not expected to have substantial effects on muscle function, as this would only 
leave the muscle cell with unprocessed, but cleaved myofilaments. Furthermore, 
considering the basic housekeeping cell functions of the proteasome it is no 
surprise that the clinical application of bortezomib is accompanied by serious toxic 
adverse events, like cytopenia and peripheral neuropathy [115]. Thus, pathways 
upstream of the proteasomes are more likely to be effective therapeutic targets 
than the proteasome itself. Indeed, inhibition of either caspases or calpains 
with specific experimental inhibitors attenuates the development of diaphragm 
atrophy and dysfunction in animal models of prolonged mechanical ventilation 
[63, 116, 117] and sepsis [118, 119]. Upstream regulators of caspases also seem 
to be potential therapeutic targets in sepsis induced diaphragm dysfunction. 
For example, inhibition of either Jun-N-terminal Kinase (JNK) [120], double 
stranded RNA-dependent protein kinase (PKR) [121] or p38 Mitogen-activated 
protein kinase (MAPK) [122] modulated cytokine induced caspase activation and 
prevent the development of diaphragm weakness in mice exposed to endotoxin. 
Unfortunately, these experimental inhibitors have so far only been investigated in 
animals. A recent study reported that beta-hydroxy-beta methylbutyrate (HMB), a 
metabolite of the amino acid leucine, can also block LPS induced activation of PKR 
and caspase-3 and prevent diaphragm weakness to occur [123]. This study was 
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performed in mice, but using comparable dosages HMB has previously shown to 
be a safe and effective agent that can help to improve skeletal muscle function in 
elderly and patients with cancer [124, 125]. Finally, although several compounds 
targeting proteolytic pathways upstream of the proteasome have a high potential 
to prevent the development of diaphragm weakness, this does not necessarily 
imply that these agents can also improve function of the weakened diaphragm. 
Nevertheless modulation of the proteolytic system is a potentially interesting 
target to modulate loss of respiratory muscle function due to controlled 
mechanical ventilation. 
Clinical implications and conclusion 
Weakness of the respiratory muscles frequently develops in the ICU patient and 
is associated with adverse outcome including prolonged mechanical ventilation. 
Despite the high incidence and clinical impact of ICU acquired respiratory muscle 
dysfunction, no specific preventive or therapeutic interventions have been tested 
in large randomized controlled trials. Therefore, we should rely on interventions 
that seem reasonable from a physiological perspective or are supported by small 
clinical studies. As pointed out in 2, interventions could be subdivided into three 
categories: prevention of respiratory muscle dysfunction, secondly therapeutic 
strategies that aim to improve respiratory muscle function and finally so-called 
rescue interventions that should only be applied in exceptional cases and only 
after discussion with the patient or primary decision makers. 
Preventive strategies should limit development of disuse atrophy and muscle 
damage associated with patient-ventilator asynchrony [126]. We suggest using 
techniques that monitor diaphragm muscle function [37, 38] to confirm a 
physiologically acceptable level of diaphragm contractility and allow the clinician 
to optimize ventilator settings in order to improve patient-ventilator interaction. 
Drugs with potential side effects on skeletal muscle should be avoided.   
Once ICU acquired weakness has developed, a combined program of respiratory 
muscle endurance training and strength training should be considered. Endurance 
training can be instituted using progressive weaning trials and strength training 
by using a device for variable inspiratory threshold loading connected to the 
endotracheal tube [16].
In patients with persistent weakness of the respiratory muscles that prevents 
unassisted breathing more controversial interventions could be considered, 
including anabolics [79] or growth hormone [81]. Using respiratory muscle positive 
inotropes seems attractive and promising for the near future (NCT01721434). 
Indeed, recent studies confirm the positive inotropic effects of levosimendan on 
the diaphragm muscle [18] and its safety profile in critically ill patients is well 
known [90]. However, its use would still be off label and therefore not routinely 
recommended. 
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Figure 2 Three groups of interventions to counteract respiratory muscle weakness during 
critical illness.
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SUMMARY 
Respiratory muscle weakness commonly occurs in the critically ill patient 
and is strongly associated with increased morbidity and mortality. It has been 
established that fiber atrophy, decreased protein synthesis and dysfunction of the 
remaining contractile proteins underlies respiratory muscle weakness in critically 
ill patients. However, the underlying pathophysiology is largely unknown. The 
studies presented in this thesis were designed to improve our understanding 
of how respiratory muscle weakness develops in the critically ill. Also, specific 
therapeutic strategies to counteract respiratory muscle weakness following 
mechanical ventilation were explored.
The study presented in chapter 2 demonstrates that 18 hours of mechanical 
ventilation in rats decreases force-generating capacity of diaphragm muscle 
fibers. Loss in force is accompanied by a reduction of myosin heavy chain 
concentration in these muscle fibers. In addition to active force, passive force in 
muscle fibers can be measured when stretching the muscle fiber. Passive elastic 
properties of skeletal muscles are indispensible for structural stability and optimal 
active force generation. Passive force generation upon stretch was significantly 
reduced in fibers from mechanically ventilated rats. However, titin content - 
the major protein responsible for passive elastic properties of skeletal muscle 
- was not different among ventilated and control animals. Dephosphorylation 
of titin by phosphatase-1 decreased passive force generation upon stretch 
in diaphragm fibers from control, but not from ventilated rats. This specifies 
that the effects of mechanical ventilation on passive force reduction can be 
mimicked by dephosphorylating the elastic protein titin. This indicates that the 
phosphorylation state of titin in diaphragm fibers from mechanically ventilated 
animals is already low. We conclude therefore that mechanical ventilation 
decreases the phosphorylation status of titin in diaphragm fibers, which results in 
reduced stiffness. Our data are of importance, as we demonstrate that respiratory 
muscle weakness after mechanical ventilation is accompanied by an impaired 
active and passive force generation of the respiratory muscles. Intact passive 
contractile properties of the muscle are assumed to be important to maintain 
structural integrity of the muscle fiber. Interestingly, mechanical ventilation did 
not affect active or passive force generation in the soleus muscle, indicating that 
respiratory muscles are more prone to the deleterious effects of disuse. 
Several studies suggest that activation of inflammatory pathways play a role 
in the development of atrophy and contribute to respiratory muscle weakness 
in the critically ill. Indeed activation of inflammation has been demonstrated 
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in the respiratory muscles of animal models with endotoxemia. However, it is 
unknown if inflammation in the muscle is secondary to systemic inflammation 
or is the result of a local inflammatory response. Therefore, in chapter 3 it was 
investigated whether plasma derived from patients with septic shock can induce an 
atrophic response in skeletal myotubes, supporting the hypothesis that systemic 
inflammation in these patients contributes to muscle atrophy. Myosin content was 
~25% lower in skeletal myotubes exposed to plasma from septic shock patients 
than in myotubes exposed to plasma of healthy controls. In myotubes exposed 
to septic shock plasma the amount of ubiquitinated myosin was increased and 
this increase was accompanied by an increased expression of E3 ligases MuRF-1 
and MAFbx in these myotubes. In myotubes exposed to septic shock plasma, we 
found evidence for activation of inflammation, as demonstrated for instance by 
activation of NF-κB, an important transcription factor for inflammatory cytokines. 
Furthermore, elevated levels of IL-6 in plasma of septic shock patients were 
associated with the severity of myosin loss in myotubes. Interestingly, addition 
of anti-IL6 to plasma from septic shock patients only partly prevented the loss 
of myosin in these myotubes. These data indicate that plasma from septic shock 
patients induces skeletal muscle atrophy by activation of inflammatory pathways, 
with a central role for IL-6. These data support a role for systemic inflammation in 
the development of respiratory muscle atrophy in the critically ill. 
In chapter 4, the role of toll like receptor4 (TLR4) in the development of atrophy 
due to controlled mechanical ventilation was investigated. Also, inflammatory 
pathways were explored upon mechanical ventilation. To this end, wild-type and 
TLR4 knock-out mice were subjected to controlled mechanical ventilation for 8 
hours. In wild-type mice mechanical ventilation resulted in a significant decrease 
of diaphragm myosin concentration. In contrast, mechanical ventilation did 
not affect myosin concentration in TLR4 knock-out mice. The pro-inflammatory 
cytokines IL-6 and keratinocyte-derived chemokine were significantly increased in 
diaphragm of ventilated wild-type mice, but not in TLR4 knock-out mice. Moreover, 
light chain 3B-II, a marker of autophagy, was upregulated after mechanical 
ventilation in the diaphragm of wild-type, but not TLR4 knock-out animals. 
This study demonstrates that TLR4 signalling plays a role in the development of 
respiratory muscle atrophy, probably by enhancing inflammatory pathways and 
activation of lysosomal autophagy.
Hypercapnic acidosis is an accepted side effect of lung-protective ventilation in 
patients with ARDS. Besides being a side effect of lung-protective ventilation, 
hypercapnic acidosis itself may exert beneficial effects, for instance by attenuating 
the systemic and pulmonary inflammatory response. As we demonstrated 
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that activation of inflammatory pathways may play a role in respiratory muscle 
atrophy (chapter 3 and 4), we decided to investigate in chapter 5 the effects 
of hypercapnia on respiratory muscle atrophy and function during controlled 
mechanical ventilation. Healthy rats were subjected to controlled mechanical 
ventilation in the absence or presence of hypercapnia. We found that diaphragm 
muscle myosin concentration was decreased in ventilated control animals, but 
not animals subjected to hypercapnia. In addition, pro-inflammatory cytokines 
were significantly upregulated in ventilated control, but not in hypercapnic 
ventilated animals. Force-generating capacity was decreased in diaphragm single 
fibers of ventilated animals, and unexpectedly also, although to a lesser extent, in 
hypercapnic ventilated animals. Since hypercapnia protected respiratory muscles 
against deleterious effects of myosin loss, probably by a decrease in proteasome 
activity, during mechanical ventilation but not against loss of muscle function, we 
investigated involvement of reversible protein modifications by oxidative agents. 
Single fibers were incubated with antioxidant dithiothreitol and contractility 
was assessed. Dithiothreitol restored contractility in diaphragm single fibers 
of hypercapnic ventilated animals but not in control ventilated animals. This 
indicates that oxidative protein modifications play a role in loss of force induced 
by controlled mechanical ventilation under hypercapnic conditions. This study 
indicates that hypercapnia partly protects respiratory muscle to the deleterious 
effects of mechanical ventilation.
The cardiac inotrope levosimendan improves cardiac muscle contractility by 
improved sensitivity of troponin for calcium. However, some studies indicate 
that levosimendan has anti-inflammatory and anti-oxidative properties as well. 
Since we found an important role for inflammatory pathways in the development 
of respiratory muscle weakness and atrophy during mechanical ventilation in 
chapter 3, 4 and 5, we investigated in chapter 6 if treatment with levosimendan 
can modulate inflammatory and oxidative pathways in respiratory muscle. Mice 
were exposed to lipopolysaccharide (LPS) to induce a systemic inflammatory 
response. Next, animals were divided in two groups: placebo and levosimendan. 
In the diaphragm of mice treated with levosimendan we found a reduction in 
nitrosylated proteins and also a reduction in markers for oxidative stress. In contrast 
to earlier studies by other groups, we did not find an effect of levosimendan on 
pro-inflammatory cytokines. This study shows that levosimendan may protect 
against nitrosative stress and oxidative stress in the respiratory muscles of 
endotoxemic mice, but does not modulate the inflammatory response.
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DISCUSSION
Respiratory muscle atrophy 
Mechanical ventilation is a life saving intervention in patients with acute respiratory 
failure, but comes with recognized side effects including ventilator-induced lung 
injury [1], and respiratory muscle dysfunction [2-5]. The current thesis focuses 
on the effects of mechanical ventilation on the respiratory muscles. Today, 
the pathophysiology of ventilator-induced respiratory muscle dysfunction is 
incompletely understood [3, 5, 6]. Studies in the current thesis report that the 
cross-sectional area of diaphragm fibers was reduced after 18 hours of controlled 
mechanical ventilation (chapter 2). Besides a reduction in cross-sectional area, 
we found a reduced myosin heavy chain concentration in rats (chapter 2) and 
mice (chapter 4) subjected to controlled mechanical ventilation for 18 and 8 hours 
respectively. These results are in line with previous findings in both humans and 
rodents [2, 7-9]. In a landmark paper, Levine et al. reported that 18 – 69 hours of 
controlled mechanical ventilation in brain death patients resulted in respiratory 
muscle atrophy [2]. That paper indicates that respiratory muscle atrophy 
develops rapidly in humans when the diaphragm is inactive. In the current thesis, 
the concentration of myosin was reduced in fibers of ventilated animals, which 
indicates that the severity of the contractile protein loss exceeds the degree of 
fiber atrophy (chapter 2). Ultimately, muscle atrophy is the result of a disbalance 
between proteolysis and protein synthesis [10-12]. The ubiquitin-proteasome 
pathway appears to play a key role in enhanced proteolysis in the diaphragm during 
mechanical ventilation and inflammation [2, 3, 12-14]. Briefly, this pathway is 
characterized by activation of two key enzymes, the E3-ligases MuRF-1 and MAFbx. 
These enzymes mark proteins for degradation by the proteasome by attachment 
of a ubiquitin protein [15]. Recent observations in mechanically ventilated critical 
ill patients confirm an important role for the ubiquitin-proteasome pathway [3]. 
In that study diaphragm biopsies of ICU patients showed enhanced activity of 
the ubiquitin-proteasome pathway. This was accompanied by signs of diaphragm 
atrophy and decrease in diaphragm muscle fiber force. In the current thesis, 
circulating ligands in plasma of septic shock patients induced atrophy in cultured 
skeletal myotubes (chapter 3). The loss of contractile protein was accompanied 
by increased expression of the E3 ligases MuRF-1 and MAFbx and increased 
concentrations of ubiquitinated myosin. Activation of MuRF-1 can be regulated by 
transcription factor NFκB [16]. Indeed, plasma of septic shock patients enhanced 
activity of NFκB in cultured myotubes (chapter 3). To conclude, plasma of septic 
shock patients induces atrophy in skeletal myotubes accompanied by activation 
of the ubiquitin-proteasome pathway and inflammatory pathways (chapter 3). 
This is of importance, since it uncovers that ligands in plasma of septic patients 
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activate atrophic pathways in “healthy” cultured muscle. Based on these data it 
can be hypothesized that circulating factors in plasma of septic shock patients 
induce muscle atrophy in vivo and such induce muscle weakness in these 
patients. Further research should identify the nature of these specific factors and 
on strategies that inactivate these atrophic factors.
Role of TLR4
Toll-like receptors (TLR’s) are essential in host defence by recognizing specific 
ligands, including microbial components, but also proteins that are released by 
damaged tissue [17]. The expression of the subtype TLR4 has been demonstrated 
in skeletal myotubes and diaphragm tissue [18]. In this thesis the role of TLR4 
on the development of ventilator-induced diaphragm atrophy was studied 
(chapter 4). TLR4 deficiency attenuated the development of diaphragm atrophy 
induced by 8 hours of mechanical ventilation in mice. Previously, activation of 
TLR4 in diaphragm by its specific ligand lipopolysaccharide (LPS), increased 
expression of pro-inflammatory cytokines and impaired diaphragm function 
[19, 20]. TLR4 receptor activation by LPS can result in downstream activation of 
both the ubiquitin-proteasome pathway and the lysosomal-autophagy pathways 
in skeletal muscles [21]. In this thesis activation of ubiquitin-proteasome was 
not different between ventilated wild-type animals and TLR4 deficient animals, 
indicating that in this model the ubiquitin-proteasome has no prominent role in 
the development of atrophy. This is in apparent contrast with previous studies 
that did show an association between mechanical ventilation and induction of 
diaphragm atrophy through activation of the ubiquitin-proteasome in ventilated 
humans [2, 3] and rodents [12, 22, 23]. Therefore, we cannot exclude for a role of 
the ubiquitin-proteasome pathway under every condition in ventilator-induced 
diaphragm atrophy, in particular after longer duration of mechanical ventilation. 
In this thesis, we found that autophagy marker LC3B-II was increased in ventilated 
wild-type animals but not in TLR4 deficient animals (chapter 4). Therefore, these 
data suggest that loss of contractile protein through TLR4 signaling results from 
activation of the lysosomal autophagy pathway. These data are supported 
by previous work of Doyle et al, demonstrating that TLR4 agonist LPS, induces 
lysosomal autophagy in skeletal muscle cells [21]. Also, in ventilated humans the 
lysosomal autophagy pathway is activated and associated with respiratory muscle 
atrophy [24]. In conclusion, mechanical ventilation induced loss of contractile 
proteins may act through activation of the TLR4. Interestingly, TLR4 ligands can 
increase autophagy in muscle. Therefore, this thesis provides a rationale to further 
investigate if blocking the TLR4 pathway would benefit the ventilated patient in 
counteracting respiratory muscle weakness.  
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Diaphragm function and mechanical ventilation 
It is generally accepted that controlled mechanical ventilation impairs 
force-generating capacity of the diaphragm in animal models and in humans [4, 
5, 25, 26]. Reduction in force generating capacity can theoretically result from 
either a loss of contractile proteins or contractile protein dysfunction. Although 
atrophy has been demonstrated in the diaphragm of ventilated animals, the role 
of contractile protein dysfunction is largely unknown. The current thesis describes 
studies evaluating the force-generating capacity of permeabilized diaphragm 
fibers  (chapter 2). Permeabilized fibers are an excellent model to study contractile 
protein function, as activation does not depend on membrane characteristics or 
calcium handling. We found that mechanical ventilation reduced force generation 
in these fibers in proportion to the reduction in cross-sectional area of these 
fibers (chapter 2). This indicates that remaining contractile proteins have normal 
force generating capacity. This is however in apparent contrast with other studies 
that report reduction in force generating capacity of the muscle fibers, even after 
correction for cross- sectional area [26-28]. For instance, a recent study among 
a heterogeneous group of critically ill patient revealed that force decrease in 
diaphragm fibers was partly due to atrophy, but also resulted from dysfunction 
of the remaining contractile proteins [4]. It should be noted that in critically ill 
patients a variety of cofactors may play a role besides mechanical ventilation, 
including administration of certain drugs and infection [9, 29]. Recently, Doorduin 
et al. demonstrated that the calcium sensitizer levosimendan improves respiratory 
muscle function in healthy volunteers [30]. In addition, the troponin activator 
CK-2066260 enhances strength in diaphragm fibers of critically ill patients [4]. To 
conclude, this thesis clearly demonstrates that mechanical ventilation induces 
loss of contractile protein in the respiratory muscles resulting in a decrease of 
force generating capacity of the muscle, but in contract to studies in humans we 
did not find evidence for contractile protein dysfunction. However, in humans and 
in particular in the critically ill patient other factors, like for example sepsis and 
drugs may impair function of the remaining contractile proteins. Therefore, further 
research for potential strategies to counteract respiratory muscle weakness in the 
critical ill should not solely focus on dampening atrophic responses but should 
also evaluate strategies that enhance contractile protein function. Recent and 
on-going studies with a calcium sensitizers or troponin activator are therefore of 
importance.
  
Role of Hypercapnia 
In critically ill patients, hypercapnia develops frequently as a consequence of low 
tidal volume ventilation. In this thesis we investigated the effects of hypercapnic 
acidosis on the respiratory muscles (chapter 5). We found that hypercapnia largely 
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protected the diaphragm against deleterious effects of mechanical ventilation by 
maintaining myosin concentration and attenuating the development of atrophy. 
Therefore it was unexpected that hypercapnia did not preserve contractility in 
our study. Previous studies have reported that mechanical ventilation under 
hypercapnic conditions protects against the development of weakness [31]. The 
data reported in the current thesis indicate that in hypercapnic ventilated animals 
contractile protein dysfunction developed as the result of posttranslational 
modification of proteins. Indeed, the reducing agent dithiothreitol restored 
diaphragm function in diaphragm fibers of hypercapnic ventilated animals, 
confirming that oxidative contractile protein modification plays an important role 
in mechanical ventilation under hypercapnic conditions. Indeed, CO2 can promote 
generation of oxidants in diaphragm muscle [32]. Our data indicate that further 
studies should focus in the combined effects of hypercapnia and antioxidants on 
diaphragm function during mechanical ventilation. 
Diaphragm passive force
Passive elastic properties are essential for structural stability and optimal active 
function of muscle fibers [33]. The protein titin is the key determinant of passive 
elastic properties in skeletal muscle fibers [34]. Mechanical ventilation reduces 
passive function of diaphragm muscle fibers (chapter 2). Unexpectedly, this 
was not accompanied by a decrease in diaphragm fiber titin content. Under 
certain conditions, posttranslational modifications of the PEVK segment of titin 
may occur, which affect its passive elastic properties [35, 36]. Indeed, we found 
that the effects of mechanical ventilation on passive force could be imitated by 
dephosphorylation of titin through incubation of diaphragm muscle fibers with 
enzyme phosphatase-1 (chapter 2). As Hooijman et al. have demonstrated that 
active muscle force is decreased in diaphragm fibers of critical ill patients [4], 
it would be interesting to investigate if suboptimal sarcomeric stability plays a 
role in this process. Therefore, phosphorylation status of titin in diaphragm 
muscle biopsies of critically ill patients should be further investigated. If titin 
phosphorylation status is indeed increased in the critical ill and contributes 
to respiratory muscle dysfunction, it gives further directions to combat the 
development of ICU acquired respiratory muscle weakness. 
Inflammatory pathways and respiratory muscle weakness
Inflammatory pathways have been linked to the development of respiratory 
muscle weakness [13, 37]. In this thesis, we show that IL-6 concentrations were 
elevated in plasma from septic patients (chapter 3). Moreover, it was significantly 
associated with the severity of contractile protein loss in skeletal myotubes. 
Importantly, adding IL-6 antibody dampened the loss of myosin in myotubes 
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exposed to plasma of septic patients. These data indicate a key role for IL-6 in 
inducing skeletal muscle atrophy during septic shock (chapter 3). It should be 
noted that when IL-6 was added to plasma of healthy subjects (in vitro), this did 
not induce a loss of contractile proteins in myotubes. Thus, although IL-6 has a 
prominent role in the atrophic response, other ligands appear required to induce 
atrophy. The important role for IL-6 in skeletal muscle atrophy is also supported 
by the fact that we found increased levels of IL-6 in diaphragm of mechanically 
ventilated rodents developing atrophy (chapter 4 & 5). Further supporting the role 
for IL-6 is that the attenuation of atrophy in TLR4 deficient ventilated animals was 
accompanied by a decrease of diaphragmatic IL-6 levels in these animals. These 
data (chapter 3, 4 & 5) are largely in line with previous studies, that found that 
IL-6 can induce an atrophic response in skeletal muscle [38-40]. It is important 
that other plasma factors are identified that play a role in the development of 
atrophy (chapter 3). Interestingly, LPS has the properties to activate TLR4 and we 
demonstrate in this thesis, that activating TLR4 induces an atrophic response in 
the diaphragm (chapter 4). It is plausible that in critically ill patients with septic 
shock, circulating LPS ligands concurrently with IL-6 induce an atrophic response 
in skeletal muscles. In conclusion, attenuating the inflammatory response by TLR4 
deficiency or by hypercapnia might protect the diaphragm from atrophy during 
mechanical ventilation (chapter 4 & 5). The present results support the concept 
that cytokines provoked by mechanical ventilation are associated with diaphragm 
contractile protein loss. Therefore, further research in critically ill patients is 
needed to test the hypothesis that acting against specific points of inflammatory 
pathways, like IL-6 and TLR4, protects against respiratory muscle atrophy and 
weakness. 
Mechanism and therapeutic applicability of interventions 
Levosimendan
Respiratory muscle weakness is a major clinical problem in the critically ill patient. 
Yet, no adequate therapeutic intervention is currently available to improve 
respiratory muscle function (reviewed in chapter 7). Levosimendan has shown 
to affect several intracellular pathways involved in inflammation and oxidative 
stress [41, 42], besides its inotropic effects mainly through calcium sensitization 
[43, 44]. In this thesis, levosimendan administration in mechanically ventilated 
endotoxemic rodents reduced protein nitrosylation and markers of oxidative 
stress (chapter 6). Both oxidative stress and nitrosative stress have been linked 
in models of mechanical ventilation and experimental sepsis to a deterioration 
of diaphragm function [22, 45-47]. Therefore, levosimendan’s proposed 
beneficial role through decreasing diaphragm nitrosative and oxidative stress 
during mechanical ventilation could protect diaphragm function under certain 
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conditions (i.e. presence of inflammation). Indeed, the data in the present thesis 
indicate that the beneficial effects of levosimendan are not only the result of 
calcium sensitization [43]. To speculate about further directions for research, 
levosimendan should be evaluated in the mechanically ventilated critically ill 
patients with sepsis to give more definitive answers if respiratory muscle function 
is indeed protected by decreased nitrosylation and oxidation of the respiratory 
muscles. 
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SAMENVATTING
Respiratoire spierzwakte komt regelmatig voor bij de kritisch zieke patiënt en is 
sterk geassocieerd met een verhoogde morbiditeit en mortaliteit. Eerder werd 
vastgesteld dat skeletspiervezel atrofie, verminderde eiwitsynthese en disfunctie 
van de resterende contractiele eiwitten ten grondslag ligt aan respiratoire 
spierzwakte bij kritisch zieke patiënten. Echter, de onderliggende pathofysiologie 
is grotendeels onbekend. De studies, beschreven in dit proefschrift, zijn ontworpen 
om ons begrip, over hoe respiratoire spierzwakte zich ontwikkelt in de kritisch 
zieke patiënt, te verbeteren. Ook is onderzocht of ademhalingsspierzwakte 
na mechanische ventilatie kan worden tegengegaan middels specifieke 
therapeutische strategieën.
De in hoofdstuk 2 gepresenteerde studie laat zien dat 18 uur beademing van 
proefdieren de kracht genererende capaciteit van diafragmavezels vermindert. 
Verlies van kracht gaat gepaard met een vermindering van de concentratie 
van het skeletspiereiwit myosine in deze spiervezels. Naast actieve kracht, 
kan passieve kracht in spiervezels worden gemeten door het oprekken van de 
spiervezel. Passieve elastische eigenschappen van skeletspieren zijn onmisbaar 
voor de structurele stabiliteit en een optimale actieve krachtgeneratie. Passieve 
krachtgeneratie tijdens het oprekken van spiervezels was significant verlaagd in de 
vezels van beademde ratten. Echter, de concentratie van titine - het belangrijkste 
eiwit dat verantwoordelijk is voor passieve elastische eigenschappen van de 
skeletspier - was niet verschillend tussen de beademde groep en de controlegroep. 
Omdat we sterke aanwijzingen hadden dat de effecten van mechanische ventilatie 
op de reductie van passieve kracht kan worden nagebootst door defosforylatie 
van het elastische eiwit titine, hebben we de mate van defosforylering van 
titine bestudeerd. Defosforylering van titine middels fosfatase-1 verlaagde de 
passieve krachtgeneratie tijdens rek in diafragmavezels van controle, maar niet 
van geventileerde ratten. Dit geeft aan dat de mate van fosforylering van titine in 
diafragmavezels van mechanisch geventileerde dieren al laag was. We concluderen 
hieruit dat mechanische ventilatie de fosforylering status van titine vermindert in 
diafragma vezels, hetgeen resulteert in verminderde elasticiteit (“stijfheid”). Onze 
resultaten zijn van belang, aangezien verondersteld wordt dat normale elastische 
eigenschappen van spiervezels  belangrijk zijn om de structurele integriteit van de 
spiervezels te waarborgen. Interessant is dat mechanische ventilatie geen invloed 
heeft op actieve of passieve kracht generatie van de soleus spier, wat aangeeft 
dat de ademhalingsspieren meer vatbaar zijn voor de schadelijke effecten van 
inactiviteit.
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Verschillende studies suggereren dat activering van ontstekingsreacties 
(inflammatie) een rol speelt bij de ontwikkeling van spieratrofie en bijdragen 
aan respiratoire spierzwakte in de kritisch zieke patiënt. Inderdaad is eerder 
activering van inflammatie in de ademhalingsspieren aangetoond in diermodellen 
voor inflammatie. Het is echter onbekend of de inflammatoire reactie in de 
spier secundair is aan systemische inflammatie of het gevolg is van een lokale 
inflammatoire reactie. In hoofdstuk 3 is daarom onderzocht of plasma, afkomstig 
van patiënten met een septische shock, een atrofische respons in gekweekte 
spiervezels (myotubes) kan induceren. Dit zou de hypothese dat systemische 
inflammatie bij deze patiënten bijdraagt aan spieratrofie ondersteunen. Myosine 
concentratie was ~ 25% lager in skelet myotubes welke blootgesteld waren aan 
het plasma van patiënten met een septische shock in vergelijking met myotubes 
die blootgesteld waren aan plasma van gezonde controles. In myotubes 
die blootgesteld waren aan septische shock plasma, was de concentratie 
geubiquitineerd myosine verhoogd. Deze stijging was parallel aan een in deze 
myotubes verhoogde expressie van de E3 ligasen MuRF-1 en MAFbx. In myotubes 
blootgesteld aan plasma van patiënten met een septische shock hebben we bewijs 
gevonden voor activatie van inflammatie, namelijk door activering van NF-κB, een 
belangrijke transcriptiefactor voor inflammatoire cytokines. Bovendien waren de 
verhoogde concentraties van IL-6 in het plasma van patiënten met een septische 
shock geassocieerd met de ernst van myosine verlies in de myotubes. Toevoegen 
van anti-IL6 aan plasma van patiënten met een septische shock voorkomt deels 
dat er verlies van myosine optreedt in deze myotubes. Deze resultaten geven 
aan dat plasma van patiënten met een septische shock, skeletspier atrofie kan 
induceren door activering van ontstekingsreacties met een centrale rol voor 
IL-6. Deze uitkomsten ondersteunen een rol voor systemische inflammatie in de 
ontwikkeling van respiratoire spieratrofie bij de kritisch zieke patiënt.
In hoofdstuk 4 is de rol van toll like receptor4 (TLR4) en de ontwikkeling van 
atrofie als gevolg van gecontroleerde mechanische ventilatie onderzocht. Ook 
zijn inflammatoire reacties als gevolg van mechanische ventilatie bestudeerd. 
Hiertoe zijn wild-type muizen en TLR4 knock-out muizen onderworpen aan 
een gecontroleerde mechanische ventilatie gedurende 8 uur. In wild-type 
muizen resulteerde mechanische ventilatie in een significante afname van de 
myosine concentratie in het diafragma. Mechanische ventilatie had daarentegen 
geen invloed op de myosine concentratie in TLR4 knock-out muizen. De 
pro-inflammatoire cytokines IL-6 en keratinocyte-derived chemokine waren 
significant verhoogd in het diafragma van geventileerde wild-type muizen, maar 
niet in TLR4 knock-out muizen. Bovendien was light chain 3B-II, een marker voor 
autofagie, verhoogd na mechanische ventilatie in het diafragma van wild-type, 
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maar niet in TLR4 knock-out dieren. Deze studie toont aan dat TLR4 signalering 
een rol speelt bij de ontwikkeling van respiratoire spieratrofie, waarschijnlijk via 
activatie van inflammatoire cascades en van lysosomale autophagy.
Hypercapnische acidose is een geaccepteerde bijwerking van long protectieve 
ventilatie bij patiënten met het acute respiratory distress syndrome. Behalve 
een neveneffect van long beschermende ventilatie, wordt gesuggereerd dat 
hypercapnische acidose gunstige effecten kan hebben, bijvoorbeeld door het 
dempen van systemische en lokale (bijvoorbeeld long) inflammatoire reacties. 
Aangezien we aangetoond hebben dat activering van inflammatoire cascades 
waarschijnlijk een rol speelt bij respiratoire spieratrofie (hoofdstuk 3 en 4), hebben 
we besloten om in hoofdstuk 5 te onderzoeken wat de effecten van hypercapnie 
op atrofie en de functie van de ademspieren zijn tijdens gecontroleerde 
mechanische ventilatie. Gezonde proefdieren zijn gecontroleerd beademd in de 
af- of aanwezigheid van hypercapnie. In lijn met eerdere studies vonden we dat 
de concentratie myosine werd verlaagd in geventileerde controle dieren, maar 
niet in de hypercapnische dieren. Hypercapnische acidose verminderde tevens de 
inflammatoire response die het gevolg is van beademing. De kracht producerende 
capaciteit was verlaagd in de diafragma spiervezels van beademde dieren, en 
onverwachts ook, zij in mindere mate, bij hypercapnische geventileerde dieren. 
Aangezien hypercapnie verlies van myosine voorkomt, maar geen beschermend 
effect heeft op de ontwikkeling van spierzwakte, hebben we de betrokkenheid 
van eiwitmodificaties door oxidatieve reacties onderzocht. Spiervezels werden 
geïncubeerd met de antioxidant dithiothreitol, waarna vervolgens contractiliteit 
werd bepaald. Dithiotreïtol herstelde de contractiliteit in diafragma spiervezels van 
hypercapnische geventileerde dieren, maar niet in normaal geventileerde dieren. 
Dit geeft aan dat oxidatieve eiwitmodificaties een rol spelen bij verlies van kracht 
ten gevolge van gecontroleerde mechanische ventilatie onder hypercapnische 
omstandigheden. Deze studie geeft aan dat de effecten van hypercapnie op de 
ademhalingsspieren complex zijn. Hoewel verlies van eiwit wordt voorkomen, 
ontstaat nog steeds zwakte.
Het cardiale inotrope middel levosimendan verbetert hartspier contractiliteit 
door optimalisering van de gevoeligheid van troponine voor calcium. Er is 
gesuggereerd dat levosimendan ook anti-inflammatoire en anti-oxidatieve 
eigenschappen heeft. Aangezien we een belangrijke rol voor inflammatoire 
cascades in de ontwikkeling van respiratoire spierzwakte en atrofie hebben 
gevonden tijdens mechanische ventilatie (hoofdstuk 3, 4 en 5), hebben we 
in hoofdstuk 6 onderzocht of levosimendan inflammatie en oxidatie in het 
diafragma kan moduleren. Om een systemische inflammatoire reactie op te 
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wekken, zijn muizen blootgesteld aan lipopolysaccharide (LPS). Vervolgens zijn de 
dieren verdeeld in twee groepen: placebo en levosimendan. In het diafragma van 
muizen die met levosimendan waren behandeld vonden we een vermindering van 
genitrosyleerde eiwitten en ook een vermindering van markers voor oxidatieve 
stress. In tegenstelling tot eerdere studies door anderen, hebben we geen effect 
van levosimendan op pro-inflammatoire cytokines gevonden. Deze studie toont 
aan dat levosimendan kan beschermen tegen nitrosatieve stress en oxidatieve 
stress in de ademhalingsspieren van endotoxemische muizen, echter zonder 
modulatie van de inflammatoire reactie.
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DISCUSSIE
Diafragma spieratrofie
Beademing is een levensreddende interventie bij patiënten met acute 
respiratoire insufficiëntie, maar kent ook bijwerkingen zoals longschade en 
disfunctie van de ademhalingsspieren. Het proefschrift richt zich op de effecten 
van beademing op de ademhalingsspieren. De pathofysiologie die ten grondslag 
ligt aan beademings-geïnduceerde ademhalingsspier disfunctie is heden 
onvolledig begrepen. Studies in dit proefschrift laten zien dat de dwarsdoorsnede 
(oppervlakte) van diafragma vezels is afgenomen na 18 uur beademing (hoofdstuk 
2). Naast afname in de dwarsdoorsnede, vonden we na respectievelijk 18 en 8 uur 
beademing een verminderde concentratie myosine in het diafragma van ratten 
(hoofdstuk 2) en muizen (hoofdstuk 4). Deze resultaten zijn in lijn met eerdere 
bevindingen bij zowel mensen als proefdieren. Een belangrijke studie van collega 
Levine meldde dat beademing van hersendode patiënten al na 18-69 uur resulteert 
in atrofie van spiervezels uit het diafragma. Dit artikel suggereert dat diafragma 
atrofie zich snel ontwikkelt bij de mens wanneer deze spier geïnactiveerd wordt. 
Studies in dit proefschrift tonen aan dat de concentratie myosine in diafragma 
vezels van beademde dieren verlaagd is, hetgeen suggereert dat de ernst van verlies 
van contractiel eiwit groter is, dan de ernst van diafragma vezel atrofie (hoofdstuk 
2). Uiteindelijk is spieratrofie het gevolg van een disbalans tussen proteolyse 
en eiwitsynthese. De ubiquitine-proteasoom cascade lijkt een belangrijke rol 
te spelen bij de verhoogde proteolyse van het diafragma tijdens beademing en 
ontsteking (inflammatie). Kort samengevat: dit traject wordt gekenmerkt door 
activering van twee belangrijke enzymen, de E3-ligases MuRF-1 en MAFbx. Deze 
enzymen markeren eiwitten voor degradatie door het proteasoom door middel 
van toevoegen van een ubiquitine-molecuul aan het te degraderen eiwit. Recente 
observaties in kritisch zieke beademde patiënten bevestigde een belangrijke rol van 
de ubiquitine-proteasoom cascade. In deze studie werd in diafragma biopten van 
deze patiënten een verhoogde activiteit van de ubiquitine-proteasoom cascade 
gevonden. Dit ging gepaard met tekenen van diafragma atrofie en verminderde 
kracht- generatie van diafragma vezels. In dit proefschrift wordt aangetoond 
dat circulerende liganden in het plasma van patiënten met een septische shock 
spieratrofie in gekweekte spiervezels (myotubes) kan induceren (hoofdstuk 3). 
Het verlies van contractiel eiwit gaat gepaard met een verhoogde expressie van 
de E3 ligases MuRF-1 en MAFbx en verhoogde concentratie van geubiquitineerd 
myosine. Activering van MuRF-1 kan worden gereguleerd door transcriptiefactor 
NFκB. Inderdaad induceert plasma van patiënten met een septische shock een 
verhoogde activiteit van NFκB in de myotubes (hoofdstuk 3). Conclusie: plasma 
van patiënten met een septische shock induceert spieratrofie in myotubes door 
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activering van de ubiquitine-proteasoom cascade alsook inflammatoire routes 
(hoofdstuk 3). Dit is een belangrijke bevinding omdat het voor het eerst laat 
zien dat liganden in plasma van patiënten met een septische shock atrofische 
cascades kan activeren in “gezonde” spiervezels. Op basis van deze data kan 
worden verondersteld dat circulerende factoren in het plasma van patiënten met 
septische shock atrofie induceert van perifere spieren en ademspieren. Verder 
onderzoek moet zich richten op identificatie van deze specifieke factoren en op 
strategieën die betreffende factoren inactiveren.
De rol van TLR4
Toll-like receptoren (TLR’s) zijn essentieel in het afweersysteem vanwege de 
herkenning van specifieke liganden, zoals microbiële producten, maar ook 
van eiwitten die vrijkomen uit weefsel dat beschadigd is. De expressie van het 
subtype TLR4 is aangetoond in myotubes en diafragma weefsel. In dit proefschrift 
is de rol van TLR4 op de ontwikkeling van beademings-geïnduceerde diafragma 
atrofie bestudeerd (hoofdstuk 4). Bij muizen met TLR4 deficiëntie is de ernst van 
diafragma atrofie geïnduceerd door 8 uur gecontroleerde beademing minder 
ernstig dan in TLR-4 sufficiënte muizen. Eerder werd reeds aangetoond dat 
activatie van TLR4 in het diafragma door de specifieke ligand lipopolysaccharide 
(LPS), de expressie van pro-inflammatoire cytokines verhoogt en de diafragma 
functie vermindert. Activatie van de TLR4 receptor kan resulteren in activering 
van zowel de ubiquitine-proteasoom cascade als ook de lysosomale-autofagie 
cascade in skeletspieren. In dit proefschrift is geen verschil gevonden in activatie 
van de ubiquitine-proteasoom tussen beademde wild-type dieren en TLR4 
deficiënte dieren. Dat geeft aan dat in dit model de ubiquitine-proteasoom 
cascade geen belangrijke rol speelt bij de ontwikkeling van atrofie. Dit is deels, 
in tegenstelling tot voorgaande studies die wel een associatie tussen beademing 
en het ontstaan van diafragma atrofie toonden, het gevolg van de activering van 
de ubiquitine-proteasoom cascade bij patiënten als ook bij dieren. Een rol van 
de ubiquitine-proteasoom cascade tijdens beademings-geïnduceerde diafragma 
atrofie - in het bijzonder na langere duur van beademing - kunnen we daarom 
niet uitsluiten. In dit proefschrift beschrijven we dat de autofagie marker LC3B-II 
is verhoogd in beademde wild-type dieren, maar niet in TLR4 deficiënte dieren 
(hoofdstuk 4). Derhalve suggereren deze bevindingen dat het verlies van contractiel 
eiwit via de TLR4 het gevolg is van activering van de lysosomale autofagie route. 
Deze data worden ondersteund door eerder werk van Doyle, waaruit blijkt dat 
de TLR4 agonist LPS, lysosomale autofagie in myotubes induceert. Ook werd in 
beademde patiënten activering van de lysosomale autofagie route, met daarop 
volgend diafragma atrofie, gevonden. Concluderend kunnen we stellen, dat 
beademing verlies van contractiele eiwitten kan induceren door activering van 
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TLR4. Het is interessant dat TLR4 liganden autofagie kan induceren in de spier. 
Dit proefschrift geeft dan ook een rationale om verder te onderzoeken of het 
blokkeren van de TLR4 route bij de beademde patiënt ademspierzwakte kan 
verminderen. 
Diafragma functie en beademing
Het is algemeen geaccepteerd dat beademing het kracht genererende-vermogen 
verminderd van het diafragma in diermodellen en bij mensen. Vermindering van 
het kracht genererend vermogen kan theoretisch het resultaat zijn van ofwel 
verlies van contractiel eiwit of disfunctioneel contractiel eiwit. Hoewel atrofie is 
aangetoond in het diafragma van beademde dieren, is de rol van disfunctioneel 
contractiel eiwit grotendeels onbekend. Dit proefschrift beschrijft studies welke 
de rol van de kracht genererende capaciteit in gepermeabiliseerde diafragma 
vezels onderzoekt (hoofdstuk 2). Gepermeabiliseerde vezels zijn een uitstekend 
model om contractiel eiwit functie in vitro te bestuderen, aangezien de activering 
niet afhankelijk is van membraankenmerken of calciumhuishouding. Wij 
ontdekten dat beademing de kracht generatie verminderde in diafragma vezels 
in proportie tot de vermindering in vezeloppervlakte (“cross sectional area”) 
(hoofdstuk 2). Dat geeft aan dat het resterend contractiel eiwit een normale 
kracht genererende capaciteit heeft. Dit is duidelijk in contrast met andere 
studies die melden dat er vermindering is van kracht genererende capaciteit van 
spiervezels, ook na correctie voor spiervezel oppervlakte. Bijvoorbeeld in een 
recente studie bij een heterogene groep van kritisch zieke patiënten bleek dat 
krachtafname van diafragma vezels niet alleen werd veroorzaakt door atrofie, 
maar dat deze ook het gevolg is van disfunctie van resterend contractiel eiwit. 
Hierbij moet wel worden opgemerkt dat bij kritisch zieke patiënten verschillende 
co-factoren een rol kunnen spelen naast beademing, waaronder toediening van 
bepaalde geneesmiddelen en infecties. Onlangs is aangetoond dat de “calcium 
sensitizer” levosimendan de ademspierfunctie in gezonde vrijwilligers verbetert. 
Bovendien is zeer recentelijk aangetoond dat de troponine activator CK-2066260 
de kracht verbetert in spiervezels van beademde IC-patiënten. Concluderend 
kunnen we stellen, dat dit proefschrift duidelijk aantoont dat beademing verlies 
van contractiel eiwit in de ademhalingsspieren veroorzaakt, hetgeen resulteert in 
een vermindering van kracht-genererend vermogen van de spier. In tegenstelling 
tot studies bij patiënten hebben we geen bewijs voor disfunctionerend contractiel 
eiwit gevonden. Echter, in de kritisch zieke patiënt kunnen andere factoren, zoals 
bijvoorbeeld sepsis en geneesmiddelen, de functie van  de resterende contractiele 
eiwitten aantasten. Daarom is verder onderzoek nodig naar mogelijke strategieën 
om ademspierzwakte tegen te gaan bij de IC patiënt. Deze interventies moeten 
niet alleen gericht zijn op vermindering van atrofische reacties, maar ook op 
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verbetering van contractiel eiwit functie. Recente en lopende onderzoeken met 
een calcium sensitizer of troponine activator zijn daarom van belang.
 
De rol van Hypercapnie
Bij ernstig zieke patiënten kan hypercapnische acidose ontstaan als gevolg van long 
protectieve beademing die gekenmerkt wordt door gebruik van lage teugvolumes. 
In dit proefschrift onderzochten we de effecten van hypercapnische acidose 
op de ademspieren (hoofdstuk 5). We vonden dat hypercapnie beschermende 
effecten heeft op het diafragma tijdens beademing, met name behoud van de 
myosine concentratie en daarmee remmen van de ontwikkeling van atrofie. 
Tot onze verrassing was er geen beschermend effect van hypercapnie op de 
contractiliteit van de ademspieren. Eerdere studies toonden aan dat beademing 
onder hypercapnische omstandigheden beschermt tegen het ontwikkelen van 
ademspierzwakte. De resultaten van het onderzoek, zoals beschreven in dit 
proefschrift, tonen aan dat bij hypercapnisch beademde dieren contractiel eiwit 
disfunctioneel is als gevolg van posttranslationele modificatie van betreffende 
eiwitten. Inderdaad kan het antioxidant dithiotreitol de diafragma functie herstellen 
in vezels van hypercapnisch beademde dieren. Dit geeft aan dat oxidatieve 
modificatie van contractiel eiwit een belangrijke rol speelt tijdens beademing 
onder hypercapnische omstandigheden. Inderdaad is eerder aangetoond dat CO2 
vorming van oxidanten kan verhogen in het diafragma. Onze resultaten tonen 
aan dat verdere studies zich moeten richten op het gecombineerde effect van 
hypercapnie en antioxidanten op spierfunctie tijdens beademing.
Passieve kracht van het diafragma
Passieve elastische eigenschappen zijn essentieel voor structurele stabiliteit en 
optimale actieve functie van spiervezels. Titine is het belangrijkste eiwit dat passieve 
elastische eigenschappen in skeletspiervezels bepaalt. Beademing vermindert 
de passieve kracht eigenschappen van diafragma vezels (hoofdstuk 2). Dit ging 
overigens niet gepaard met een afname van de titine concentratie in diafragma 
vezels. Onder bepaalde omstandigheden kunnen post-translationele modificaties 
ontstaan van het PEVK segment van het titine molecuul, die invloed hebben op 
de passief elastische eigenschappen. Inderdaad vonden we dat de effecten van 
beademing op passieve kracht kon worden nagebootst door defosforylering van 
titine. In de studie in dit proefschrift werd defosforylering geïnduceerd door 
incubatie van diafragma vezels met het enzym fosfatase-1 (hoofdstuk 2). Hooijman 
heeft eerder aangetoond dat actieve spierkracht is verminderd in diafragma 
vezels van kritische zieke patiënten. Het zou interessant zijn om te onderzoeken 
of suboptimale spiervezel stabiliteit (door veranderingen in eigenschappen van 
titine) een rol speelt in dit proces. Daarvoor moet de fosforylering status van 
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titine in diafragma van spierbiopten van ernstig zieke patiënten nader worden 
onderzocht. Indien titine’s fosforyleringsstatus inderdaad verhoogd is bij de 
kritisch zieke patiënt en daarmee bijdraagt  aan ademspierdisfunctie, zou dit 
verdere richting geven hoe ademspierzwakte te verminderen of te voorkomen is 
bij onze patiënten.
Inflammatoire routes en ademhalingsspierzwakte 
Eerdere studies toonden aan dat inflammatoire reacties een rol kunnen spelen 
bij de ontwikkeling van ademspierzwakte. In dit proefschrift laten we zien dat 
de concentratie van IL-6 verhoogd is in het plasma van patiënten met een 
septische shock (hoofdstuk 3). Bovendien was dit significant geassocieerd met 
de ernst van verlies van contractiel eiwit in myotubes. Belangrijk was dat de 
toevoeging van een IL-6 antilichaam verlies van myosine vermindert in myotubes 
welke blootgesteld waren aan plasma van septische patiënten. Deze resultaten 
wijzen op een belangrijke rol voor IL-6 bij het induceren van skeletspier atrofie 
tijdens een septische shock (hoofdstuk 3). Wanneer echter IL-6 werd toegevoegd 
aan plasma van gezonde personen, gaf dit geen verlies van contractiel eiwit in 
myotubes. Ofschoon IL-6 een belangrijke rol speelt bij de atrofische reacties, 
zijn andere moleculen nodig voor het ontstaan van atrofie. De belangrijke rol 
van IL-6 in skeletspieratrofie wordt ondersteund door het feit dat we verhoogde 
concentraties van IL-6 hebben gevonden in het diafragma van beademde dieren, 
die atrofie ontwikkelen (hoofdstuk 4 en 5). Verdere ondersteuning voor de rol 
van IL-6 is dat de verminderde atrofische response in beademde TLR4 deficiënte 
dieren gepaard gaat met een afname van de concentratie van IL-6 in het 
diafragma van deze dieren. Deze data (hoofdstuk 3, 4 en 5) worden ondersteund 
door eerdere studies waaruit bleek dat IL-6 een atrofische reactie in skeletspieren 
kan opwekken. Het is belangrijk dat andere factoren in plasma geïdentificeerd 
worden die een rol spelen bij de ontwikkeling van atrofie (hoofdstuk 3). Zoals 
eerder genoemd, kan LPS de TLR4 activeren. In dit proefschrift laten we zien dat 
het activeren van TLR4 leidt tot een atrofische respons in het diafragma (hoofdstuk 
4). Het is aannemelijk dat bij ernstig zieke patiënten met een septische shock, 
circulerende LPS liganden gelijktijdig met IL-6 een atrofisch reactie opwekt in 
skeletspieren. Concluderend kan gesteld worden dat, door het verminderen van 
een inflammatoire reactie door TLR4 deficiëntie of hypercapnie, dit bescherming 
kan bieden tegen diafragma atrofie geïnduceerd door beademing (hoofdstuk 4 en 
5). Deze resultaten ondersteunen het concept dat aanwezigheid van cytokines in 
het diafragma tijdens beademing, geassocieerd worden met verlies van contractiel 
eiwit in het diafragma. Daarom is verder onderzoek nodig om het effect van 
modulatie van specifieke stappen in inflammatoire cascades, zoals IL-6 en TLR4, 
te onderzoeken op de ontwikkeling van atrofie en zwakte in ademspieren van 
beademde IC patiënten.
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Mechanismen en therapeutische toepasbaarheid van interventies
Levosimendan
Ademspierzwakte is een klinisch relevant probleem voor de kritisch zieke patiënt. 
Toch is er geen adequate therapeutische interventie momenteel beschikbaar om 
de ademspierfunctie te verbeteren (beschreven in hoofdstuk 7). Eerdere studies 
in inflammatoire cellen suggereren dat levosimendan naast de bekende inotrope 
effecten ook inflammatie en oxidatieve stress kan moduleren. In dit proefschrift 
laten we zien dat toediening van levosimendan in beademde endotoxemische 
dieren leidt tot vermindering van genitrosyleerde eiwitten en markers van 
oxidatieve stress in het diafragma (hoofdstuk 6). Het is bekend dat zowel 
oxidatieve stress als nitrosatieve stress mogelijk een rol speelt bij de afname in 
diafragma functie tijdens beademing en/of experimentele sepsis. Vanwege de 
effecten van levosimendan op oxidatieve en nitrosatieve stress zou dit middel een 
beschermend effect kunnen hebben op het diafragma onder bepaalde condities 
(d.w.z. de aanwezigheid van inflammatie). De resultaten in dit proefschrift 
suggereren inderdaad dat levosimendan nitrosatieve stress tijdens beademing 
vermindert. Daarmee tonen wij aan dat de positieve effecten van levosimendan 
op ademspierfunctie niet alleen gemedieerd zijn via bekende calcium sensitizing, 
maar ook door modulatie van andere moleculaire pathways. In de toekomst 
moet het effect van levosimendan worden onderzocht op diafragmafunctie bij de 
beademde ernstig zieke patiënt met sepsis.
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Tijdens mijn onderzoeksstage in het kader van mijn opleiding geneeskunde kwam 
ik voor het eerst in aanraking met de “onderzoekswereld”. Door het dynamische 
karakter van onderzoek doen, alsook de link van het lab werk met de kliniek, 
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Dr. Heunks (co-promotor), Leo, het is een enorm voorrecht om jou als co-promotor 
te mogen hebben. Je bent als een mentor voor mij opgetreden om mij op zowel 
wetenschappelijk als klinisch vlak te ontwikkelen. Jouw oneindige energie in onze 
wetenschappelijke discussies brachten altijd voor mij nieuwe stof om weer verder 
aan te werken in de juiste richting. Of het nou ‘s ochtends vroeg of laat in de avond 
was, altijd stond jij klaar voor een overleg met mij, om het onderzoek verder in de 
juiste banen te leiden. Jouw besmettelijke enthousiasme voor het bedrijven van 
wetenschap heeft mij enorm geholpen om dit proefschrift tot een goed eind te 
brengen en heeft mij geleerd hoe interessant het is om onderzoek te verrichten.
Dr. van Hees (co-promotor), Jeroen, ook de begeleiding van jouw kant was van 
onschatbare waarde voor het tot stand komen van dit proefschrift. De levendige 
discussies die we (meestal) op wetenschappelijk vlak hebben gevoerd hebben mij 
hierbij ontzettend geholpen. Jouw kennis en kunde in het spierfysiologie-onder-
zoek hebben mij enorm geholpen om mij als ‘clinician’ ook verder wetenschappelijk 
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thuishaven alsook mijn flex plek op jouw werkkamer waarvoor heel veel dank.
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gewerkt hebben. Ik ben jullie dan ook zeer erkentelijk voor de fijne samenwerking, 
maar ook voor de gezellige gespreken aan de koffietafel in het lab. Beste Gilberto, 
met veel doorzettingsvermogen had jij in korte tijd, onder begeleiding van Jeroen, 
het single fiber model in je vingers wat een ongekende prestatie is. Ik ben je dan 
ook zeer dankbaar voor je inzet en toewijding. Beste Theo, jouw expertise in de 
histologie en jouw kunde om deze vast te leggen op de gevoelige plaat, bracht 
letterlijk het onderzoek weer verder in beeld. Maar ook jouw humor tijdens 
besprekingen en op congressen brachten vaak even een “balance” in het serieuze 
onderzoeksland. Ook ben ik je zeer dankbaar voor je hulp bij het opmaken van de 
layout van mijn proefschrift. Verder wil ik graag Joris en Wim Kleinhans bedanken 
voor jullie inzet en de technische expertise die jullie hadden bij het opzetten van 
de verschillende proefopstellingen en de daarbij behorende apparatuur. 
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als ook het mogen delen van een kamer met enkele van jullie. Jonne, als beide 
promovendi in dezelfde onderzoeksgroep hebben we vele van onze onderzoeken 
met elkander mogen delen, waarbij ik veel van jouw klinisch onderzoek heb 
mogen leren. Matthijs, van jouw energie en grote kennis in de wetenschap heb 
ik veel geleerd, waarvoor ik je zeer dankbaar ben. Beste Michiel, in mijn derde 
studiejaar geneeskunde mocht ik een dag met je meelopen op de OK en ik was 
meteen verkocht voor het razend interessante vakgebied anesthesiologie. Maar 
ook jouw kennis en kunde in de wetenschap waren zeer besmettelijk en hebben 
een belangrijke stempel gedrukt op zowel mijn klinisch doorlopen traject als ook 
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voor de steun in de afgelopen jaren.
Lieve Claire, eerder ging jij mij voor mit deiner Promotion in Zürich. Jij weet dus 
als geen ander hoe het is om aan een dissertatie te werken en jouw steun is dan 
ook van onschatbare waarde geweest. Mede dankzij jouw steun en geduld, als ik 
bijvoorbeeld nog even wat langer moest werken aan een deel van deze dissertatie, 
heb ik dit proefschrift tot een goed eind kunnen volbrengen. Ik prijs mij dan ook 
zeer gelukkig om jou naast mijn zijde te mogen hebben.
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